Sex,Race/Ethnicity,Age,Rate Type,Year,"Age-adjusted (AA) Rate per 100,000",AA Rate Lower Confidence Interval,AA Rate Upper Confidence Interval,Trend Year Range,Annual Percent Change (APC) (%),APC Lower Confidence Interval (%),APC Upper Confidence Interval (%),Trend Direction,Type
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2000,19.4146,19.1435,19.6887,2000-2008,0.7132,0.3275,1.1003,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2001,19.5918,19.3213,19.8651,2008-2016,-0.8454,-1.2019,-0.4877,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2002,19.6621,19.393,19.9339,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2003,19.9661,19.6967,20.2382,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2004,20.2815,20.0116,20.5542,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2005,20.2834,20.0123,20.5573,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2006,20.2987,20.0315,20.5685,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2007,20.4323,20.1663,20.7009,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2008,20.5247,20.2599,20.7922,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2009,20.5001,20.2371,20.7657,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2010,20.3215,20.0619,20.5837,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2011,19.8279,19.5734,20.0848,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2012,19.9412,19.6886,20.1963,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2013,19.6983,19.4494,19.9496,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2014,20.0064,19.7578,20.2574,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2015,19.6693,19.4249,19.916,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Observed Rates,2016,18.8922,18.6546,19.1321,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2000,19.4146,19.1435,19.6887,2000-2008,0.7051,0.3609,1.0506,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2001,19.5918,19.3213,19.8651,2008-2016,-0.5421,-0.8613,-0.2219,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2002,19.6621,19.393,19.9339,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2003,19.9661,19.6967,20.2382,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2004,20.2815,20.0116,20.5542,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2005,20.2834,20.0123,20.5573,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2006,20.2987,20.0315,20.5685,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2007,20.4323,20.1663,20.7009,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2008,20.5638,20.2984,20.8318,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2009,20.5779,20.3139,20.8445,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2010,20.4369,20.1758,20.7006,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2011,19.98,19.7236,20.2389,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2012,20.1322,19.8771,20.3898,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2013,19.923,19.6713,20.1772,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2014,20.3103,20.0579,20.5651,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2015,20.0653,19.816,20.317,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2016,19.478,19.2331,19.7253,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2000,5.4022,5.2391,5.5691,2000-2016,-0.5299,-0.7283,-0.3311,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2001,5.3176,5.1565,5.4823,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2002,5.2017,5.0429,5.3643,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2003,5.176,5.0178,5.3378,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2004,5.2118,5.0531,5.3742,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2005,5.2375,5.0767,5.4021,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2006,5.1117,4.9543,5.2729,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2007,5.1766,5.0177,5.3392,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2008,5.2952,5.1341,5.46,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2009,5.3543,5.1919,5.5204,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2010,5.0884,4.9298,5.2507,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2011,4.9607,4.8037,5.1215,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2012,4.9979,4.8401,5.1595,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2013,5.0052,4.8471,5.1671,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2014,5.0123,4.8534,5.175,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2015,4.864,4.7073,5.0246,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Observed Rates,2016,4.8446,4.6885,5.0047,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,5.4022,5.2391,5.5691,2000-2016,-0.3974,-0.5833,-0.2111,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,5.3176,5.1565,5.4823,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,5.2017,5.0429,5.3643,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,5.176,5.0178,5.3378,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,5.2118,5.0531,5.3742,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,5.2375,5.0767,5.4021,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,5.1117,4.9543,5.2729,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,5.1766,5.0177,5.3392,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,5.3046,5.1433,5.4697,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,5.3734,5.2104,5.5401,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,5.1154,4.9559,5.2786,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,4.997,4.8389,5.159,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,5.043,4.8838,5.2061,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,5.0591,4.8993,5.2227,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,5.0843,4.9231,5.2493,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,4.9563,4.7966,5.1199,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,4.9747,4.8143,5.139,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2000,31.3756,30.4954,32.2748,2000-2002,2.8657,-2.0247,8.0003,Stable,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2001,31.866,30.9936,32.7566,2002-2016,-0.5754,-0.7742,-0.3761,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2002,32.8983,32.0289,33.7853,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2003,32.4761,31.6288,33.3403,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2004,32.747,31.9106,33.5997,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2005,32.3389,31.5135,33.1805,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2006,32.6421,31.8338,33.4656,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2007,32.5948,31.8028,33.4015,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2008,32.2973,31.5205,33.0884,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2009,31.5182,30.763,32.2873,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2010,31.6191,30.8746,32.3771,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2011,30.7372,30.0134,31.4742,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2012,31.6164,30.8857,32.36,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2013,30.7562,30.0398,31.4855,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2014,31.4118,30.6927,32.1435,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2015,30.8813,30.1715,31.6036,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Observed Rates,2016,29.8475,29.1516,30.5558,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,31.3756,30.4954,32.2748,2000-2002,2.503,-1.9095,7.1139,Stable,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,31.866,30.9936,32.7566,2002-2016,-0.3924,-0.5724,-0.2121,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,32.8983,32.0289,33.7853,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,32.4761,31.6288,33.3403,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,32.747,31.9106,33.5997,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,32.3389,31.5135,33.1805,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,32.6421,31.8338,33.4656,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,32.5948,31.8028,33.4015,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,32.3592,31.5809,33.1518,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,31.6389,30.8808,32.4109,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,31.8003,31.0516,32.5626,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,30.9715,30.2422,31.714,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,31.9216,31.1839,32.6723,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,31.1092,30.3845,31.8468,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,31.8907,31.1607,32.6336,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,31.5001,30.776,32.2368,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,30.7896,30.0716,31.5202,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2000,85.4538,83.8355,87.0955,2000-2008,1.2867,0.7796,1.7963,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2001,86.7582,85.1339,88.4057,2008-2016,-0.8436,-1.3009,-0.3843,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2002,86.7526,85.1338,88.3945,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2003,89.8065,88.166,91.4698,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2004,91.7758,90.123,93.4513,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2005,92.1279,90.462,93.8167,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2006,92.6091,90.9605,94.28,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2007,93.3508,91.7075,95.016,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2008,93.7564,92.1212,95.4133,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2009,94.1477,92.5212,95.7955,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2010,94.137,92.5253,95.7697,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2011,92.009,90.431,93.6075,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2012,91.6496,90.0966,93.2224,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2013,90.7061,89.183,92.2486,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2014,92.3256,90.8099,93.8601,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2015,91.1366,89.6508,92.6406,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Observed Rates,2016,86.3257,84.8988,87.7705,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,85.4538,83.8355,87.0955,2000-2008,1.2765,0.8208,1.7343,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,86.7582,85.1339,88.4057,2008-2016,-0.5307,-0.9429,-0.1168,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,86.7526,85.1338,88.3945,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,89.8065,88.166,91.4698,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,91.7758,90.123,93.4513,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,92.1279,90.462,93.8167,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,92.6091,90.9605,94.28,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,93.3508,91.7075,95.016,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,93.938,92.2996,95.598,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,94.5103,92.8775,96.1645,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,94.681,93.0599,96.3231,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,92.7264,91.1361,94.3374,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,92.5402,90.9722,94.1283,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,91.7571,90.2163,93.3174,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,93.7496,92.2105,95.3076,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,93.0075,91.4912,94.5423,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,89.0984,87.6255,90.5895,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2000,0.8505,0.7356,0.9782,2000-2016,1.9351,1.1001,2.777,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2001,0.9995,0.8747,1.137,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2002,0.9003,0.7821,1.0314,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2003,0.7684,0.6593,0.8904,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2004,0.9662,0.8434,1.1018,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2005,0.9787,0.8532,1.1174,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2006,0.873,0.7552,1.0038,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2007,1.0125,0.885,1.1532,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2008,1.0231,0.8951,1.1643,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2009,0.9428,0.8199,1.079,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2010,1.0948,0.9623,1.2405,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2011,0.9114,0.7906,1.0454,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2012,1.1335,0.9984,1.2818,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2013,1.1079,0.9743,1.2547,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2014,1.2049,1.0652,1.3578,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2015,1.1115,0.9771,1.259,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Observed Rates,2016,1.1994,1.0596,1.3525,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,0.8505,0.7356,0.9782,2000-2016,2.0762,1.2311,2.9284,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,0.9995,0.8747,1.137,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,0.9003,0.7821,1.0314,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,0.7684,0.6593,0.8904,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,0.9662,0.8434,1.1018,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,0.9787,0.8532,1.1174,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,0.873,0.7552,1.0038,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,1.0125,0.885,1.1532,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,1.025,0.8967,1.1663,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,0.9462,0.8228,1.0829,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,1.1008,0.9675,1.2473,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,0.9179,0.7962,1.0527,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,1.1435,1.0072,1.293,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,1.1198,0.9847,1.2681,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,1.2224,1.0807,1.3775,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,1.1321,0.9953,1.2823,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,1.2305,1.0871,1.3875,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2000,4.4592,4.2518,4.6741,2000-2016,-0.3059,-0.6199,0.0091,Stable,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2001,4.4613,4.2534,4.6766,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2002,4.2481,4.0445,4.4592,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2003,4.3074,4.1016,4.5207,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2004,4.1665,3.9631,4.3775,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2005,4.3215,4.1119,4.539,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2006,4.0784,3.8765,4.2879,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2007,4.122,3.9191,4.3327,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2008,4.3581,4.1494,4.5746,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2009,4.5385,4.3249,4.7597,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2010,4.1299,3.9264,4.3412,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2011,4.203,3.9969,4.4167,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2012,4.218,4.0123,4.4314,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2013,4.1465,3.9437,4.3569,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2014,4.179,3.9759,4.3897,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2015,4.0543,3.8554,4.2607,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Observed Rates,2016,4.2617,4.0589,4.472,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,4.4592,4.2518,4.6741,2000-2016,-0.1711,-0.4967,0.1556,Stable,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,4.4613,4.2534,4.6766,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,4.2481,4.0445,4.4592,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,4.3074,4.1016,4.5207,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,4.1665,3.9631,4.3775,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,4.3215,4.1119,4.539,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,4.0784,3.8765,4.2879,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,4.122,3.9191,4.3327,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,4.3659,4.1567,4.5827,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,4.5546,4.3402,4.7766,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,4.1519,3.9473,4.3643,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,4.2332,4.0257,4.4485,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,4.2564,4.0488,4.4717,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,4.1913,3.9863,4.4039,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,4.2398,4.0337,4.4535,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,4.1314,3.9288,4.3417,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,4.3757,4.1674,4.5915,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2000,22.5346,22.0111,23.0674,2000-2006,0.3013,-0.3927,1.0001,Stable,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2001,22.4673,21.9521,22.9916,2006-2016,-0.9733,-1.2694,-0.6763,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2002,23.02,22.5068,23.5419,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2003,22.7742,22.2716,23.2854,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2004,23.0181,22.5193,23.5252,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2005,22.688,22.1937,23.1906,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2006,22.8967,22.4101,23.3913,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2007,22.8783,22.3975,23.3669,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2008,22.7306,22.2552,23.2136,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2009,22.333,21.8659,22.8077,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2010,22.1195,21.6593,22.5872,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2011,21.4246,20.9755,21.8811,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2012,21.7726,21.3211,22.2313,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2013,21.4671,21.0185,21.923,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2014,21.701,21.2508,22.1584,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2015,21.2979,20.8523,21.7508,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Observed Rates,2016,20.4372,20.0014,20.8803,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,22.5346,22.0111,23.0674,2000-2006,0.2389,-0.4124,0.8945,Stable,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,22.4673,21.9521,22.9916,2006-2016,-0.7299,-1.0086,-0.4504,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,23.02,22.5068,23.5419,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,22.7742,22.2716,23.2854,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,23.0181,22.5193,23.5252,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,22.688,22.1937,23.1906,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,22.8967,22.4101,23.3913,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,22.8783,22.3975,23.3669,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,22.7733,22.297,23.2572,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,22.4168,21.9479,22.8933,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,22.2432,21.7804,22.7135,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,21.5868,21.1343,22.0467,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,21.9787,21.5229,22.4418,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,21.7089,21.2552,22.1699,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,22.0253,21.5685,22.4895,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,21.7182,21.2639,22.18,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,21.0567,20.6079,21.513,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2000,71.428,69.3828,73.5182,2000-2008,0.8728,0.3192,1.4295,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2001,70.9924,68.9514,73.0786,2008-2016,-0.7636,-1.2493,-0.2754,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2002,72.6327,70.5661,74.7443,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2003,72.1895,70.1315,74.2925,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2004,73.004,70.9373,75.1155,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2005,74.7974,72.6877,76.9526,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2006,75.3567,73.2691,77.4886,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2007,74.8461,72.7913,76.9442,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2008,75.4676,73.4354,77.5416,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2009,74.9269,72.9339,76.9605,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2010,75.9168,73.9392,77.9337,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2011,73.6949,71.779,75.6489,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2012,74.3585,72.4823,76.2708,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2013,72.8475,71.0393,74.6899,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2014,73.5914,71.8159,75.3996,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2015,73.8086,72.0647,75.5839,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Observed Rates,2016,69.3732,67.7132,71.0635,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,71.428,69.3828,73.5182,2000-2008,0.8615,0.365,1.3604,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,70.9924,68.9514,73.0786,2008-2016,-0.4481,-0.8852,-0.0092,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,72.6327,70.5661,74.7443,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,72.1895,70.1315,74.2925,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,73.004,70.9373,75.1155,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,74.7974,72.6877,76.9526,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,75.3567,73.2691,77.4886,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,74.8461,72.7913,76.9442,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,75.6146,73.5784,77.6926,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,75.2184,73.2176,77.2598,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,76.3569,74.3678,78.3855,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,74.2732,72.3422,76.2424,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,75.0816,73.1871,77.0123,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,73.6991,71.8698,75.5629,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,74.7335,72.9304,76.5696,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,75.3223,73.5426,77.1338,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,71.5916,69.8784,73.3357,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2000,100.801,98.2647,103.3863,2000-2008,1.5918,0.9253,2.2627,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2001,104.0093,101.4523,106.6145,2008-2016,-0.9055,-1.5174,-0.2898,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2002,102.203,99.6859,104.7675,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2003,109.0833,106.4973,111.7161,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2004,112.3163,109.7043,114.9747,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2005,111.0913,108.4843,113.7449,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2006,111.487,108.9067,114.1128,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2007,113.5989,111.0019,116.241,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2008,113.7684,111.1721,116.4097,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2009,115.1794,112.5705,117.8331,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2010,114.074,111.4911,116.7012,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2011,112.0486,109.5014,114.6396,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2012,110.5697,108.0545,113.1283,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2013,110.2474,107.7521,112.7854,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2014,112.8249,110.3214,115.3705,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2015,110.0971,107.646,112.5896,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Observed Rates,2016,104.8754,102.5088,107.2825,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,100.801,98.2647,103.3863,2000-2007,1.8202,1.0381,2.6083,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,104.0093,101.4523,106.6145,2007-2016,-0.4307,-0.921,0.0619,Stable,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,102.203,99.6859,104.7675,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,109.0833,106.4973,111.7161,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,112.3163,109.7043,114.9747,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,111.0913,108.4843,113.7449,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,111.487,108.9067,114.1128,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,113.5989,111.0019,116.241,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,113.9877,111.3864,116.6341,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,115.6199,113.001,118.2837,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,114.7315,112.1337,117.3738,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,112.9184,110.3514,115.5294,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,111.6438,109.1041,114.2271,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,111.5164,108.9924,114.0835,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,114.5573,112.0152,117.1418,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,112.3588,109.8572,114.9023,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,108.2545,105.8115,110.7389,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2000,1.1126,0.9972,1.2378,2000-2016,1.49,0.8202,2.1641,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2001,1.1873,1.0683,1.3159,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2002,1.1652,1.0475,1.2926,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2003,1.0349,0.9243,1.1552,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2004,1.1531,1.0365,1.2792,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2005,1.2468,1.1243,1.379,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2006,1.1588,1.0421,1.2851,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2007,1.2475,1.1261,1.3783,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2008,1.1941,1.0755,1.3222,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2009,1.2194,1.0998,1.3486,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2010,1.24,1.1188,1.3707,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2011,1.1003,0.986,1.2242,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2012,1.3612,1.2335,1.4986,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2013,1.2971,1.1721,1.4317,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2014,1.4975,1.3627,1.642,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2015,1.3579,1.2295,1.4961,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Observed Rates,2016,1.4116,1.2804,1.5526,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,1.1126,0.9972,1.2378,2000-2016,1.6321,0.9488,2.3199,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,1.1873,1.0683,1.3159,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,1.1652,1.0475,1.2926,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,1.0349,0.9243,1.1552,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,1.1531,1.0365,1.2792,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,1.2468,1.1243,1.379,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,1.1588,1.0421,1.2851,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,1.2475,1.1261,1.3783,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,1.1962,1.0774,1.3245,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,1.2237,1.1036,1.3534,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,1.2467,1.1249,1.3782,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,1.1082,0.9931,1.233,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,1.3736,1.2447,1.5122,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,1.3112,1.1849,1.4473,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,1.5191,1.3824,1.6657,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,1.3832,1.2523,1.5239,,,,,,Non-Hodgkin Lymphoma
Both Sexes,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,1.4494,1.3147,1.5941,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2000,11.706,8.3046,15.9196,2000-2016,-0.4959,-1.9148,0.9436,Stable,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2001,13.4871,9.9422,17.7917,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2002,9.1944,6.4979,12.579,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2003,13.3925,9.8265,17.7123,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2004,11.1287,8.0727,14.8736,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2005,13.7766,10.4481,17.7542,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2006,14.5055,11.0815,18.5696,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2007,10.0259,7.3309,13.3186,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2008,12.8096,9.795,16.3944,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2009,14.3984,11.1567,18.2092,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2010,13.3756,10.5237,16.7218,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2011,12.9454,10.0808,16.315,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2012,11.9779,9.2146,15.2455,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2013,10.9132,8.4147,13.8758,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2014,9.8152,7.5518,12.5124,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2015,11.3348,8.7762,14.3513,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2016,12.2892,9.7589,15.2392,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2000,11.706,8.3046,15.9196,2000-2016,0.1149,-1.3115,1.562,Stable,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2001,13.4871,9.9422,17.7917,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2002,9.1944,6.4979,12.579,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2003,13.3925,9.8265,17.7123,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2004,11.1287,8.0727,14.8736,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2005,13.7766,10.4481,17.7542,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2006,14.5055,11.0815,18.5696,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2007,10.0259,7.3309,13.3186,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2008,12.8942,9.8597,16.5015,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2009,14.5894,11.3046,18.4484,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2010,13.6426,10.7338,17.0521,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2011,13.2912,10.35,16.7462,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2012,12.3791,9.5233,15.7507,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2013,11.3533,8.754,14.4289,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2014,10.3182,7.9389,13.1455,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2015,12.1724,9.4248,15.4008,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2016,13.8701,11.0144,17.1812,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2000,3.4802,2.0452,5.5086,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2003,3.2839,1.8765,5.2789,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2005,3.8175,2.3733,5.7897,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2006,3.5819,2.1784,5.5136,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2008,3.401,2.0386,5.2806,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2009,2.7927,1.6351,4.4286,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2010,3.0086,1.773,4.7329,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2011,3.2887,1.9864,5.0791,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2013,3.5777,2.1993,5.4482,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2014,2.515,1.4471,4.0416,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,3.4802,2.0452,5.5086,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,3.2839,1.8765,5.2789,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,3.8175,2.3733,5.7897,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,3.5819,2.1784,5.5136,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,3.4235,2.0521,5.3141,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,2.8298,1.6568,4.4846,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,3.0687,1.8084,4.8234,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,3.3766,2.0395,5.2095,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,3.722,2.288,5.6603,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,2.6439,1.5212,4.2383,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2001,31.7007,20.2857,47.1985,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2002,21.6841,12.8398,34.3487,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2004,18.0221,10.2829,29.269,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2005,18.0931,10.5175,28.9859,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2006,23.5101,15.038,35.034,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2007,18.7219,11.4225,28.9234,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2008,18.6415,11.531,28.4896,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2009,20.9415,13.5471,30.9014,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2010,25.6816,17.6751,36.072,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2011,17.9447,11.4962,26.7003,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2012,16.6278,10.5378,24.9567,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2013,14.681,9.0842,22.4519,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2014,16.2277,10.3918,24.165,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2015,16.801,10.8615,24.8114,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2016,23.1651,16.2059,32.1145,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,31.7007,20.2857,47.1985,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,21.6841,12.8398,34.3487,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,18.0221,10.2829,29.269,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,18.0931,10.5175,28.9859,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,23.5101,15.038,35.034,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,18.7219,11.4225,28.9234,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,18.7648,11.6072,28.6695,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,21.2193,13.7268,31.2959,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,26.1943,18.028,36.771,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,18.4239,11.8032,27.385,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,17.1848,10.8908,25.7578,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,15.273,9.4506,23.3162,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,17.0593,10.9244,25.3535,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,18.0425,11.6641,26.5758,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,26.1453,18.2908,36.1332,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2000,56.3511,33.5759,88.6444,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2001,57.9829,35.5706,89.3666,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2003,69.3671,44.7831,102.4885,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2004,50.6891,30.8111,78.6607,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2005,65.6781,43.4606,95.42,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2006,66.3671,43.692,96.5348,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2007,47.2003,29.455,71.8608,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2008,59.7607,39.8783,86.1922,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2009,73.0855,50.7879,101.7568,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2010,58.1322,39.8849,82.0853,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2011,62.3054,43.181,87.0605,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2012,63.053,43.9698,87.573,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2013,48.4432,32.4794,69.5332,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2014,44.0051,29.4788,63.3088,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2015,61.1242,43.4197,83.5585,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2016,58.4405,41.7357,79.5812,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,56.3511,33.5759,88.6444,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,57.9829,35.5706,89.3666,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,69.3671,44.7831,102.4885,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,50.6891,30.8111,78.6607,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,65.6781,43.4606,95.42,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,66.3671,43.692,96.5348,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,47.2003,29.455,71.8608,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,60.1558,40.1419,86.7417,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,74.055,51.4616,103.0699,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,59.2927,40.6812,83.6693,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,63.9694,44.3342,89.3177,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,65.1649,45.4425,90.4266,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,50.3968,33.7892,72.2431,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,46.2603,30.9895,66.4375,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,65.6412,46.6284,89.5854,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,65.9588,47.105,89.575,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2001,18.32,12.2439,26.3076,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2002,14.7973,9.6507,21.7106,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2003,12.8363,8.2108,19.1351,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2004,13.2094,8.5304,19.5133,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2005,12.654,8.1727,18.6919,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2006,16.1139,11.1452,22.5389,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2007,10.5615,6.6879,15.8513,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2008,14.5949,10.0393,20.4995,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2009,13.7631,9.4675,19.3406,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2010,15.5949,11.1349,21.264,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2011,13.3497,9.2246,18.6871,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2012,10.0241,6.5901,14.6352,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2013,12.5013,8.5763,17.6065,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2014,10.1701,6.7908,14.6796,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2015,10.6045,7.1198,15.223,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2016,12.7022,9.0112,17.4605,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,18.32,12.2439,26.3076,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,14.7973,9.6507,21.7106,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,12.8363,8.2108,19.1351,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,13.2094,8.5304,19.5133,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,12.654,8.1727,18.6919,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,16.1139,11.1452,22.5389,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,10.5615,6.6879,15.8513,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,14.6914,10.1057,20.6311,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,13.9457,9.5931,19.5896,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,15.9062,11.3572,21.6777,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,13.7062,9.471,19.1718,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,10.3599,6.8108,15.1068,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,13.0054,8.9221,18.2953,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,10.6912,7.1388,15.4041,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,11.3881,7.646,16.3089,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,14.3363,10.1704,19.6409,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2005,69.6939,41.7771,109.0954,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2008,49.2634,27.9843,80.3775,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2010,65.3557,41.2242,98.3574,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2011,46.481,27.403,73.8812,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2012,42.7921,24.7534,68.8383,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2013,36.9991,20.9727,60.5303,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2014,41.9815,25.0717,65.9773,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2015,38.555,22.641,61.2759,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2016,44.5655,27.3657,68.3419,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,69.6939,41.7771,109.0954,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,49.5891,28.1693,80.877,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,66.6605,42.0472,100.2401,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,47.7223,28.1349,75.7445,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,44.2253,25.5825,71.0151,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,38.4911,21.8184,62.8209,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,44.133,26.3565,69.185,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,41.4041,24.3141,65.5687,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,50.2987,30.8862,76.7624,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2006,96.8467,56.3247,155.3303,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2009,103.0916,63.7564,157.7437,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2011,79.6208,47.1727,125.956,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2012,85.2228,52.0495,131.6464,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2015,85.8199,54.3874,128.764,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2016,73.6228,45.5524,112.6141,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,96.8467,56.3247,155.3303,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,104.4591,64.6021,159.7402,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,81.7472,48.4325,129.1403,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,88.0773,53.7928,135.8462,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,92.1618,58.4065,137.8902,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,83.0942,51.4126,126.449,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2000,13.2202,12.2942,14.1943,2000-2016,-0.0335,-0.3719,0.3061,Stable,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2001,14.3355,13.3993,15.3169,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2002,13.5679,12.6844,14.4943,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2003,13.5049,12.6384,14.4128,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2004,13.4381,12.6004,14.3148,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2005,13.1241,12.319,13.9664,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2006,12.3594,11.5905,13.1642,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2007,13.2282,12.4495,14.0413,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2008,13.9668,13.186,14.7805,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2009,13.9454,13.1771,14.7456,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2010,13.3668,12.6376,14.1263,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2011,13.7749,13.0525,14.5263,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2012,13.4339,12.7345,14.1611,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2013,13.428,12.7453,14.1375,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2014,13.6603,12.9879,14.3584,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2015,13.5822,12.9256,14.2635,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2016,13.0531,12.4272,13.7025,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2000,13.2202,12.2942,14.1943,2000-2016,0.3338,-0.0148,0.6837,Stable,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2001,14.3355,13.3993,15.3169,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2002,13.5679,12.6844,14.4943,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2003,13.5049,12.6384,14.4128,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2004,13.4381,12.6004,14.3148,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2005,13.1241,12.319,13.9664,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2006,12.3594,11.5905,13.1642,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2007,13.2282,12.4495,14.0413,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2008,14.0371,13.2524,14.855,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2009,14.0832,13.3073,14.8913,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2010,13.5722,12.8317,14.3432,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2011,14.0515,13.3146,14.8178,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2012,13.7687,13.0518,14.5139,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2013,13.8396,13.1359,14.5706,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2014,14.1938,13.4949,14.9189,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2015,14.2103,13.5233,14.9227,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2016,13.8456,13.1815,14.5341,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2000,3.424,2.9773,3.9189,2000-2016,0.858,0.0371,1.6857,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2001,3.7937,3.3291,4.3049,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2002,3.2332,2.8122,3.6993,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2003,3.0941,2.6902,3.5417,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2004,3.3837,2.9636,3.8467,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2005,3.4834,3.0598,3.9494,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2006,3.0545,2.6641,3.4861,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2007,3.2311,2.8327,3.6698,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2008,3.6308,3.2149,4.0859,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2009,3.5444,3.1371,3.99,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2010,3.2433,2.8573,3.6672,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2011,3.2382,2.8584,3.6548,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2012,3.7123,3.3078,4.1531,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2013,4.027,3.6077,4.4821,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2014,3.9884,3.5733,4.4387,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2015,3.4445,3.0646,3.8588,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2016,3.842,3.4496,4.2676,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,3.424,2.9773,3.9189,2000-2016,1.1842,0.3295,2.0461,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,3.7937,3.3291,4.3049,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,3.2332,2.8122,3.6993,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,3.0941,2.6902,3.5417,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,3.3837,2.9636,3.8467,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,3.4834,3.0598,3.9494,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,3.0545,2.6641,3.4861,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,3.2311,2.8327,3.6698,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,3.6471,3.2293,4.1041,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,3.5767,3.1657,4.0262,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,3.2886,2.8972,3.7183,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,3.2986,2.9118,3.7228,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,3.7924,3.3791,4.2424,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,4.1326,3.7022,4.5993,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,4.1345,3.7042,4.6008,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,3.5887,3.1929,4.0198,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,4.0563,3.6419,4.505,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2000,18.0351,15.5773,20.7705,2000-2016,-0.0155,-0.643,0.6159,Stable,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2001,20.2668,17.7283,23.0665,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2002,21.869,19.3026,24.6809,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2003,20.507,18.105,23.1389,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2004,20.5803,18.2411,23.1362,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2005,19.8983,17.6541,22.3482,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2006,18.5946,16.4934,20.8892,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2007,19.4711,17.3772,21.7476,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2008,20.3343,18.255,22.5858,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2009,18.9391,16.9834,21.0585,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2010,21.7892,19.7402,23.9934,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2011,22.0861,20.063,24.2584,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2012,19.049,17.204,21.0386,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2013,19.875,18.0127,21.8778,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2014,19.2309,17.4351,21.162,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2015,20.6583,18.8183,22.6301,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2016,19.563,17.7925,21.4626,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,18.0351,15.5773,20.7705,2000-2016,0.3606,-0.2701,0.9952,Stable,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,20.2668,17.7283,23.0665,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,21.869,19.3026,24.6809,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,20.507,18.105,23.1389,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,20.5803,18.2411,23.1362,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,19.8983,17.6541,22.3482,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,18.5946,16.4934,20.8892,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,19.4711,17.3772,21.7476,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,20.4393,18.3493,22.7021,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,19.1311,17.1556,21.2714,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,22.1396,20.0576,24.3783,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,22.5349,20.4706,24.7502,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,19.5408,17.6479,21.5804,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,20.5085,18.5865,22.5738,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,19.9739,18.1085,21.9779,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,21.654,19.725,23.7189,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,20.7631,18.8836,22.7766,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2000,63.5976,57.4679,70.2043,2000-2016,-0.3431,-0.7948,0.1106,Stable,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2001,67.6568,61.5182,74.2439,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2002,62.892,57.16,69.0458,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2003,64.8066,59.0897,70.9269,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2004,62.5323,57.0883,68.3566,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2005,60.2862,55.1033,65.8273,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2006,58.2385,53.2261,63.5954,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2007,63.0615,57.9693,68.4811,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2008,65.5923,60.5143,70.9823,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2009,67.5735,62.5186,72.9271,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2010,61.3375,56.653,66.3053,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2011,64.2437,59.5893,69.1648,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2012,62.4343,57.9648,67.1559,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2013,59.606,55.3567,64.0936,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2014,62.4298,58.225,66.8575,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2015,63.232,59.0993,67.5762,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2016,58.0692,54.2386,62.0985,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,63.5976,57.4679,70.2043,2000-2016,0.0332,-0.4093,0.4776,Stable,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,67.6568,61.5182,74.2439,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,62.892,57.16,69.0458,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,64.8066,59.0897,70.9269,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,62.5323,57.0883,68.3566,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,60.2862,55.1033,65.8273,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,58.2385,53.2261,63.5954,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,63.0615,57.9693,68.4811,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,65.931,60.8268,71.3483,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,68.2517,63.1461,73.6579,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,62.2875,57.5303,67.3309,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,65.5538,60.8043,70.5736,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,64.0415,59.4567,68.8826,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,61.5066,57.1215,66.1348,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,64.9323,60.5582,69.535,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,66.1945,61.8675,70.7394,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,61.6882,57.6174,65.9657,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2001,0.9315,0.5324,1.5102,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2004,0.9248,0.5386,1.4789,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2007,0.9388,0.556,1.4816,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2008,1.1225,0.7033,1.697,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2009,1.2463,0.8064,1.838,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2010,1.1486,0.7357,1.7095,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2012,0.9866,0.6106,1.5084,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2013,0.9374,0.5725,1.4465,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2014,1.3711,0.925,1.957,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2015,1.0849,0.6951,1.6132,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2016,0.8497,0.5115,1.3264,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,0.9315,0.5324,1.5102,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,0.9248,0.5386,1.4789,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,0.9388,0.556,1.4816,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,1.1276,0.7064,1.7043,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,1.2558,0.8125,1.8514,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,1.1657,0.7466,1.734,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,1.0075,0.6235,1.5388,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,0.9617,0.5873,1.4824,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,1.4165,0.9556,2.0199,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,1.1261,0.7214,1.6721,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,0.8961,0.5394,1.3953,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2000,3.0942,2.5228,3.7562,2000-2016,1.724,0.5658,2.8956,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2001,2.9979,2.4459,3.6373,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2002,2.6842,2.1682,3.2858,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2003,2.8428,2.3193,3.4494,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2004,3.0813,2.536,3.7086,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2005,2.8266,2.3085,3.4255,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2006,2.4891,2.0138,3.0425,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2007,2.4799,2.0117,3.0243,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2008,3.1012,2.5851,3.6906,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2009,3.3455,2.8085,3.9552,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2010,2.7215,2.2432,3.2717,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2011,2.9618,2.4671,3.5268,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2012,3.5701,3.0266,4.1829,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2013,3.3511,2.8292,3.9413,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2014,3.6805,3.1325,4.2962,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2015,3.0533,2.564,3.6085,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2016,4.0135,3.4648,4.625,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,3.0942,2.5228,3.7562,2000-2016,2.0568,0.8477,3.2804,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,2.9979,2.4459,3.6373,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,2.6842,2.1682,3.2858,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,2.8428,2.3193,3.4494,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,3.0813,2.536,3.7086,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,2.8266,2.3085,3.4255,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,2.4891,2.0138,3.0425,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,2.4799,2.0117,3.0243,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,3.1142,2.596,3.706,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,3.3765,2.8346,3.9915,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,2.7584,2.2736,3.3156,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,3.0186,2.5144,3.5939,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,3.6466,3.0914,4.272,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,3.439,2.9034,4.0441,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,3.818,3.2495,4.4557,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,3.1839,2.6737,3.7617,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,4.2301,3.6517,4.8734,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2000,12.8112,11.371,14.3827,2000-2016,-0.0202,-0.5505,0.5129,Stable,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2001,14.8732,13.3589,16.5117,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2002,14.9524,13.4693,16.5537,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2003,13.6561,12.2803,15.1438,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2004,13.9589,12.6013,15.4229,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2005,14.2839,12.9372,15.7327,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2006,12.9796,11.7299,14.3266,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2007,13.7406,12.4812,15.0932,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2008,14.263,13.0096,15.6052,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2009,12.996,11.8265,14.2508,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2010,14.4833,13.2752,15.7728,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2011,14.7734,13.5741,16.0513,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2012,13.3713,12.2439,14.5753,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2013,14.8186,13.6385,16.0739,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2014,13.7176,12.6047,14.9033,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2015,14.0618,12.9532,15.2409,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2016,13.5124,12.4365,14.6574,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,12.8112,11.371,14.3827,2000-2016,0.3396,-0.1965,0.8786,Stable,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,14.8732,13.3589,16.5117,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,14.9524,13.4693,16.5537,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,13.6561,12.2803,15.1438,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,13.9589,12.6013,15.4229,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,14.2839,12.9372,15.7327,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,12.9796,11.7299,14.3266,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,13.7406,12.4812,15.0932,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,14.3349,13.0752,15.6837,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,13.1248,11.9436,14.3916,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,14.7089,13.482,16.0179,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,15.0671,13.844,16.3698,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,13.7004,12.5454,14.9332,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,15.2626,14.0474,16.5545,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,14.2395,13.0842,15.4692,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,14.7147,13.5548,15.9472,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,14.3292,13.1882,15.5418,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2000,48.1662,41.6024,55.4684,2000-2016,-0.0982,-0.5766,0.3826,Stable,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2001,52.8167,46.0725,60.2687,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2002,49.7623,43.3484,56.8568,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2003,43.7703,37.8578,50.3416,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2004,46.7975,40.8013,53.426,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2005,51.4109,45.2147,58.2166,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2006,45.5444,39.8166,51.8603,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2007,48.223,42.4856,54.5176,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2008,51.4795,45.6633,57.8295,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2009,47.8353,42.3626,53.8172,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2010,46.5416,41.2802,52.2868,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2011,50.2755,44.9398,56.0697,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2012,46.7973,41.7934,52.2333,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2013,46.4703,41.6205,51.7273,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2014,48.7873,43.9919,53.9614,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2015,48.795,44.1184,53.8291,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2016,48.2672,43.7763,53.0927,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,48.1662,41.6024,55.4684,2000-2016,0.2777,-0.2206,0.7785,Stable,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,52.8167,46.0725,60.2687,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,49.7623,43.3484,56.8568,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,43.7703,37.8578,50.3416,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,46.7975,40.8013,53.426,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,51.4109,45.2147,58.2166,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,45.5444,39.8166,51.8603,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,48.223,42.4856,54.5176,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,51.7461,45.8998,58.128,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,48.3299,42.8005,54.3718,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,47.2578,41.9153,53.0888,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,51.2987,45.854,57.2077,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,48.021,42.8858,53.5954,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,47.9441,42.9404,53.363,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,50.7831,45.7905,56.1642,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,51.0706,46.1749,56.3346,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,51.2271,46.4593,56.3426,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2000,80.4828,69.9959,92.1051,2000-2016,-0.52,-1.2384,0.2036,Stable,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2001,83.895,73.5157,95.3347,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2002,77.2588,67.6604,87.8448,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2003,87.8249,77.8733,98.7018,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2004,79.7495,70.5495,89.8218,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2005,69.9977,61.6493,79.1662,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2006,72.1285,63.8252,81.2134,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2007,79.298,70.7869,88.5514,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2008,81.0347,72.6212,90.1549,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2009,89.1713,80.5375,98.478,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2010,77.5273,69.6784,86.017,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2011,79.5279,71.8136,87.8444,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2012,79.5444,72.0369,87.6204,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2013,73.9792,66.917,81.5809,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2014,77.3576,70.3616,84.8599,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2015,79.0293,72.1206,86.4185,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2016,68.7946,62.5236,75.5216,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,80.4828,69.9959,92.1051,2000-2016,-0.1447,-0.8443,0.5599,Stable,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,83.895,73.5157,95.3347,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,77.2588,67.6604,87.8448,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,87.8249,77.8733,98.7018,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,79.7495,70.5495,89.8218,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,69.9977,61.6493,79.1662,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,72.1285,63.8252,81.2134,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,79.298,70.7869,88.5514,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,81.4524,72.9955,90.6182,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,90.0504,81.3315,99.4464,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,78.7332,70.762,87.3514,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,81.152,73.2797,89.634,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,81.5713,73.8717,89.8486,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,76.3468,69.058,84.1862,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,80.4145,73.1404,88.2076,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,82.7433,75.5092,90.4723,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,73.1348,66.4666,80.2774,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2000,1.1733,0.7731,1.7077,2000-2016,2.3682,-0.0273,4.8211,Stable,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2001,1.0764,0.6965,1.588,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2002,0.9246,0.5794,1.3993,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2003,0.9875,0.6326,1.4685,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2004,1.0492,0.6852,1.5365,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2005,1.0992,0.7301,1.589,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2006,0.7808,0.4767,1.2053,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2007,0.8837,0.5598,1.3251,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2008,1.1577,0.7863,1.6425,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2009,1.4174,1.0076,1.9375,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2010,1.2022,0.8323,1.6806,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2011,0.6744,0.4059,1.0533,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2012,1.3613,0.9679,1.8613,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2013,1.3545,0.9631,1.8513,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2014,1.8792,1.4156,2.4459,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2015,1.3492,0.9639,1.8367,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2016,1.0319,0.7011,1.4646,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,1.1733,0.7731,1.7077,2000-2016,2.6828,0.2697,5.1541,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,1.0764,0.6965,1.588,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,0.9246,0.5794,1.3993,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,0.9875,0.6326,1.4685,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,1.0492,0.6852,1.5365,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,1.0992,0.7301,1.589,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,0.7808,0.4767,1.2053,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,0.8837,0.5598,1.3251,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,1.1627,0.7896,1.6493,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,1.4282,1.0153,1.952,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,1.2192,0.8441,1.7037,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,0.6863,0.4131,1.0709,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,1.3894,0.9879,1.8987,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,1.3902,0.9884,1.8989,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,1.946,1.4659,2.5314,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,1.4045,1.0033,1.9102,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,1.0862,0.7379,1.5394,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2000,13.6239,12.9101,14.3655,2000-2016,0.1008,-0.2093,0.412,Stable,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2001,14.7573,14.0222,15.5196,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2002,14.3816,13.6649,15.125,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2003,14.6828,13.9641,15.4278,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2004,15.3262,14.5944,16.0839,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2005,15.3777,14.6362,16.1459,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2006,14.5253,13.8264,15.2494,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2007,14.4993,13.8098,15.2134,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2008,14.9764,14.2811,15.6959,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2009,15.3384,14.6428,16.0576,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2010,15.2271,14.5383,15.9391,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2011,14.9473,14.2731,15.6442,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2012,14.9939,14.3304,15.6795,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2013,14.5924,13.9443,15.2622,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2014,14.8818,14.2409,15.5437,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2015,14.3826,13.7561,15.0298,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Observed Rates,2016,14.7114,14.085,15.3581,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2000,13.6239,12.9101,14.3655,2000-2016,0.3494,0.0656,0.6341,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2001,14.7573,14.0222,15.5196,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2002,14.3816,13.6649,15.125,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2003,14.6828,13.9641,15.4278,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2004,15.3262,14.5944,16.0839,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2005,15.3777,14.6362,16.1459,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2006,14.5253,13.8264,15.2494,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2007,14.4993,13.8098,15.2134,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2008,15.0248,14.3272,15.7466,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2009,15.437,14.7369,16.1609,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2010,15.37,14.6748,16.0886,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2011,15.1422,14.4591,15.8482,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2012,15.2304,14.5564,15.9267,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2013,14.8788,14.218,15.5617,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2014,15.2639,14.6064,15.9427,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2015,14.8389,14.1925,15.5065,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2016,15.399,14.7433,16.0756,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2000,6.3434,5.8508,6.8651,2000-2016,-1.3514,-1.6765,-1.0254,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2001,6.5241,6.0283,7.0486,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2002,6.3049,5.8212,6.817,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2003,6.0595,5.5882,6.5589,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2004,6.1684,5.6943,6.6706,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2005,6.1172,5.6354,6.6284,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2006,5.8848,5.4223,6.3754,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2007,5.8836,5.422,6.3731,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2008,5.8849,5.4241,6.3735,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2009,6.1429,5.6711,6.6425,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2010,5.5024,5.0582,5.9744,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2011,5.2905,4.8527,5.7562,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2012,5.656,5.2046,6.1353,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2013,5.4502,5.0075,5.9206,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2014,5.344,4.9065,5.8091,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2015,5.0067,4.5818,5.4593,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Observed Rates,2016,5.3561,4.9184,5.8212,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,6.3434,5.8508,6.8651,2000-2016,-1.1405,-1.4711,-0.8088,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,6.5241,6.0283,7.0486,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,6.3049,5.8212,6.817,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,6.0595,5.5882,6.5589,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,6.1684,5.6943,6.6706,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,6.1172,5.6354,6.6284,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,5.8848,5.4223,6.3754,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,5.8836,5.422,6.3731,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,5.9028,5.4406,6.3929,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,6.1791,5.7045,6.6816,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,5.5489,5.1009,6.0248,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,5.3526,4.9096,5.8236,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,5.7386,5.2805,6.2246,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,5.5506,5.0997,6.0294,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,5.4702,5.0223,5.9461,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,5.1522,4.7149,5.6177,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,5.5905,5.1336,6.0756,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2000,22.8753,20.6175,25.3129,2000-2003,6.3742,-0.0492,13.2104,Stable,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2001,26.2415,23.8675,28.7879,2003-2016,-0.3672,-0.8887,0.157,Stable,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2002,26.6399,24.291,29.1548,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2003,28.3019,25.9264,30.8367,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2004,28.311,25.9798,30.7952,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2005,29.8936,27.4844,32.4577,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2006,26.9067,24.7178,29.2377,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2007,27.1278,24.9765,29.4149,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2008,27.612,25.4846,29.8697,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2009,28.2377,26.1298,30.4704,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2010,27.7013,25.6607,29.8611,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2011,27.4012,25.4077,29.5095,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2012,28.0235,26.0348,30.1239,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2013,26.7108,24.7885,28.7425,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2014,28.7573,26.7853,30.8362,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2015,26.5376,24.6629,28.5172,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Observed Rates,2016,27.0099,25.1312,28.9919,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,22.8753,20.6175,25.3129,2000-2003,5.971,-0.5807,12.9545,Stable,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,26.2415,23.8675,28.7879,2003-2016,-0.0405,-0.5766,0.4985,Stable,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,26.6399,24.291,29.1548,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,28.3019,25.9264,30.8367,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,28.311,25.9798,30.7952,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,29.8936,27.4844,32.4577,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,26.9067,24.7178,29.2377,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,27.1278,24.9765,29.4149,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,27.703,25.5685,29.9679,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,28.427,26.3049,30.6744,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,27.9845,25.9229,30.1658,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,27.7694,25.7491,29.9055,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,28.4911,26.4692,30.626,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,27.2533,25.2917,29.3257,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,29.5248,27.4998,31.6584,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,27.4047,25.4686,29.4478,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,28.3284,26.3576,30.4057,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2000,44.333,40.3146,48.6455,2000-2016,0.9571,0.536,1.38,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2001,48.2716,44.1215,52.7095,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2002,46.0811,42.0646,50.3805,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2003,47.8979,43.8308,52.2431,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2004,52.3537,48.1186,56.8634,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2005,51.1764,46.9286,55.7075,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2006,49.3072,45.2695,53.6101,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2007,48.8459,44.8762,53.0744,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2008,52.0392,47.9844,56.3468,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2009,52.6834,48.6516,56.9615,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2010,56.1062,51.9943,60.4576,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2011,55.4622,51.4453,59.7104,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2012,52.9993,49.1412,57.0804,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2013,52.5588,48.7824,56.5503,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2014,53.0286,49.3437,56.9177,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2015,53.6438,49.9924,57.4926,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Observed Rates,2016,53.6845,50.0854,57.4745,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,44.333,40.3146,48.6455,2000-2016,1.2195,0.8274,1.6132,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,48.2716,44.1215,52.7095,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,46.0811,42.0646,50.3805,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,47.8979,43.8308,52.2431,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,52.3537,48.1186,56.8634,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,51.1764,46.9286,55.7075,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,49.3072,45.2695,53.6101,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,48.8459,44.8762,53.0744,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,52.2114,48.1432,56.533,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,53.0318,48.9733,57.3375,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,56.6347,52.4841,61.0262,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,56.2118,52.14,60.517,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,53.8434,49.9237,57.9884,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,53.6067,49.7547,57.6766,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,54.4183,50.6363,58.4079,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,55.3923,51.621,59.3651,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,56.2186,52.4496,60.1842,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2000,0.6018,0.3771,0.9117,2000-2016,2.6132,0.0959,5.1938,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2001,0.6497,0.4162,0.9674,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2002,0.9188,0.6361,1.2852,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2003,0.6003,0.3759,0.9105,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2004,0.9434,0.6528,1.3199,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2005,0.9314,0.6366,1.3172,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2006,0.758,0.4992,1.1045,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2007,1.0229,0.7162,1.4168,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2008,1.2849,0.9371,1.7194,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2009,1.0409,0.7289,1.4406,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2010,0.9278,0.6345,1.3092,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2011,0.8354,0.5594,1.1993,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2012,1.4156,1.0472,1.8711,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2013,0.7778,0.5126,1.1313,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2014,1.0135,0.7059,1.4091,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2015,0.7273,0.4706,1.073,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Observed Rates,2016,1.2527,0.9065,1.6867,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,0.6018,0.3771,0.9117,2000-2016,2.8518,0.3409,5.4256,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,0.6497,0.4162,0.9674,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,0.9188,0.6361,1.2852,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,0.6003,0.3759,0.9105,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,0.9434,0.6528,1.3199,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,0.9314,0.6366,1.3172,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,0.758,0.4992,1.1045,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,1.0229,0.7162,1.4168,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,1.2886,0.9398,1.7243,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,1.0466,0.7329,1.4484,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,0.9364,0.6404,1.321,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,0.8432,0.5646,1.2102,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,1.4362,1.0624,1.8978,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,0.7914,0.5215,1.1504,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,1.0348,0.7207,1.4378,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,0.7477,0.4838,1.102,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,1.3096,0.9476,1.7618,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2000,5.5005,4.8797,6.1778,2000-2016,-1.4771,-2.0817,-0.8688,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2001,5.8468,5.2061,6.5439,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2002,5.1231,4.5247,5.7779,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2003,5.5552,4.9291,6.2379,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2004,5.234,4.6235,5.9014,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2005,5.6043,4.9557,6.3128,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2006,4.9314,4.335,5.5853,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2007,5.1058,4.4996,5.7692,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2008,5.1457,4.5393,5.8089,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2009,5.4476,4.8215,6.1304,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2010,4.4196,3.8649,5.0299,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2011,4.6447,4.0686,5.2772,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2012,5.1276,4.5248,5.7863,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2013,4.9369,4.3532,5.5753,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2014,4.416,3.8732,5.0121,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2015,4.2198,3.6925,4.7999,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Observed Rates,2016,4.5139,3.9685,5.1117,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,5.5005,4.8797,6.1778,2000-2016,-1.2657,-1.8672,-0.6606,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,5.8468,5.2061,6.5439,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,5.1231,4.5247,5.7779,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,5.5552,4.9291,6.2379,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,5.234,4.6235,5.9014,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,5.6043,4.9557,6.3128,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,4.9314,4.335,5.5853,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,5.1058,4.4996,5.7692,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,5.1609,4.5528,5.826,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,5.4785,4.8488,6.165,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,4.4556,3.8965,5.0708,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,4.6988,4.116,5.3384,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,5.2043,4.5925,5.8725,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,5.0307,4.4358,5.6808,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,4.5204,3.9648,5.1302,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,4.343,3.8003,4.9394,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,4.7127,4.1432,5.3362,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2000,19.5407,18.1023,21.063,2000-2002,5.2372,-3.1068,14.2997,Stable,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2001,21.1936,19.717,22.7516,2002-2016,-0.6863,-1.0256,-0.3459,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2002,21.5236,20.0599,23.0659,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2003,21.4795,20.0395,22.9956,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2004,21.8761,20.4459,23.3799,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2005,22.1111,20.6587,23.6387,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2006,20.9924,19.6292,22.4255,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2007,20.7078,19.3728,22.1106,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2008,20.7181,19.3997,22.1027,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2009,21.4608,20.1362,22.85,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2010,20.952,19.6612,22.3055,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2011,20.1016,18.8531,21.4115,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2012,20.3051,19.061,21.6096,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2013,19.8406,18.6133,21.1279,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2014,21.0394,19.7829,22.3554,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2015,19.5723,18.3623,20.8416,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Observed Rates,2016,19.9227,18.7086,21.1957,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,19.5407,18.1023,21.063,2000-2016,-0.1614,-0.4971,0.1754,Stable,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,21.1936,19.717,22.7516,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,21.5236,20.0599,23.0659,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,21.4795,20.0395,22.9956,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,21.8761,20.4459,23.3799,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,22.1111,20.6587,23.6387,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,20.9924,19.6292,22.4255,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,20.7078,19.3728,22.1106,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,20.7853,19.4626,22.1742,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,21.6004,20.2672,22.9984,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,21.1542,19.851,22.5205,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,20.3624,19.0977,21.6889,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,20.6281,19.3644,21.9529,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,20.2281,18.977,21.5402,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,21.5817,20.2929,22.9309,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,20.1884,18.9406,21.4967,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,20.8589,19.588,22.1903,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2000,40.712,35.713,46.2131,2000-2016,0.7468,0.2737,1.2221,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2001,45.4285,40.2106,51.136,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2002,44.3375,39.2158,49.9416,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2003,43.6849,38.6712,49.1689,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2004,49.0158,43.6889,54.8101,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2005,46.6742,41.4409,52.3854,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2006,44.9887,40.0114,50.413,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2007,44.3031,39.4463,49.5933,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2008,48.1816,43.181,53.6026,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2009,48.2479,43.3049,53.5997,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2010,49.5535,44.617,54.8863,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2011,48.3436,43.5832,53.4837,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2012,45.9811,41.4334,50.892,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2013,46.2559,41.7812,51.0781,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2014,51.2541,46.6719,56.1648,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2015,50.5879,46.1123,55.3792,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Observed Rates,2016,47.1638,42.9426,51.6869,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,40.712,35.713,46.2131,2000-2016,1.0088,0.5498,1.4698,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,45.4285,40.2106,51.136,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,44.3375,39.2158,49.9416,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,43.6849,38.6712,49.1689,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,49.0158,43.6889,54.8101,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,46.6742,41.4409,52.3854,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,44.9887,40.0114,50.413,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,44.3031,39.4463,49.5933,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,48.3444,43.3268,53.7832,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,48.5724,43.5962,53.9592,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,50.0293,45.0453,55.4117,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,48.9735,44.1504,54.1795,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,46.7023,42.0832,51.6881,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,47.1788,42.6146,52.095,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,52.6166,47.9114,57.6559,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,52.1807,47.5644,57.119,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,49.4096,44.9874,54.1426,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2000,48.2952,42.0101,55.2572,2000-2011,2.0993,1.124,3.0841,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2001,51.3826,44.9392,58.4921,2011-2016,-1.2698,-3.9025,1.4349,Stable,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2002,47.989,41.8256,54.8073,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2003,52.5078,46.0959,59.5638,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2004,56.006,49.4255,63.2206,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2005,56.1028,49.4003,63.4618,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2006,54.0326,47.6628,61.0172,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2007,53.8168,47.5193,60.7164,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2008,56.2603,49.8613,63.2515,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2009,57.5369,51.1447,64.5055,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2010,63.2763,56.6568,70.4549,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2011,63.2514,56.7287,70.3162,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2012,60.6787,54.393,67.4891,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2013,59.4555,53.3225,66.0977,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2014,54.9702,49.1828,61.2495,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2015,56.9876,51.1894,63.2602,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Observed Rates,2016,60.8195,54.9318,67.1644,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,48.2952,42.0101,55.2572,2000-2016,1.4312,0.8543,2.0114,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,51.3826,44.9392,58.4921,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,47.989,41.8256,54.8073,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,52.5078,46.0959,59.5638,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,56.006,49.4255,63.2206,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,56.1028,49.4003,63.4618,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,54.0326,47.6628,61.0172,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,53.8168,47.5193,60.7164,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,56.4428,50.023,63.456,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,57.9114,51.4775,64.924,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,63.8625,57.1815,71.106,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,64.1321,57.5182,71.2928,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,61.6574,55.2701,68.5747,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,60.6403,54.3844,67.4119,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,56.3896,50.4519,62.8272,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,58.9066,52.9123,65.3854,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,63.6691,57.505,70.3039,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2000,0.7852,0.5526,1.0823,2000-2016,1.6718,-0.0856,3.46,Stable,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2001,0.972,0.7114,1.2965,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2002,0.9924,0.7315,1.3166,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2003,0.9818,0.7212,1.3061,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2004,1.1613,0.8769,1.5089,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2005,1.3943,1.0757,1.7786,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2006,1.2321,0.9421,1.5844,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2007,1.1467,0.8657,1.4903,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2008,1.4305,1.1145,1.8087,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2009,1.1529,0.8702,1.4984,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2010,1.0543,0.7844,1.3872,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2011,0.937,0.6832,1.2543,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2012,1.5193,1.1885,1.9135,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2013,1.0728,0.7986,1.4108,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2014,1.2787,0.9757,1.6459,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2015,1.067,0.7919,1.4068,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Observed Rates,2016,1.4393,1.1153,1.8278,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,0.7852,0.5526,1.0823,2000-2016,1.9095,0.1596,3.6901,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,0.972,0.7114,1.2965,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,0.9924,0.7315,1.3166,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,0.9818,0.7212,1.3061,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,1.1613,0.8769,1.5089,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,1.3943,1.0757,1.7786,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,1.2321,0.9421,1.5844,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,1.1467,0.8657,1.4903,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,1.4347,1.1178,1.8139,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,1.1593,0.875,1.5065,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,1.0642,0.7918,1.4,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,0.9474,0.6907,1.2679,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,1.5418,1.2061,1.9415,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,1.0927,0.8135,1.4365,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,1.3076,0.9977,1.6825,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,1.0972,0.8143,1.4459,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,1.5033,1.1648,1.9079,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2000,17.6445,16.7381,18.5835,2000-2010,0.6236,0.0793,1.1708,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2001,16.7809,15.9058,17.6876,2010-2016,-0.984,-1.9275,-0.0314,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2002,17.5879,16.7144,18.4916,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2003,17.868,17.0036,18.7614,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2004,18.4759,17.6148,19.3647,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2005,18.5756,17.7294,19.4485,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2006,18.2267,17.4157,19.0628,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2007,17.9934,17.2039,18.807,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2008,18.2732,17.4975,19.0717,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2009,18.4464,17.6821,19.2327,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2010,18.8593,18.1006,19.6391,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2011,18.1495,17.4254,18.8936,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2012,17.882,17.1882,18.5948,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2013,17.9779,17.2921,18.682,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2014,18.4345,17.7577,19.1288,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2015,17.5973,16.9495,18.2619,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Observed Rates,2016,17.4499,16.8179,18.098,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2000,17.6445,16.7381,18.5835,2000-2016,0.2099,-0.0507,0.4713,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2001,16.7809,15.9058,17.6876,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2002,17.5879,16.7144,18.4916,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2003,17.868,17.0036,18.7614,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2004,18.4759,17.6148,19.3647,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2005,18.5756,17.7294,19.4485,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2006,18.2267,17.4157,19.0628,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2007,17.9934,17.2039,18.807,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2008,18.3098,17.5326,19.1099,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2009,18.5219,17.7545,19.3114,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2010,18.9734,18.2101,19.7578,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2011,18.296,17.5662,19.0461,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2012,18.0636,17.3627,18.7836,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2013,18.1948,17.5007,18.9074,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2014,18.7373,18.0494,19.4429,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2015,17.9998,17.3372,18.6795,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),All Ages,Delay-adjusted Rates,2016,18.0716,17.417,18.7428,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2000,5.2825,4.8709,5.7174,2000-2016,-0.9049,-1.2485,-0.5601,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2001,4.719,4.3419,5.1181,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2002,5.0101,4.6293,5.412,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2003,4.6022,4.2427,4.9822,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2004,5.0173,4.6481,5.4065,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2005,4.7694,4.4142,5.1441,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2006,4.7733,4.4252,5.1402,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2007,4.5276,4.1933,4.8801,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2008,4.8106,4.4716,5.1674,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2009,4.7372,4.4055,5.0862,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2010,4.4495,4.132,4.7839,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2011,4.5409,4.2226,4.8759,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2012,4.6678,4.3488,5.0031,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2013,4.3569,4.0501,4.6798,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2014,4.5126,4.2032,4.8379,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2015,4.3349,4.0337,4.6518,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Observed Rates,2016,4.2977,4.0001,4.6108,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2000,5.2825,4.8709,5.7174,2000-2016,-0.7344,-1.0794,-0.3883,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2001,4.719,4.3419,5.1181,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2002,5.0101,4.6293,5.412,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2003,4.6022,4.2427,4.9822,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2004,5.0173,4.6481,5.4065,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2005,4.7694,4.4142,5.1441,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2006,4.7733,4.4252,5.1402,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2007,4.5276,4.1933,4.8801,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2008,4.8208,4.481,5.1784,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2009,4.7568,4.4236,5.1072,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2010,4.4773,4.1578,4.8137,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2011,4.579,4.258,4.9167,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2012,4.716,4.3937,5.0547,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2013,4.4109,4.1003,4.7377,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2014,4.5862,4.2718,4.9168,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2015,4.4347,4.1266,4.7588,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2016,4.4478,4.1398,4.7717,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2000,30.5419,27.8361,33.4391,2000-2016,-0.0202,-0.3984,0.3593,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2001,27.4629,24.9702,30.1366,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2002,29.3964,26.8847,32.0791,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2003,29.4154,26.9764,32.0156,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2004,28.6522,26.3157,31.1407,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2005,28.2689,25.994,30.6891,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2006,30.5384,28.2456,32.9675,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2007,28.4611,26.31,30.741,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2008,28.6029,26.5057,30.8217,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2009,28.886,26.839,31.0475,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2010,28.3846,26.4142,30.4629,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2011,28.5867,26.6608,30.6149,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2012,30.5735,28.626,32.6185,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2013,29.8573,27.9726,31.8355,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2014,30.3773,28.5179,32.326,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2015,28.297,26.5442,30.1351,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Observed Rates,2016,27.9621,26.2542,29.752,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2000,30.5419,27.8361,33.4391,2000-2016,0.1675,-0.1962,0.5326,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2001,27.4629,24.9702,30.1366,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2002,29.3964,26.8847,32.0791,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2003,29.4154,26.9764,32.0156,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2004,28.6522,26.3157,31.1407,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2005,28.2689,25.994,30.6891,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2006,30.5384,28.2456,32.9675,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2007,28.4611,26.31,30.741,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2008,28.6605,26.559,30.8836,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2009,29.0066,26.951,31.177,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2010,28.5609,26.5782,30.6518,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2011,28.8191,26.8775,30.8634,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2012,30.8809,28.9138,32.9462,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2013,30.2127,28.3055,32.214,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2014,30.8842,28.9937,32.8649,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2015,28.9497,27.1564,30.8295,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2016,28.9638,27.1946,30.8168,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2000,73.1223,67.227,79.4035,2000-2005,3.42,0.4537,6.4739,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2001,73.1693,67.3564,79.3529,2005-2016,-0.4183,-1.098,0.266,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2002,75.5941,69.8124,81.7289,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2003,80.1233,74.3327,86.2474,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2004,83.4612,77.6602,89.5816,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2005,86.1251,80.3938,92.1588,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2006,80.6489,75.2376,86.3478,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2007,82.675,77.348,88.2744,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2008,83.0992,77.8783,88.5798,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2009,84.5548,79.3928,89.9648,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2010,90.0635,84.8786,95.4829,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2011,83.6843,78.7937,88.7985,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2012,78.484,73.8877,83.2913,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2013,81.8722,77.2846,86.6606,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2014,83.9768,79.463,88.6802,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2015,80.8381,76.5135,85.343,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Observed Rates,2016,80.2824,76.0702,84.6664,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2000,73.1223,67.227,79.4035,2000-2005,3.2726,0.382,6.2465,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2001,73.1693,67.3564,79.3529,2005-2016,-0.147,-0.8119,0.5223,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2002,75.5941,69.8124,81.7289,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2003,80.1233,74.3327,86.2474,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2004,83.4612,77.6602,89.5816,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2005,86.1251,80.3938,92.1588,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2006,80.6489,75.2376,86.3478,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2007,82.675,77.348,88.2744,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2008,83.2621,78.0309,88.7532,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2009,84.8967,79.7138,90.3281,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2010,90.5983,85.3826,96.0493,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2011,84.3497,79.4203,89.5039,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2012,79.2803,74.6372,84.1357,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2013,82.8579,78.2149,87.7032,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2014,85.3497,80.762,90.1291,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2015,82.6775,78.2542,87.2837,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2016,83.154,78.7909,87.6929,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2000,0.8165,0.5903,1.0995,2000-2016,0.5043,-1.0034,2.0349,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2001,0.8606,0.6321,1.1438,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2002,1.0476,0.7972,1.3508,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2003,0.6813,0.4843,0.9306,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2004,0.9335,0.7028,1.2148,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2005,0.8341,0.6167,1.1021,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2006,0.6676,0.4768,0.9085,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2007,0.8685,0.6485,1.1378,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2008,0.8349,0.6231,1.0945,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2009,0.7477,0.5491,0.9937,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2010,1.0115,0.7803,1.2889,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2011,0.8222,0.6157,1.0748,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2012,1.1499,0.9041,1.4412,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2013,0.8944,0.6806,1.1535,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2014,0.8359,0.6312,1.0855,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2015,0.935,0.7167,1.1983,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Observed Rates,2016,0.833,0.6291,1.0815,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2000,0.8165,0.5903,1.0995,2000-2016,0.6754,-0.8321,2.2058,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2001,0.8606,0.6321,1.1438,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2002,1.0476,0.7972,1.3508,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2003,0.6813,0.4843,0.9306,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2004,0.9335,0.7028,1.2148,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2005,0.8341,0.6167,1.1021,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2006,0.6676,0.4768,0.9085,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2007,0.8685,0.6485,1.1378,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2008,0.8367,0.6245,1.0968,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2009,0.7514,0.5518,0.9985,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2010,1.018,0.7853,1.2971,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2011,0.8294,0.621,1.084,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2012,1.1618,0.9134,1.4558,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2013,0.9062,0.6896,1.1685,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2014,0.8497,0.6417,1.1031,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2015,0.9563,0.7331,1.2252,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages <15,Delay-adjusted Rates,2016,0.8619,0.6509,1.1184,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2000,4.0223,3.5795,4.5037,2000-2016,-0.3965,-0.9614,0.1716,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2001,3.8745,3.446,4.3406,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2002,3.9277,3.5012,4.3909,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2003,3.4884,3.0939,3.9185,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2004,3.7847,3.3745,4.2301,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2005,3.4963,3.1057,3.9215,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2006,3.7676,3.3682,4.2005,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2007,3.4035,3.0287,3.8112,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2008,3.9535,3.5507,4.3888,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2009,4.0689,3.6631,4.5065,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2010,3.5371,3.1629,3.9426,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2011,3.595,3.2203,4.0004,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2012,3.5605,3.1919,3.9593,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2013,3.5955,3.2219,3.9996,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2014,3.8241,3.4431,4.2349,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2015,3.5017,3.1405,3.8923,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Observed Rates,2016,3.636,3.2696,4.0314,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2000,4.0223,3.5795,4.5037,2000-2016,-0.2252,-0.7993,0.3523,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2001,3.8745,3.446,4.3406,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2002,3.9277,3.5012,4.3909,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2003,3.4884,3.0939,3.9185,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2004,3.7847,3.3745,4.2301,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2005,3.4963,3.1057,3.9215,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2006,3.7676,3.3682,4.2005,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2007,3.4035,3.0287,3.8112,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2008,3.9616,3.5579,4.3977,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2009,4.0859,3.6784,4.5253,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2010,3.5599,3.1832,3.9679,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2011,3.6255,3.2477,4.0343,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2012,3.597,3.2246,3.9998,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2013,3.641,3.2626,4.0501,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2014,3.8867,3.4995,4.3041,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2015,3.5834,3.2138,3.983,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2016,3.7641,3.3848,4.1732,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2000,22.3726,20.8034,24.0279,2000-2016,-0.4427,-0.7834,-0.1008,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2001,19.653,18.2207,21.1671,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2002,21.1059,19.6612,22.6278,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2003,20.9159,19.5167,22.3882,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2004,21.0036,19.6423,22.4339,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2005,20.6312,19.3083,22.0203,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2006,21.5611,20.2431,22.9418,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2007,20.2343,18.9898,21.5385,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2008,20.3597,19.1421,21.634,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2009,20.2513,19.0669,21.4896,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2010,19.7537,18.613,20.9458,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2011,20.1372,19.0116,21.3118,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2012,21.2284,20.0942,22.4099,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2013,20.2744,19.1852,21.4092,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2014,20.676,19.5959,21.8002,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2015,19.5331,18.5029,20.6058,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Observed Rates,2016,19.1944,18.1899,20.24,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2000,22.3726,20.8034,24.0279,2000-2016,-0.2608,-0.5899,0.0693,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2001,19.653,18.2207,21.1671,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2002,21.1059,19.6612,22.6278,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2003,20.9159,19.5167,22.3882,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2004,21.0036,19.6423,22.4339,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2005,20.6312,19.3083,22.0203,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2006,21.5611,20.2431,22.9418,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2007,20.2343,18.9898,21.5385,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2008,20.4016,19.1815,21.6785,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2009,20.335,19.1457,21.5783,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2010,19.8756,18.7278,21.0749,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2011,20.3019,19.1671,21.486,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2012,21.4438,20.298,22.6371,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2013,20.5167,19.4145,21.6649,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2014,21.0185,19.9204,22.1611,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2015,19.9822,18.9283,21.0792,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2016,19.8759,18.8357,20.9582,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2000,66.7128,59.8547,74.1402,2000-2008,1.7046,0.0638,3.3722,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2001,59.3165,52.9662,66.2162,2008-2016,-1.0758,-2.3759,0.2416,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2002,58.6299,52.4364,65.352,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2003,62.7647,56.457,69.5828,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2004,63.4953,57.2097,70.2787,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2005,67.9519,61.569,74.8144,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2006,65.4248,59.2994,72.0103,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2007,68.5679,62.4433,75.1319,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2008,71.4485,65.3048,78.0137,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2009,66.9533,61.1437,73.1648,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2010,72.3979,66.4951,78.6833,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2011,64.0447,58.6099,69.8463,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2012,65.9461,60.5586,71.6816,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2013,64.0047,58.8722,69.4634,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2014,67.3076,62.2171,72.7039,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2015,64.2999,59.4298,69.4612,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Observed Rates,2016,63.4777,58.7634,68.4678,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2000,66.7128,59.8547,74.1402,2000-2016,0.3501,-0.1966,0.8997,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2001,59.3165,52.9662,66.2162,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2002,58.6299,52.4364,65.352,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2003,62.7647,56.457,69.5828,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2004,63.4953,57.2097,70.2787,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2005,67.9519,61.569,74.8144,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2006,65.4248,59.2994,72.0103,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2007,68.5679,62.4433,75.1319,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2008,71.5887,65.4329,78.1664,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2009,67.2269,61.3936,73.4632,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2010,72.8364,66.8978,79.1591,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2011,64.5703,59.0907,70.4185,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2012,66.6054,61.1639,72.397,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2013,64.7634,59.5701,70.2854,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2014,68.4033,63.2298,73.8857,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2015,65.7464,60.7668,71.0214,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2016,65.7268,60.8456,70.89,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2000,80.1358,70.4722,90.7647,2000-2004,5.834,-0.296,12.341,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2001,88.3272,78.4547,99.1066,2004-2016,-0.34,-1.1605,0.4874,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2002,94.1567,84.2364,104.9311,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2003,99.1173,89.2551,109.7791,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2004,105.3082,95.397,115.9754,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2005,106.0105,96.3495,116.384,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2006,97.3073,88.2671,107.0249,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2007,98.1113,89.2863,107.5761,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2008,95.8477,87.3165,104.9887,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2009,103.8147,95.154,113.0531,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2010,109.3935,100.7445,118.5874,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2011,105.1742,96.9095,113.955,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2012,92.2031,84.668,100.2281,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2013,101.4232,93.695,109.6174,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2014,102.2164,94.6429,110.2331,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2015,98.9345,91.6723,106.6175,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Observed Rates,2016,98.6703,91.5723,106.1706,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2000,80.1358,70.4722,90.7647,2000-2003,7.925,-2.1476,19.0345,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2001,88.3272,78.4547,99.1066,2003-2016,0.04,-0.7032,0.7887,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2002,94.1567,84.2364,104.9311,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2003,99.1173,89.2551,109.7791,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2004,105.3082,95.397,115.9754,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2005,106.0105,96.3495,116.384,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2006,97.3073,88.2671,107.0249,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2007,98.1113,89.2863,107.5761,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2008,96.0354,87.4875,105.194,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2009,104.2312,95.5358,113.5058,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2010,110.0336,101.3339,119.2801,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2011,105.9926,97.6635,114.8403,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2012,93.1493,85.5368,101.2549,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2013,102.6572,94.8348,110.9492,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2014,103.8928,96.1949,112.0386,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2015,101.2037,93.7747,109.0598,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2016,102.2231,94.8692,109.9884,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2000,0.9885,0.7655,1.2552,2000-2016,0.78,-0.5646,2.1428,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2001,0.9516,0.7371,1.2083,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2002,1.371,1.1124,1.6707,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2003,0.8322,0.6362,1.0686,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2004,0.9963,0.7845,1.2471,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2005,0.992,0.7812,1.2412,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2006,0.9293,0.7282,1.1679,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2007,0.9878,0.7819,1.2305,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2008,0.9025,0.7096,1.1311,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2009,0.9816,0.7817,1.2166,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2010,1.1036,0.8927,1.349,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2011,1.0096,0.8085,1.2449,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2012,1.2929,1.0644,1.5556,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2013,1.0454,0.8415,1.2834,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2014,1.0148,0.8148,1.2487,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2015,1.1576,0.9427,1.4063,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Observed Rates,2016,1.1716,0.9562,1.4207,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2000,0.9885,0.7655,1.2552,2000-2016,0.9602,-0.4026,2.3417,Stable,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2001,0.9516,0.7371,1.2083,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2002,1.371,1.1124,1.6707,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2003,0.8322,0.6362,1.0686,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2004,0.9963,0.7845,1.2471,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2005,0.992,0.7812,1.2412,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2006,0.9293,0.7282,1.1679,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2007,0.9878,0.7819,1.2305,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2008,0.9045,0.7112,1.1335,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2009,0.9861,0.7852,1.2221,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2010,1.1106,0.8983,1.3574,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2011,1.0181,0.8153,1.2553,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2012,1.3059,1.075,1.5711,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2013,1.0599,0.8532,1.301,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2014,1.0326,0.829,1.2704,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2015,1.1847,0.9649,1.439,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2016,1.2124,0.9895,1.4697,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2000,20.5957,20.2719,20.9234,2000-2007,1.0403,0.5176,1.5657,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2001,20.7545,20.4305,21.0825,2007-2016,-0.7519,-1.094,-0.4086,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2002,20.8604,20.5368,21.1881,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2003,21.2493,20.9237,21.579,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2004,21.5601,21.2328,21.8914,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2005,21.5525,21.222,21.887,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2006,21.8349,21.506,22.1678,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2007,22.0465,21.717,22.3801,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2008,21.9174,21.5894,22.2493,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2009,21.8267,21.4999,22.1575,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2010,21.7107,21.3858,22.0395,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2011,21.1276,20.808,21.4511,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2012,21.3174,20.9984,21.6403,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2013,21.0841,20.7681,21.404,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2014,21.4119,21.0942,21.7335,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2015,21.1327,20.8183,21.4509,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Observed Rates,2016,20.082,19.7759,20.392,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2000,20.5957,20.2719,20.9234,2000-2007,0.9957,0.557,1.4363,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2001,20.7545,20.4305,21.0825,2007-2016,-0.377,-0.6653,-0.0878,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2002,20.8604,20.5368,21.1881,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2003,21.2493,20.9237,21.579,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2004,21.5601,21.2328,21.8914,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2005,21.5525,21.222,21.887,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2006,21.8349,21.506,22.1678,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2007,22.0465,21.717,22.3801,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2008,21.9755,21.6467,22.3083,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2009,21.9426,21.614,22.2752,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2010,21.8826,21.5552,22.2141,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2011,21.3542,21.0312,21.6812,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2012,21.6019,21.2786,21.9291,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2013,21.4201,21.099,21.745,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2014,21.8521,21.5279,22.1803,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2015,21.7138,21.3908,22.0408,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,All Ages,Delay-adjusted Rates,2016,20.9469,20.6276,21.2702,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2000,5.4229,5.2174,5.6346,2000-2009,0.139,-0.3083,0.5882,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2001,5.3888,5.1833,5.6006,2009-2016,-1.0851,-1.795,-0.3701,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2002,5.2144,5.0119,5.4233,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2003,5.3327,5.1269,5.5449,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2004,5.2725,5.0667,5.4847,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2005,5.3816,5.1693,5.6005,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2006,5.2431,5.0346,5.4583,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2007,5.4159,5.2019,5.6367,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2008,5.4473,5.2305,5.6709,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2009,5.5056,5.2856,5.7325,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2010,5.3699,5.1504,5.5965,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2011,5.1854,4.9675,5.4106,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2012,5.0665,4.8498,5.2904,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2013,5.1699,4.9499,5.3972,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2014,5.1688,4.9459,5.3993,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2015,5.1007,4.8781,5.3308,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Observed Rates,2016,4.9767,4.7553,5.2058,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2000,5.4229,5.2174,5.6346,2000-2002,-1.9545,-5.7552,1.9995,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2001,5.3888,5.1833,5.6006,2002-2009,0.6713,-0.0208,1.3682,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2002,5.2144,5.0119,5.4233,2009-2012,-1.8476,-5.9931,2.4808,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2003,5.3327,5.1269,5.5449,2012-2016,0.2355,-1.1905,1.682,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2004,5.2725,5.0667,5.4847,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2005,5.3816,5.1693,5.6005,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2006,5.2431,5.0346,5.4583,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2007,5.4159,5.2019,5.6367,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2008,5.4621,5.2447,5.6863,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2009,5.5355,5.3143,5.7636,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2010,5.4136,5.1923,5.642,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2011,5.2439,5.0235,5.4715,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2012,5.1368,4.9171,5.3638,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2013,5.2545,5.031,5.4856,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2014,5.2726,5.0451,5.5076,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2015,5.2345,5.006,5.4706,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2016,5.1846,4.954,5.4232,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2000,33.7415,32.6696,34.8396,2000-2006,0.3488,-0.6824,1.3907,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2001,34.1413,33.0777,35.2304,2006-2016,-0.9031,-1.3367,-0.4675,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2002,35.0132,33.9544,36.0965,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2003,34.4979,33.4644,35.5551,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2004,34.9406,33.9148,35.9895,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2005,34.3304,33.3177,35.366,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2006,34.9559,33.956,35.9777,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2007,35.1547,34.1673,36.1634,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2008,34.4828,33.5154,35.4711,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2009,33.3349,32.3947,34.2956,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2010,33.4718,32.5392,34.4243,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2011,32.0975,31.1943,33.0202,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2012,33.382,32.4594,34.3242,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2013,32.3689,31.4611,33.2962,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2014,33.1237,32.2059,34.061,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2015,32.7963,31.8815,33.7309,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Observed Rates,2016,31.3983,30.5005,32.316,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2000,33.7415,32.6696,34.8396,2000-2016,-0.3015,-0.51,-0.0925,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2001,34.1413,33.0777,35.2304,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2002,35.0132,33.9544,36.0965,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2003,34.4979,33.4644,35.5551,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2004,34.9406,33.9148,35.9895,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2005,34.3304,33.3177,35.366,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2006,34.9559,33.956,35.9777,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2007,35.1547,34.1673,36.1634,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2008,34.5776,33.6075,35.5686,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2009,33.5195,32.5741,34.4854,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2010,33.7454,32.8052,34.7057,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2011,32.4505,31.5375,33.3834,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2012,33.841,32.9057,34.796,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2013,32.9055,31.9827,33.8481,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2014,33.8275,32.8902,34.7847,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2015,33.7215,32.7808,34.6823,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2016,32.7837,31.8461,33.7418,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2000,91.8725,89.9957,93.7786,2000-2006,1.762,1.3532,2.1724,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2001,92.85,90.9641,94.7651,2006-2014,-0.1845,-0.486,0.1178,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2002,93.6523,91.7549,95.579,2014-2016,-2.9744,-5.0933,-0.8081,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2003,96.6637,94.7373,98.6193,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2004,98.9419,96.9925,100.9205,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2005,98.981,97.0117,100.98,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2006,101.2663,99.2907,103.2711,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2007,101.7155,99.744,103.7161,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2008,101.3114,99.3521,103.2994,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2009,101.622,99.6674,103.6051,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2010,101.3188,99.3781,103.2877,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2011,99.392,97.4809,101.3309,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2012,100.0508,98.1543,101.9745,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2013,98.8146,96.9524,100.7035,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2014,100.5188,98.6573,102.4065,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2015,99.0882,97.2586,100.9434,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Observed Rates,2016,93.1431,91.3861,94.9251,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2000,91.8725,89.9957,93.7786,2000-2007,1.6083,1.0476,2.1722,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2001,92.85,90.9641,94.7651,2007-2016,-0.2858,-0.6429,0.0725,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2002,93.6523,91.7549,95.579,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2003,96.6637,94.7373,98.6193,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2004,98.9419,96.9925,100.9205,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2005,98.981,97.0117,100.98,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2006,101.2663,99.2907,103.2711,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2007,101.7155,99.744,103.7161,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2008,101.5738,99.6095,103.5669,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2009,102.1489,100.1841,104.1422,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2010,102.1042,100.1484,104.0883,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2011,100.4312,98.5001,102.3902,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2012,101.3547,99.4334,103.3034,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2013,100.3516,98.4603,102.2696,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2014,102.5726,100.673,104.4987,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2015,101.8225,99.9423,103.7288,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2016,97.1523,95.3195,99.0109,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2000,0.8913,0.7339,1.0727,2000-2016,2.3433,1.1828,3.517,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2001,1.1355,0.9563,1.3387,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2002,0.8572,0.701,1.0381,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2003,0.8245,0.6707,1.0033,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2004,0.9836,0.8147,1.1776,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2005,1.0511,0.872,1.2564,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2006,1.0033,0.8282,1.2046,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2007,1.065,0.8828,1.2736,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2008,0.9746,0.8002,1.1759,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2009,0.9235,0.753,1.1213,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2010,1.178,0.9835,1.4,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2011,0.9961,0.8171,1.2029,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2012,1.0089,0.8276,1.2182,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2013,1.3053,1.0966,1.5422,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2014,1.3534,1.1399,1.5953,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2015,1.2843,1.0753,1.5221,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Observed Rates,2016,1.3784,1.1602,1.6256,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2000,0.8913,0.7339,1.0727,2000-2016,2.5474,1.3602,3.7485,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2001,1.1355,0.9563,1.3387,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2002,0.8572,0.701,1.0381,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2003,0.8245,0.6707,1.0033,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2004,0.9836,0.8147,1.1776,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2005,1.0511,0.872,1.2564,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2006,1.0033,0.8282,1.2046,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2007,1.065,0.8828,1.2736,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2008,0.9772,0.8023,1.1789,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2009,0.9287,0.7572,1.1275,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2010,1.1878,0.9916,1.4115,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2011,1.007,0.8261,1.2159,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2012,1.022,0.8383,1.2339,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2013,1.3265,1.1144,1.5671,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2014,1.3804,1.1627,1.627,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2015,1.3174,1.103,1.561,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2016,1.4323,1.2056,1.6888,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2000,4.4686,4.1985,4.7516,2000-2016,-0.2167,-0.5098,0.0772,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2001,4.51,4.2361,4.797,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2002,4.3185,4.0479,4.6026,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2003,4.4411,4.1636,4.7324,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2004,4.1695,3.8977,4.4552,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2005,4.4823,4.1949,4.7843,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2006,4.1566,3.8809,4.4465,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2007,4.3231,4.04,4.6207,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2008,4.4391,4.1501,4.7428,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2009,4.5448,4.2504,4.8539,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2010,4.4004,4.1088,4.707,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2011,4.4459,4.1499,4.757,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2012,4.2824,3.9918,4.5882,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2013,4.196,3.9109,4.4962,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2014,4.1761,3.8905,4.4769,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2015,4.2657,3.9784,4.5681,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Observed Rates,2016,4.3345,4.0454,4.6386,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2000,4.4686,4.1985,4.7516,2000-2016,-0.0208,-0.3247,0.284,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2001,4.51,4.2361,4.797,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2002,4.3185,4.0479,4.6026,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2003,4.4411,4.1636,4.7324,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2004,4.1695,3.8977,4.4552,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2005,4.4823,4.1949,4.7843,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2006,4.1566,3.8809,4.4465,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2007,4.3231,4.04,4.6207,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2008,4.4509,4.1612,4.7554,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2009,4.5689,4.2729,4.8796,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2010,4.4359,4.1419,4.745,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2011,4.4941,4.195,4.8086,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2012,4.3418,4.0472,4.6518,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2013,4.2638,3.9741,4.5688,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2014,4.2625,3.9709,4.5694,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2015,4.378,4.0831,4.6882,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2016,4.5167,4.2155,4.8334,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2000,23.7115,23.0739,24.3622,2000-2007,0.2998,-0.3525,0.9564,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2001,23.6068,22.9778,24.2486,2007-2016,-1.1949,-1.6322,-0.7557,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2002,24.0419,23.4155,24.6809,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2003,23.9491,23.3308,24.5797,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2004,24.2291,23.6126,24.8578,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2005,23.7747,23.1623,24.3993,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2006,24.1678,23.5598,24.7877,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2007,24.4394,23.8312,25.0593,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2008,24.1107,23.5076,24.7257,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2009,23.596,22.9998,24.2039,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2010,23.3292,22.7389,23.9312,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2011,22.2873,21.7122,22.8742,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2012,22.8198,22.2364,23.415,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2013,22.4577,21.874,23.0534,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2014,22.8167,22.224,23.4216,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2015,22.4372,21.8466,23.0401,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Observed Rates,2016,21.3055,20.7267,21.8968,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2000,23.7115,23.0739,24.3622,2000-2008,0.3211,0.0034,0.6399,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2001,23.6068,22.9778,24.2486,2008-2011,-2.2203,-4.9587,0.5971,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2002,24.0419,23.4155,24.6809,2011-2014,0.8018,-2.0763,3.7645,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2003,23.9491,23.3308,24.5797,2014-2016,-2.0329,-4.9336,0.9562,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2004,24.2291,23.6126,24.8578,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2005,23.7747,23.1623,24.3993,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2006,24.1678,23.5598,24.7877,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2007,24.4394,23.8312,25.0593,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2008,24.1773,23.5724,24.7939,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2009,23.7264,23.1269,24.3376,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2010,23.5199,22.9248,24.1268,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2011,22.5366,21.955,23.13,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2012,23.135,22.5435,23.7383,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2013,22.8298,22.2364,23.4353,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2014,23.2911,22.6862,23.9084,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2015,23.0578,22.451,23.6772,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2016,22.2332,21.6293,22.85,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2000,77.5111,75.0772,80.0039,2000-2007,1.1388,0.3041,1.9804,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2001,76.5013,74.0698,78.9924,2007-2016,-0.781,-1.2962,-0.263,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2002,79.7697,77.2711,82.3286,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2003,79.0207,76.5266,81.5753,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2004,79.6072,77.0979,82.1773,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2005,80.9312,78.3686,83.5562,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2006,83.5039,80.9282,86.1406,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2007,82.2833,79.7496,84.877,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2008,81.3536,78.8703,83.895,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2009,81.5252,79.0743,84.0325,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2010,82.2368,79.8041,84.7247,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2011,80.2584,77.8895,82.6809,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2012,81.3941,79.0694,83.7696,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2013,79.4795,77.2424,81.7648,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2014,79.5902,77.3951,81.8316,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2015,80.049,77.8873,82.2553,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Observed Rates,2016,74.3615,72.3086,76.4576,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2000,77.5111,75.0772,80.0039,2000-2006,1.2907,0.409,2.1801,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2001,76.5013,74.0698,78.9924,2006-2016,-0.3126,-0.6802,0.0563,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2002,79.7697,77.2711,82.3286,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2003,79.0207,76.5266,81.5753,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2004,79.6072,77.0979,82.1773,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2005,80.9312,78.3686,83.5562,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2006,83.5039,80.9282,86.1406,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2007,82.2833,79.7496,84.877,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2008,81.564,79.0743,84.1119,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2009,81.9437,79.4803,84.4638,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2010,82.8692,80.4177,85.3761,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2011,81.0921,78.6985,83.5396,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2012,82.4472,80.0924,84.8532,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2013,80.7221,78.4499,83.0429,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2014,81.2167,78.9766,83.5036,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2015,82.2436,80.0224,84.5102,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2016,77.5501,75.409,79.7357,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2000,107.587,104.7078,110.5252,2000-2007,2.0503,1.2098,2.8978,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2001,110.739,107.8316,113.7048,2007-2016,-0.5825,-1.1266,-0.0353,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2002,108.8429,105.971,111.7727,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2003,115.969,113.0093,118.9863,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2004,120.0983,117.0887,123.1655,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2005,118.7313,115.7191,121.8018,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2006,120.7022,117.685,123.7767,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2007,122.9786,119.9305,126.0841,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2008,123.1495,120.0861,126.2707,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2009,123.6123,120.5304,126.7523,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2010,122.1987,119.138,125.3174,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2011,120.3283,117.2892,123.4255,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2012,120.4653,117.425,123.5637,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2013,119.9715,116.9449,123.0559,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2014,123.4193,120.3577,126.5383,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2015,119.9212,116.9158,122.9835,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Observed Rates,2016,113.6942,110.7887,116.656,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2000,107.587,104.7078,110.5252,2000-2007,2.0036,1.2392,2.7737,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2001,110.739,107.8316,113.7048,2007-2016,-0.207,-0.7039,0.2924,Stable,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2002,108.8429,105.971,111.7727,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2003,115.969,113.0093,118.9863,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2004,120.0983,117.0887,123.1655,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2005,118.7313,115.7191,121.8018,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2006,120.7022,117.685,123.7767,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2007,122.9786,119.9305,126.0841,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2008,123.4689,120.3976,126.5981,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2009,124.2577,121.1597,127.414,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2010,123.1516,120.067,126.2944,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2011,121.5923,118.5213,124.7217,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2012,122.0435,118.9633,125.1822,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2013,121.8305,118.7571,124.9623,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2014,125.9407,122.8165,129.123,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2015,123.2461,120.1573,126.393,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2016,118.6013,115.57,121.6905,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2000,1.1852,1.0262,1.3619,2000-2016,1.618,0.8091,2.4333,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2001,1.3256,1.1569,1.5122,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2002,1.1454,0.9882,1.3207,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2003,1.1199,0.9642,1.2938,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2004,1.2068,1.0448,1.3871,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2005,1.2768,1.107,1.4656,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2006,1.2771,1.1079,1.4651,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2007,1.4131,1.2341,1.611,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2008,1.2329,1.0652,1.4198,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2009,1.2518,1.0819,1.441,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2010,1.3501,1.1713,1.5486,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2011,1.2109,1.0412,1.4006,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2012,1.2923,1.1158,1.489,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2013,1.438,1.2495,1.647,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2014,1.6714,1.4673,1.8962,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2015,1.4998,1.3054,1.7151,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Observed Rates,2016,1.5151,1.3182,1.7331,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2000,1.1852,1.0262,1.3619,2000-2016,1.8232,0.9972,2.6559,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2001,1.3256,1.1569,1.5122,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2002,1.1454,0.9882,1.3207,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2003,1.1199,0.9642,1.2938,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2004,1.2068,1.0448,1.3871,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2005,1.2768,1.107,1.4656,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2006,1.2771,1.1079,1.4651,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2007,1.4131,1.2341,1.611,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2008,1.2362,1.068,1.4235,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2009,1.2587,1.0879,1.449,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2010,1.3612,1.181,1.5613,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2011,1.2241,1.0525,1.4158,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2012,1.311,1.1319,1.5105,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2013,1.462,1.2703,1.6744,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2014,1.7052,1.4969,1.9344,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2015,1.5384,1.3389,1.759,,,,,,Non-Hodgkin Lymphoma
Both Sexes,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2016,1.5774,1.3725,1.804,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2000,20.405,20.1005,20.7129,2000-2007,1.0071,0.4845,1.5324,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2001,20.4172,20.1143,20.7235,2007-2016,-0.8118,-1.1466,-0.4758,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2002,20.6246,20.3217,20.9309,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2003,20.9245,20.621,21.2313,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2004,21.3001,20.9952,21.6085,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2005,21.2663,20.9598,21.5761,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2006,21.544,21.2392,21.852,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2007,21.6567,21.3529,21.9637,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2008,21.5874,21.2855,21.8926,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2009,21.4897,21.1898,21.7929,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2010,21.4084,21.111,21.7091,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2011,20.7981,20.5066,21.0929,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2012,20.9983,20.7078,21.292,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2013,20.6856,20.3993,20.975,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2014,21.034,20.747,21.3241,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2015,20.6521,20.3696,20.9377,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Observed Rates,2016,19.7082,19.4338,19.9858,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2000,20.405,20.1005,20.7129,2000-2007,0.9609,0.5266,1.3971,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2001,20.4172,20.1143,20.7235,2007-2016,-0.4435,-0.7228,-0.1634,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2002,20.6246,20.3217,20.9309,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2003,20.9245,20.621,21.2313,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2004,21.3001,20.9952,21.6085,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2005,21.2663,20.9598,21.5761,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2006,21.544,21.2392,21.852,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2007,21.6567,21.3529,21.9637,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2008,21.6429,21.3402,21.9489,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2009,21.6001,21.2986,21.9048,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2010,21.5725,21.2728,21.8755,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2011,21.0137,20.7191,21.3115,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2012,21.2704,20.9761,21.5679,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2013,21.0047,20.714,21.2986,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2014,21.4562,21.1635,21.7521,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2015,21.1999,20.91,21.493,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),All Ages,Delay-adjusted Rates,2016,20.5461,20.26,20.8353,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2000,5.3881,5.204,5.577,2000-2002,-1.7932,-4.3036,0.7831,Stable,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2001,5.2786,5.0968,5.4651,2002-2009,0.2461,-0.1983,0.6924,Stable,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2002,5.2104,5.0299,5.3957,2009-2016,-1.4091,-1.7759,-1.0409,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2003,5.1829,5.0029,5.3677,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2004,5.2345,5.0533,5.4205,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2005,5.2506,5.067,5.4392,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2006,5.1846,5.0031,5.371,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2007,5.2512,5.0677,5.4398,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2008,5.3332,5.1472,5.5242,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2009,5.3609,5.1734,5.5534,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2010,5.1798,4.9947,5.37,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2011,5.0497,4.8661,5.2385,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2012,5.0007,4.8175,5.1892,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2013,4.9658,4.7825,5.1543,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2014,4.9729,4.7881,5.163,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2015,4.9021,4.7182,5.0914,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Observed Rates,2016,4.7721,4.5902,4.9593,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,5.3881,5.204,5.577,2000-2003,-1.2407,-2.5952,0.1327,Stable,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,5.2786,5.0968,5.4651,2003-2009,0.5463,-0.0798,1.1764,Stable,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,5.2104,5.0299,5.3957,2009-2012,-1.8687,-4.6701,1.015,Stable,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,5.1829,5.0029,5.3677,2012-2016,-0.3031,-1.2488,0.6515,Stable,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,5.2345,5.0533,5.4205,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,5.2506,5.067,5.4392,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,5.1846,5.0031,5.371,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,5.2512,5.0677,5.4398,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,5.3456,5.1591,5.537,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,5.3855,5.1972,5.5789,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,5.2152,5.0288,5.4067,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,5.0976,4.9122,5.2881,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,5.0593,4.8739,5.25,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,5.0344,4.8485,5.2254,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,5.0596,4.8715,5.2529,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,5.0149,4.8267,5.2085,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,4.9521,4.7633,5.1463,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2000,33.5344,32.5272,34.5647,2000-2006,0.3177,-0.7091,1.3551,Stable,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2001,33.4464,32.4558,34.4597,2006-2016,-0.8616,-1.2854,-0.436,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2002,34.526,33.5377,35.5361,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2003,33.9695,33.0067,34.9533,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2004,34.3605,33.4069,35.3344,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2005,33.7148,32.7766,34.6731,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2006,34.5907,33.6615,35.5389,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2007,34.5064,33.5947,35.4367,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2008,33.8918,32.9995,34.8021,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2009,32.9151,32.0479,33.7999,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2010,32.9102,32.0548,33.7828,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2011,31.7867,30.9566,32.6334,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2012,33.2108,32.3637,34.0745,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2013,32.096,31.2668,32.9416,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2014,32.8614,32.0261,33.7132,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2015,32.1458,31.3218,32.986,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Observed Rates,2016,30.9251,30.1177,31.7487,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,33.5344,32.5272,34.5647,2000-2016,-0.2851,-0.4826,-0.0872,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,33.4464,32.4558,34.4597,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,34.526,33.5377,35.5361,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,33.9695,33.0067,34.9533,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,34.3605,33.4069,35.3344,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,33.7148,32.7766,34.6731,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,34.5907,33.6615,35.5389,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,34.5064,33.5947,35.4367,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,33.9857,33.0909,34.8985,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,33.0989,32.2269,33.9886,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,33.1819,32.3193,34.0616,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,32.1383,31.299,32.9943,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,33.6738,32.8149,34.5495,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,32.6305,31.7875,33.4901,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,33.5658,32.7125,34.4357,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,33.0441,32.197,33.9077,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,32.2793,31.4364,33.1389,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2000,90.8093,89.0107,92.6351,2000-2007,1.662,1.0026,2.3257,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2001,91.6372,89.8343,93.467,2007-2016,-0.7218,-1.134,-0.3079,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2002,92.3876,90.5785,94.2236,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2003,95.578,93.742,97.4409,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2004,97.7912,95.9368,99.6723,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2005,98.1969,96.3247,100.0963,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2006,99.7328,97.8645,101.6277,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2007,100.3431,98.4792,102.2333,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2008,100.0549,98.2043,101.9314,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2009,100.2824,98.4399,102.1505,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2010,100.6818,98.8488,102.54,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2011,97.931,96.1362,99.7508,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2012,98.1057,96.3311,99.9045,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2013,97.1538,95.4109,98.9204,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2014,98.962,97.2215,100.7257,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2015,97.1946,95.4899,98.9219,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Observed Rates,2016,91.9192,90.2792,93.5814,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,90.8093,89.0107,92.6351,2000-2007,1.6113,1.0641,2.1614,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,91.6372,89.8343,93.467,2007-2016,-0.3447,-0.6882,-0.0001,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,92.3876,90.5785,94.2236,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,95.578,93.742,97.4409,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,97.7912,95.9368,99.6723,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,98.1969,96.3247,100.0963,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,99.7328,97.8645,101.6277,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,100.3431,98.4792,102.2333,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,100.3119,98.4565,102.1932,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,100.7963,98.9444,102.674,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,101.455,99.608,103.3275,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,98.9455,97.132,100.7841,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,99.3735,97.5759,101.1955,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,98.6521,96.8823,100.4458,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,100.9706,99.1947,102.77,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,99.817,98.0662,101.5908,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,95.9112,94.1998,97.6454,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2000,0.8701,0.7368,1.0205,2000-2016,1.6854,0.7269,2.653,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2001,1.0777,0.9288,1.2437,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2002,0.9308,0.7925,1.0862,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2003,0.8024,0.674,0.948,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2004,0.9691,0.8276,1.1278,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2005,0.98,0.8356,1.1421,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2006,0.9133,0.7742,1.07,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2007,1.0236,0.8755,1.1896,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2008,0.9574,0.8143,1.1183,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2009,0.8486,0.7138,1.0013,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2010,1.1396,0.9825,1.3146,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2011,0.9386,0.7962,1.0991,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2012,1.0796,0.9264,1.2509,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2013,1.1637,1.0041,1.3414,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2014,1.1702,1.0097,1.3489,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2015,1.1777,1.0162,1.3575,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Observed Rates,2016,1.1888,1.0262,1.3699,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,0.8701,0.7368,1.0205,2000-2016,1.8614,0.884,2.8482,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,1.0777,0.9288,1.2437,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,0.9308,0.7925,1.0862,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,0.8024,0.674,0.948,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,0.9691,0.8276,1.1278,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,0.98,0.8356,1.1421,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,0.9133,0.7742,1.07,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,1.0236,0.8755,1.1896,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,0.9596,0.8162,1.1209,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,0.8524,0.717,1.0057,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,1.1474,0.9892,1.3236,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,0.9476,0.8038,1.1095,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,1.0918,0.9368,1.2649,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,1.1789,1.0172,1.3588,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,1.1913,1.0279,1.3731,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,1.2036,1.0385,1.3872,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,1.23,1.0617,1.4171,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2000,4.3566,4.1233,4.5997,2000-2016,-0.334,-0.6147,-0.0524,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2001,4.3788,4.1439,4.6236,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2002,4.2632,4.0298,4.5066,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2003,4.1963,3.9633,4.4393,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2004,4.1031,3.8712,4.3451,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2005,4.2542,4.015,4.5038,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2006,4.0916,3.8583,4.3351,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2007,4.0963,3.8623,4.3406,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2008,4.3291,4.0875,4.5811,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2009,4.4695,4.2231,4.7264,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2010,4.1936,3.9544,4.4434,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2011,4.2449,4.0029,4.4974,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2012,4.0678,3.8315,4.3146,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2013,4.0427,3.8081,4.2879,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2014,4.0813,3.8456,4.3275,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2015,4.0515,3.8179,4.2955,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Observed Rates,2016,4.1118,3.8772,4.3567,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,4.3566,4.1233,4.5997,2000-2016,-0.161,-0.4481,0.1269,Stable,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,4.3788,4.1439,4.6236,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,4.2632,4.0298,4.5066,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,4.1963,3.9633,4.4393,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,4.1031,3.8712,4.3451,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,4.2542,4.015,4.5038,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,4.0916,3.8583,4.3351,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,4.0963,3.8623,4.3406,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,4.3388,4.0967,4.5914,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,4.4901,4.2425,4.7481,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,4.2223,3.9815,4.4737,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,4.2849,4.0407,4.5398,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,4.1158,3.8767,4.3655,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,4.0984,3.8605,4.3469,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,4.1538,3.9139,4.4043,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,4.1462,3.9071,4.3959,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,4.2644,4.0211,4.5183,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2000,23.6721,23.0757,24.2799,2000-2007,0.2132,-0.4442,0.875,Stable,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2001,23.1954,22.6127,23.7892,2007-2016,-1.1972,-1.6259,-0.7667,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2002,23.8046,23.223,24.397,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2003,23.6333,23.0617,24.2156,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2004,23.9402,23.3713,24.5195,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2005,23.4757,22.9131,24.0487,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2006,23.9878,23.4287,24.557,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2007,24.0215,23.4672,24.5857,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2008,23.6882,23.1409,24.2454,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2009,23.1851,22.6468,23.7332,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2010,22.8683,22.3378,23.4083,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2011,22.0861,21.5682,22.6136,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2012,22.7795,22.2536,23.3149,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2013,22.1162,21.5972,22.6448,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2014,22.4611,21.9373,22.9944,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2015,21.969,21.4502,22.4973,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Observed Rates,2016,20.9788,20.4715,21.4958,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,23.6721,23.0757,24.2799,2000-2006,0.3095,-0.482,1.1074,Stable,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,23.1954,22.6127,23.7892,2006-2016,-0.7704,-1.116,-0.4236,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,23.8046,23.223,24.397,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,23.6333,23.0617,24.2156,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,23.9402,23.3713,24.5195,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,23.4757,22.9131,24.0487,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,23.9878,23.4287,24.557,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,24.0215,23.4672,24.5857,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,23.7511,23.2023,24.3097,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,23.3078,22.7666,23.8587,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,23.0475,22.513,23.5917,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,22.3206,21.7972,22.8535,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,23.0829,22.5501,23.6253,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,22.4674,21.9402,23.0042,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,22.9154,22.3812,23.4592,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,22.5519,22.0196,23.0939,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,21.8682,21.3395,22.4068,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2000,76.6766,74.3652,79.0416,2000-2008,0.9866,0.3541,1.6231,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2001,75.1921,72.8953,77.543,2008-2016,-0.9823,-1.5454,-0.4159,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2002,77.8892,75.542,80.2907,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2003,77.6656,75.3189,80.0669,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2004,78.1396,75.7838,80.5501,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2005,79.8278,77.4224,82.2889,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2006,81.9098,79.5005,84.3734,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2007,81.1209,78.7483,83.5466,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2008,80.7559,78.4234,83.14,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2009,80.3087,78.0179,82.6495,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2010,81.5072,79.2288,83.8343,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2011,78.477,76.275,80.7263,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2012,80.0698,77.9017,82.2826,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2013,77.8064,75.7267,79.9286,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2014,78.3135,76.2705,80.3971,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2015,78.3019,76.2968,80.3462,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Observed Rates,2016,73.2761,71.3675,75.2227,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,76.6766,74.3652,79.0416,2000-2007,1.1393,0.449,1.8344,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,75.1921,72.8953,77.543,2007-2016,-0.4541,-0.8767,-0.0296,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,77.8892,75.542,80.2907,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,77.6656,75.3189,80.0669,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,78.1396,75.7838,80.5501,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,79.8278,77.4224,82.2889,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,81.9098,79.5005,84.3734,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,81.1209,78.7483,83.5466,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,80.9645,78.626,83.3547,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,80.7199,78.4173,83.0726,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,82.1319,79.836,84.4767,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,79.2908,77.0659,81.5633,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,81.1024,78.9064,83.3437,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,79.0142,76.9022,81.1691,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,79.9064,77.8218,82.0323,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,80.406,78.3468,82.505,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,76.4443,74.453,78.4745,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2000,106.2735,103.4928,109.11,2000-2007,2.0136,1.1717,2.8625,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2001,109.6316,106.8245,112.4937,2007-2016,-0.6451,-1.1809,-0.1063,Trend is Falling,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2002,108.252,105.4774,111.0809,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2003,115.1781,112.3266,118.0835,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2004,119.2942,116.4,122.2419,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2005,118.2967,115.4013,121.2461,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2006,119.2351,116.3543,122.1688,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2007,121.3764,118.4716,124.334,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2008,121.1722,118.2657,124.1316,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2009,122.1379,119.214,125.1149,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2010,121.6629,118.7535,124.6251,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2011,119.218,116.3421,122.1464,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2012,117.8408,114.989,120.7449,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2013,118.324,115.4786,121.2213,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2014,121.556,118.6851,124.4782,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2015,117.8673,115.059,120.7263,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Observed Rates,2016,112.3188,109.5998,115.0876,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,106.2735,103.4928,109.11,2000-2007,1.9646,1.1973,2.7378,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,109.6316,106.8245,112.4937,2007-2016,-0.2698,-0.7602,0.223,Stable,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,108.252,105.4774,111.0809,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,115.1781,112.3266,118.0835,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,119.2942,116.4,122.2419,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,118.2967,115.4013,121.2461,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,119.2351,116.3543,122.1688,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,121.3764,118.4716,124.334,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,121.4821,118.5681,124.4491,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,122.7643,119.8253,125.7564,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,122.5988,119.6669,125.5836,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,120.4521,117.5464,123.4106,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,119.366,116.4772,122.3074,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,120.1402,117.2511,123.0816,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,124.0194,121.0901,127.0006,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,121.0569,118.1724,123.9929,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,117.2123,114.3746,120.1013,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2000,1.1301,0.9966,1.2764,2000-2016,1.2539,0.5912,1.921,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2001,1.2386,1.0989,1.391,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2002,1.2351,1.0956,1.3874,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2003,1.0482,0.92,1.1893,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2004,1.1592,1.0245,1.3067,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2005,1.1983,1.06,1.3496,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2006,1.186,1.0494,1.3356,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2007,1.3104,1.1664,1.4673,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2008,1.1558,1.0207,1.3038,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2009,1.1637,1.0282,1.3123,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2010,1.2993,1.1549,1.4568,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2011,1.151,1.015,1.3002,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2012,1.3147,1.1686,1.474,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2013,1.305,1.1588,1.4645,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2014,1.4475,1.2929,1.6154,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2015,1.3981,1.2458,1.5639,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Observed Rates,2016,1.3999,1.2471,1.5662,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,1.1301,0.9966,1.2764,2000-2016,1.4337,0.7503,2.1217,Trend is Rising,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,1.2386,1.0989,1.391,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,1.2351,1.0956,1.3874,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,1.0482,0.92,1.1893,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,1.1592,1.0245,1.3067,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,1.1983,1.06,1.3496,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,1.186,1.0494,1.3356,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,1.3104,1.1664,1.4673,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,1.1584,1.023,1.3068,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,1.1691,1.0329,1.3183,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,1.3084,1.163,1.467,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,1.1622,1.0248,1.3127,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,1.3305,1.1827,1.4916,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,1.3225,1.1744,1.4841,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,1.4734,1.3161,1.6443,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,1.4291,1.2734,1.5985,,,,,,Non-Hodgkin Lymphoma
Both Sexes,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,1.4509,1.2925,1.623,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2000,16.4089,16.0751,16.7478,2000-2008,0.4598,0.089,0.8319,Trend is Rising,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2001,16.4242,16.0927,16.7609,2008-2016,-0.909,-1.2563,-0.5606,Trend is Falling,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2002,16.5004,16.1697,16.8361,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2003,17.003,16.6697,17.3413,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2004,17.1218,16.7891,17.4596,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2005,16.8026,16.4713,17.139,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2006,17.0218,16.693,17.3555,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2007,16.9017,16.5761,17.2322,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2008,16.9945,16.6699,17.3239,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2009,17.0453,16.722,17.3735,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2010,16.874,16.5551,17.1977,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2011,16.4541,16.141,16.7718,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2012,16.4868,16.176,16.8022,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2013,16.2106,15.9048,16.521,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2014,16.3814,16.0767,16.6905,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2015,16.1733,15.873,16.4781,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Observed Rates,2016,15.7912,15.4965,16.0903,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2000,16.4089,16.0751,16.7478,2000-2004,1.2688,0.2163,2.3323,Trend is Rising,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2001,16.4242,16.0927,16.7609,2004-2016,-0.3537,-0.539,-0.1681,Trend is Falling,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2002,16.5004,16.1697,16.8361,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2003,17.003,16.6697,17.3413,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2004,17.1218,16.7891,17.4596,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2005,16.8026,16.4713,17.139,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2006,17.0218,16.693,17.3555,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2007,16.9017,16.5761,17.2322,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2008,17.027,16.7018,17.3571,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2009,17.1106,16.786,17.44,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2010,16.9707,16.6499,17.2962,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2011,16.5804,16.2649,16.9005,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2012,16.6446,16.3309,16.963,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2013,16.397,16.0877,16.7109,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2014,16.6317,16.3224,16.9456,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2015,16.5007,16.1943,16.8116,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2016,16.282,15.9783,16.5903,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2000,4.0831,3.884,4.2898,2000-2016,-0.0664,-0.2994,0.1672,Stable,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2001,4.0131,3.8165,4.2172,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2002,3.9912,3.7958,4.1941,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2003,4.0695,3.8726,4.2739,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2004,4.0143,3.8187,4.2174,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2005,4.0576,3.8588,4.264,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2006,3.9966,3.801,4.1997,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2007,4.09,3.8911,4.2964,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2008,4.158,3.9575,4.3659,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2009,4.2931,4.0887,4.5052,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2010,3.9401,3.7437,4.144,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2011,3.997,3.7991,4.2026,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2012,4.0719,3.8718,4.2797,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2013,4.0872,3.8864,4.2956,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2014,4.0063,3.8066,4.2137,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2015,3.9267,3.7289,4.1321,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Observed Rates,2016,3.9748,3.7758,4.1816,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,4.0831,3.884,4.2898,2000-2016,0.0682,-0.1508,0.2877,Stable,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,4.0131,3.8165,4.2172,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,3.9912,3.7958,4.1941,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,4.0695,3.8726,4.2739,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,4.0143,3.8187,4.2174,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,4.0576,3.8588,4.264,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,3.9966,3.801,4.1997,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,4.09,3.8911,4.2964,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,4.1655,3.9647,4.3738,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,4.3087,4.1035,4.5214,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,3.9613,3.764,4.1663,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,4.0261,3.8267,4.2331,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,4.1086,3.9067,4.3182,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,4.1318,3.9289,4.3424,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,4.0638,3.8612,4.2741,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,4.0015,3.8,4.2109,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,4.0808,3.8764,4.293,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2000,26.3881,25.2724,27.5403,2000-2016,-0.4151,-0.6239,-0.206,Trend is Falling,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2001,27.0438,25.9327,28.1903,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2002,28.0837,26.9728,29.2287,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2003,27.6413,26.5601,28.7552,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2004,27.7573,26.6918,28.8545,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2005,26.5891,25.5534,27.656,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2006,27.6916,26.6607,28.7522,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2007,27.2292,26.2265,28.2605,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2008,26.6766,25.6981,27.6829,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2009,26.0204,25.0694,26.9982,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2010,26.5844,25.6378,27.5571,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2011,25.9127,24.9905,26.8604,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2012,26.6562,25.7251,27.6125,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2013,25.7371,24.8275,26.6715,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2014,26.3082,25.394,27.2469,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2015,25.8814,24.9789,26.8083,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Observed Rates,2016,25.757,24.8582,26.6801,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,26.3881,25.2724,27.5403,2000-2016,-0.2569,-0.4638,-0.0496,Trend is Falling,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,27.0438,25.9327,28.1903,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,28.0837,26.9728,29.2287,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,27.6413,26.5601,28.7552,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,27.7573,26.6918,28.8545,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,26.5891,25.5534,27.656,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,27.6916,26.6607,28.7522,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,27.2292,26.2265,28.2605,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,26.7277,25.7474,27.7359,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,26.1211,25.1665,27.1027,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,26.7365,25.7844,27.7147,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,26.1088,25.1796,27.0636,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,26.9132,25.9731,27.8786,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,26.0346,25.1145,26.9798,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,26.7126,25.7843,27.6657,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,26.4053,25.4846,27.3508,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,26.5729,25.6455,27.525,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2000,75.142,73.1745,77.1487,2000-2008,0.7872,0.2033,1.3745,Trend is Rising,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2001,74.8864,72.9304,76.8814,2008-2016,-1.1818,-1.7233,-0.6373,Trend is Falling,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2002,74.38,72.429,76.37,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2003,78.4334,76.4359,80.4696,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2004,79.5524,77.5446,81.5988,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2005,78.165,76.1597,80.2094,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2006,78.9401,76.9474,80.9712,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2007,78.0043,76.0344,80.0119,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2008,79.0049,77.0331,81.014,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2009,79.4117,77.4471,81.4132,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2010,79.4086,77.4587,81.3948,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2011,76.5567,74.6562,78.493,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2012,75.5047,73.6413,77.4028,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2013,74.3227,72.4981,76.1811,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2014,75.4589,73.6459,77.3049,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2015,74.7754,72.9925,76.5906,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Observed Rates,2016,71.624,69.9029,73.3765,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,75.142,73.1745,77.1487,2000-2008,0.7779,0.1989,1.3602,Trend is Rising,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,74.8864,72.9304,76.8814,2008-2016,-0.869,-1.4077,-0.3275,Trend is Falling,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,74.38,72.429,76.37,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,78.4334,76.4359,80.4696,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,79.5524,77.5446,81.5988,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,78.165,76.1597,80.2094,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,78.9401,76.9474,80.9712,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,78.0043,76.0344,80.0119,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,79.1586,77.183,81.1716,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,79.7198,77.7476,81.729,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,79.8712,77.9099,81.8689,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,77.157,75.2416,79.1085,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,76.2385,74.357,78.155,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,75.1888,73.343,77.0688,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,76.6311,74.7899,78.5057,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,76.3156,74.4958,78.168,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,73.9327,72.156,75.7414,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2000,0.5426,0.415,0.697,2000-2016,1.4432,0.2102,2.6915,Trend is Rising,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2001,0.727,0.5782,0.9023,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2002,0.5833,0.4511,0.7422,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2003,0.5316,0.4056,0.6844,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2004,0.6986,0.553,0.8708,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2005,0.6488,0.5066,0.8185,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2006,0.5275,0.4005,0.6819,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2007,0.6883,0.5413,0.8626,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2008,0.6256,0.4867,0.7916,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2009,0.5297,0.4022,0.6846,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2010,0.7189,0.5692,0.896,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2011,0.6765,0.5312,0.8492,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2012,0.7581,0.6038,0.9397,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2013,0.7121,0.5629,0.8886,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2014,0.7759,0.6197,0.9593,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2015,0.6347,0.4939,0.8032,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Observed Rates,2016,0.7922,0.6336,0.9783,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,0.5426,0.415,0.697,2000-2016,1.5832,0.3422,2.8395,Trend is Rising,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,0.727,0.5782,0.9023,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,0.5833,0.4511,0.7422,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,0.5316,0.4056,0.6844,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,0.6986,0.553,0.8708,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,0.6488,0.5066,0.8185,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,0.5275,0.4005,0.6819,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,0.6883,0.5413,0.8626,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,0.6267,0.4875,0.793,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,0.5316,0.4037,0.6871,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,0.7228,0.5723,0.9008,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,0.6812,0.5349,0.855,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,0.7648,0.6092,0.9479,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,0.7202,0.5693,0.8986,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,0.7868,0.6284,0.9727,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,0.6475,0.5038,0.8192,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,0.8121,0.6496,1.0026,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2000,3.4846,3.2265,3.7579,2000-2016,0.0648,-0.296,0.4269,Stable,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2001,3.4293,3.1727,3.7012,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2002,3.2789,3.0273,3.5459,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2003,3.3143,3.0603,3.5837,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2004,3.2846,3.0307,3.5539,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2005,3.4722,3.2082,3.7521,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2006,3.255,3.0015,3.5241,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2007,3.3725,3.1134,3.6472,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2008,3.4452,3.1846,3.7212,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2009,3.6998,3.4281,3.987,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2010,3.2823,3.0267,3.5534,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2011,3.3261,3.0684,3.5993,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2012,3.5102,3.246,3.7898,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2013,3.3527,3.0965,3.6243,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2014,3.3767,3.1196,3.6491,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2015,3.3258,3.0721,3.5946,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Observed Rates,2016,3.4863,3.2276,3.7601,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,3.4846,3.2265,3.7579,2000-2016,0.2004,-0.1654,0.5676,Stable,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,3.4293,3.1727,3.7012,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,3.2789,3.0273,3.5459,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,3.3143,3.0603,3.5837,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,3.2846,3.0307,3.5539,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,3.4722,3.2082,3.7521,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,3.255,3.0015,3.5241,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,3.3725,3.1134,3.6472,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,3.4514,3.1904,3.728,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,3.7134,3.4407,4.0017,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,3.3002,3.0432,3.5727,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,3.3493,3.0898,3.6244,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,3.542,3.2755,3.8242,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,3.3892,3.1301,3.6637,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,3.4257,3.1649,3.702,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,3.3893,3.1307,3.6631,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,3.5779,3.3123,3.8587,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2000,18.2888,17.6343,18.9615,2000-2002,2.5137,-1.3877,6.5695,Stable,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2001,18.38,17.7333,19.0443,2002-2016,-0.5444,-0.71,-0.3784,Trend is Falling,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2002,19.1181,18.4689,19.7843,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2003,19.0815,18.4427,19.7367,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2004,18.924,18.2962,19.568,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2005,18.2666,17.6509,18.8985,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2006,19.0049,18.389,19.6362,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2007,18.7481,18.1433,19.3681,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2008,18.5967,17.9986,19.2099,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2009,18.3652,17.7757,18.9695,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2010,18.1567,17.5775,18.7504,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2011,17.9398,17.3678,18.5261,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2012,18.2123,17.6378,18.8011,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2013,18.0115,17.4386,18.5988,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2014,18.0277,17.4564,18.6133,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2015,17.7867,17.2196,18.368,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Observed Rates,2016,17.5412,16.9786,18.1181,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,18.2888,17.6343,18.9615,2000-2002,2.1781,-1.6638,6.1702,Stable,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,18.38,17.7333,19.0443,2002-2016,-0.3685,-0.5325,-0.2044,Trend is Falling,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,19.1181,18.4689,19.7843,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,19.0815,18.4427,19.7367,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,18.924,18.2962,19.568,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,18.2666,17.6509,18.8985,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,19.0049,18.389,19.6362,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,18.7481,18.1433,19.3681,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,18.6318,18.0325,19.2461,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,18.4346,17.8429,19.0411,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,18.2588,17.6763,18.8558,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,18.0753,17.4989,18.6659,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,18.3845,17.8046,18.9787,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,18.2163,17.6369,18.8102,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,18.2991,17.7193,18.8933,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,18.1402,17.562,18.7329,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,18.075,17.4955,18.6691,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2000,62.8225,60.2504,65.4762,2000-2016,-0.2601,-0.5566,0.0372,Stable,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2001,59.8191,57.3045,62.4156,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2002,63.2663,60.6731,65.9418,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2003,64.3205,61.706,67.0174,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2004,64.1459,61.5367,66.8374,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2005,63.6562,61.031,66.3652,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2006,64.1067,61.5077,66.7871,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2007,61.5307,59.0138,64.1272,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2008,64.76,62.215,67.3822,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2009,63.9608,61.4689,66.5276,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2010,64.5751,62.1052,67.1179,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2011,61.9072,59.5301,64.3549,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2012,62.2769,59.9479,64.6728,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2013,60.2837,58.0485,62.5825,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2014,61.8531,59.6443,64.1226,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2015,62.3187,60.1418,64.5539,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Observed Rates,2016,58.1728,56.1088,60.2931,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,62.8225,60.2504,65.4762,2000-2016,-0.0993,-0.3653,0.1674,Stable,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,59.8191,57.3045,62.4156,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,63.2663,60.6731,65.9418,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,64.3205,61.706,67.0174,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,64.1459,61.5367,66.8374,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,63.6562,61.031,66.3652,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,64.1067,61.5077,66.7871,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,61.5307,59.0138,64.1272,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,64.8866,62.3366,67.5139,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,64.209,61.7075,66.7857,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,64.9548,62.4704,67.5124,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,62.3949,59.9989,64.8617,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,62.8825,60.5308,65.3015,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,60.9936,58.7321,63.3193,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,62.823,60.5795,65.1278,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,63.6022,61.3804,65.8831,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,60.0428,57.9124,62.2307,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2000,88.6221,85.6285,91.6932,2000-2007,1.3017,0.4036,2.2078,Trend is Rising,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2001,91.3732,88.3542,94.4687,2007-2016,-1.2065,-1.7943,-0.6153,Trend is Falling,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2002,86.5408,83.6169,89.5404,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2003,93.8758,90.8397,96.9871,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2004,96.4103,93.3391,99.5563,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2005,94.0408,90.9934,97.1636,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2006,95.1712,92.1324,98.2839,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2007,96.03,92.9736,99.1604,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2008,94.5919,91.5577,97.7,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2009,96.3183,93.2516,99.4592,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2010,95.6396,92.5924,98.7605,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2011,92.5864,89.5873,95.6591,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2012,89.9787,87.0367,92.9938,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2013,89.6844,86.7612,92.6799,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2014,90.3466,87.4304,93.334,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2015,88.4058,85.5421,91.3399,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Observed Rates,2016,86.3425,83.5447,89.2092,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,88.6221,85.6285,91.6932,2000-2007,1.2661,0.3699,2.1703,Trend is Rising,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,91.3732,88.3542,94.4687,2007-2016,-0.9253,-1.5137,-0.3333,Trend is Falling,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,86.5408,83.6169,89.5404,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,93.8758,90.8397,96.9871,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,96.4103,93.3391,99.5563,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,94.0408,90.9934,97.1636,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,95.1712,92.1324,98.2839,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,96.03,92.9736,99.1604,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,94.7752,91.7352,97.8893,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,96.692,93.6133,99.845,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,96.1929,93.1281,99.3318,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,93.3101,90.2875,96.4066,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,90.8529,87.8822,93.897,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,90.7215,87.7644,93.7513,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,91.7402,88.7789,94.7735,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,90.2268,87.304,93.2209,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,89.1312,86.2429,92.0899,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2000,0.738,0.6059,0.8902,2000-2016,1.0661,0.1304,2.0105,Trend is Rising,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2001,0.8673,0.7241,1.0306,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2002,0.7636,0.6298,0.9173,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2003,0.687,0.5607,0.8333,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2004,0.8269,0.6883,0.9853,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2005,0.8829,0.7381,1.0479,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2006,0.8414,0.7019,1.0007,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2007,0.8864,0.7425,1.0501,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2008,0.8056,0.6694,0.9614,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2009,0.7402,0.6099,0.8902,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2010,0.8029,0.6661,0.9595,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2011,0.7819,0.6466,0.9371,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2012,0.9439,0.7945,1.1133,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2013,0.8019,0.6643,0.9596,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2014,0.9978,0.8435,1.1722,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2015,0.8401,0.6987,1.0017,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Observed Rates,2016,0.9716,0.8189,1.1446,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,0.738,0.6059,0.8902,2000-2016,1.2099,0.265,2.1637,Trend is Rising,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,0.8673,0.7241,1.0306,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,0.7636,0.6298,0.9173,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,0.687,0.5607,0.8333,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,0.8269,0.6883,0.9853,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,0.8829,0.7381,1.0479,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,0.8414,0.7019,1.0007,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,0.8864,0.7425,1.0501,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,0.807,0.6706,0.9631,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,0.7427,0.612,0.8933,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,0.8073,0.6698,0.9648,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,0.7875,0.6512,0.9438,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,0.9529,0.8021,1.1239,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,0.8113,0.672,0.9707,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,1.0121,0.8556,1.1888,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,0.8568,0.7126,1.0214,,,,,,Non-Hodgkin Lymphoma
Female,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,0.9972,0.8404,1.1745,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2000,12.4881,7.8335,18.6553,2000-2016,0.0191,-1.9375,2.0147,Stable,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2001,10.2117,6.2247,15.6065,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2002,6.9167,3.886,11.2471,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2003,12.8833,8.3803,18.7366,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2004,12.7321,8.5394,18.1365,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2005,10.6975,6.8817,15.7169,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2006,14.1048,9.702,19.6709,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2007,7.2034,4.3159,11.1757,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2008,10.5184,6.8414,15.3031,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2009,13.188,9.201,18.1927,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2010,11.8888,8.4346,16.2322,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2011,12.7938,9.0204,17.5082,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2012,9.0326,5.9353,13.0587,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2013,10.2223,7.0803,14.2131,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2014,10.4806,7.3262,14.464,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2015,10.274,7.1251,14.2555,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2016,12.8434,9.4504,17.0065,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2000,12.4881,7.8335,18.6553,2000-2016,0.653,-1.3671,2.7144,Stable,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2001,10.2117,6.2247,15.6065,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2002,6.9167,3.886,11.2471,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2003,12.8833,8.3803,18.7366,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2004,12.7321,8.5394,18.1365,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2005,10.6975,6.8817,15.7169,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2006,14.1048,9.702,19.6709,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2007,7.2034,4.3159,11.1757,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2008,10.5879,6.8866,15.4017,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2009,13.3629,9.3231,18.4293,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2010,12.1261,8.603,16.5492,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2011,13.1355,9.2613,17.9669,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2012,9.3352,6.1341,13.4849,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2013,10.6345,7.3658,14.7733,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2014,11.0177,7.7016,15.1892,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2015,11.0332,7.6517,15.2867,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2016,14.4957,10.6662,19.1574,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2010,29.8819,18.2488,46.1642,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2016,28.5968,18.0872,42.9993,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,30.4784,18.6131,47.0418,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,32.2758,20.4141,48.3004,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2003,71.6873,40.6195,117.1475,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2006,66.7708,38.0025,108.4791,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2008,58.488,33.1216,95.5381,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2009,65.8342,39.3653,103.2726,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2010,46.9066,26.4506,77.3805,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2011,65.1104,39.9463,100.1835,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2012,53.0215,31.1883,84.2654,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2013,47.9041,28.0005,76.6445,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2014,54.6623,33.4619,84.3274,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2015,54.0707,33.0985,83.2626,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2016,57.3217,35.95,86.5684,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,71.6873,40.6195,117.1475,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,66.7708,38.0025,108.4791,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,58.8747,33.3406,96.1323,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,66.7075,39.8875,104.5737,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,47.843,26.9787,78.8194,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,66.8493,41.0131,102.7349,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,54.7974,32.233,86.9364,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,49.8358,29.1297,79.5587,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,57.4635,35.1767,88.4426,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,58.0664,35.5444,89.1371,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,64.696,40.5749,97.2562,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2006,14.4914,8.273,23.5693,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2009,13.7599,8.0039,22.0592,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2010,16.4641,10.3071,25.0028,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2011,11.8804,6.7649,19.3799,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2014,10.4663,5.967,17.1716,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2016,14.9542,9.5491,22.4649,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,14.4914,8.273,23.5693,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,13.9425,8.1101,22.3354,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,16.7928,10.5129,25.4788,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,12.1976,6.9456,19.8657,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,11.0027,6.2728,17.9903,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,16.878,10.7776,25.2144,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2000,10.9444,9.8248,12.152,2000-2016,-0.1094,-0.6151,0.3989,Stable,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2001,12.0373,10.894,13.2638,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2002,11.4813,10.4136,12.6262,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2003,12.0104,10.9326,13.1628,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2004,11.163,10.1545,12.2423,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2005,10.4183,9.4741,11.4297,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2006,10.2147,9.2942,11.2001,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2007,10.6648,9.7446,11.6473,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2008,11.6997,10.7534,12.7058,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2009,11.6789,10.7535,12.6618,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2010,11.0641,10.1877,11.9955,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2011,11.6907,10.8119,12.6221,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2012,10.7422,9.9102,11.6254,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2013,10.6749,9.8646,11.5343,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2014,11.4242,10.6046,12.291,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2015,10.9814,10.1968,11.8113,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2016,11.3412,10.5568,12.1696,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2000,10.9444,9.8248,12.152,2000-2016,0.2606,-0.2773,0.8013,Stable,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2001,12.0373,10.894,13.2638,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2002,11.4813,10.4136,12.6262,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2003,12.0104,10.9326,13.1628,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2004,11.163,10.1545,12.2423,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2005,10.4183,9.4741,11.4297,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2006,10.2147,9.2942,11.2001,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2007,10.6648,9.7446,11.6473,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2008,11.7579,10.8069,12.769,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2009,11.793,10.8586,12.7853,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2010,11.2387,10.3485,12.1845,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2011,11.9252,11.0288,12.8748,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2012,11.0098,10.157,11.9147,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2013,11.0008,10.1657,11.886,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2014,11.875,11.0229,12.7756,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2015,11.4981,10.6765,12.3663,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2016,12.0332,11.2009,12.9112,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2000,2.2891,1.7948,2.8791,2000-2016,1.2121,0.2791,2.1537,Trend is Rising,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2001,2.8349,2.2873,3.4749,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2002,2.9921,2.4363,3.6377,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2003,2.4834,1.9888,3.0649,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2004,2.604,2.1018,3.1911,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2005,3.1935,2.6384,3.8319,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2006,2.5388,2.0537,3.1051,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2007,2.8131,2.3071,3.3984,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2008,3.2164,2.6837,3.8257,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2009,3.2386,2.7106,3.8413,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2010,2.8853,2.3877,3.4574,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2011,2.8523,2.3706,3.4056,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2012,3.0511,2.5501,3.6237,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2013,3.2702,2.757,3.853,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2014,3.1088,2.6067,3.6807,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2015,2.8111,2.3472,3.342,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2016,3.3668,2.866,3.9325,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,2.2891,1.7948,2.8791,2000-2016,1.5476,0.6173,2.4864,Trend is Rising,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,2.8349,2.2873,3.4749,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,2.9921,2.4363,3.6377,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,2.4834,1.9888,3.0649,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,2.604,2.1018,3.1911,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,3.1935,2.6384,3.8319,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,2.5388,2.0537,3.1051,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,2.8131,2.3071,3.3984,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,3.2302,2.6951,3.8419,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,3.2684,2.7355,3.8764,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,2.9258,2.4212,3.5055,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,2.9072,2.4162,3.4707,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,3.1194,2.607,3.7042,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,3.3546,2.8282,3.9518,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,3.2235,2.7029,3.8154,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,2.9264,2.4435,3.4779,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,3.5555,3.0266,4.1514,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2000,15.2862,12.2558,18.8419,2000-2016,-0.043,-1.0502,0.9745,Stable,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2001,15.6583,12.6493,19.1664,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2002,20.2751,16.9362,24.0793,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2003,18.8318,15.7191,22.3805,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2004,17.8887,14.9423,21.2456,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2005,16.2721,13.5495,19.3814,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2006,16.1519,13.5178,19.1495,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2007,16.6758,14.0686,19.6262,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2008,15.6687,13.22,18.4405,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2009,16.1328,13.7055,18.8668,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2010,19.5866,16.9676,22.4964,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2011,19.2127,16.6766,22.027,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2012,14.5979,12.4278,17.0391,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2013,17.2056,14.8771,19.7963,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2014,16.763,14.4989,19.2814,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2015,17.4782,15.1906,20.0139,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2016,17.1073,14.8712,19.5856,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,15.2862,12.2558,18.8419,2000-2016,0.3357,-0.6881,1.37,Stable,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,15.6583,12.6493,19.1664,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,20.2751,16.9362,24.0793,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,18.8318,15.7191,22.3805,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,17.8887,14.9423,21.2456,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,16.2721,13.5495,19.3814,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,16.1519,13.5178,19.1495,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,16.6758,14.0686,19.6262,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,15.7473,13.2863,18.5323,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,16.2955,13.8437,19.056,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,19.9177,17.2543,22.8749,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,19.619,17.0291,22.4907,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,14.9705,12.745,17.4714,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,17.7511,15.3482,20.4213,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,17.3883,15.0393,19.9975,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,18.3265,15.9275,20.9809,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,18.1756,15.7998,20.8029,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2000,55.3509,47.9164,63.6146,2000-2016,-0.5723,-1.3761,0.238,Stable,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2001,60.4315,52.88,68.7607,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2002,49.6539,43.0662,56.9697,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2003,58.4656,51.4555,66.1663,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2004,52.1893,45.7538,59.2794,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2005,44.8398,39.042,51.2585,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2006,47.1204,41.2838,53.5507,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2007,48.4893,42.6927,54.8524,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2008,55.5632,49.4863,62.1794,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2009,54.7212,48.8169,61.1412,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2010,47.7814,42.3913,53.6645,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2011,53.3718,47.8469,59.3593,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2012,50.204,44.9694,55.8781,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2013,45.323,40.4469,50.6195,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2014,52.7011,47.6451,58.1464,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2015,50.0537,45.238,55.2397,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2016,50.1591,45.4307,55.2415,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,55.3509,47.9164,63.6146,2000-2016,-0.1957,-1.0311,0.6468,Stable,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,60.4315,52.88,68.7607,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,49.6539,43.0662,56.9697,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,58.4656,51.4555,66.1663,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,52.1893,45.7538,59.2794,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,44.8398,39.042,51.2585,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,47.1204,41.2838,53.5507,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,48.4893,42.6927,54.8524,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,55.8523,49.7437,62.5019,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,55.2602,49.2977,61.7415,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,48.538,43.0623,54.5116,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,54.4304,48.7957,60.5335,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,51.489,46.1202,57.3045,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,46.7713,41.7387,52.233,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,54.8699,49.6045,60.5348,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,52.4752,47.4256,57.9065,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,53.2866,48.2626,58.6787,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2000,2.1546,1.5134,2.9773,2000-2016,2.3301,1.0092,3.6682,Trend is Rising,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2001,2.2967,1.6427,3.1258,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2002,2.2979,1.6504,3.116,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2003,2.208,1.5794,3.0039,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2004,2.5198,1.847,3.3567,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2005,2.8528,2.1381,3.7285,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2006,2.1544,1.5555,2.9081,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2007,2.4728,1.8386,3.2566,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2008,2.8158,2.1502,3.6251,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2009,3.4723,2.7279,4.3585,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2010,2.5934,1.9562,3.3724,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2011,2.636,2.0096,3.3988,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2012,3.2676,2.5513,4.122,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2013,2.8942,2.2393,3.6823,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2014,2.7256,2.0836,3.5022,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2015,2.7194,2.098,3.4689,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2016,3.6283,2.9147,4.4658,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,2.1546,1.5134,2.9773,2000-2016,2.676,1.3519,4.0174,Trend is Rising,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,2.2967,1.6427,3.1258,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,2.2979,1.6504,3.116,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,2.208,1.5794,3.0039,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,2.5198,1.847,3.3567,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,2.8528,2.1381,3.7285,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,2.1544,1.5555,2.9081,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,2.4728,1.8386,3.2566,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,2.8271,2.1588,3.6393,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,3.5049,2.7536,4.3988,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,2.6296,1.9835,3.4186,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,2.6865,2.0481,3.4627,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,3.3381,2.6062,4.2101,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,2.9723,2.2997,3.7803,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,2.8306,2.1637,3.635,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,2.8309,2.1842,3.6088,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,3.8265,3.074,4.7069,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2000,10.2168,8.4814,12.2026,2000-2016,0.0209,-0.8171,0.866,Stable,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2001,11.1999,9.4184,13.2195,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2002,13.9508,12.0055,16.1209,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2003,12.2993,10.5281,14.2832,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2004,11.7683,10.0782,13.6607,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2005,11.8434,10.1865,13.6934,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2006,11.1098,9.5463,12.8572,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2007,11.5845,10.0188,13.3263,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2008,11.4366,9.9197,13.1213,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2009,11.2565,9.7821,12.8918,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2010,12.7438,11.2135,14.4271,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2011,13.0526,11.5282,14.7248,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2012,10.2421,8.9107,11.718,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2013,12.3593,10.908,13.9515,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2014,11.6338,10.249,13.1554,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2015,11.6829,10.3165,13.1822,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2016,11.8978,10.529,13.397,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,10.2168,8.4814,12.2026,2000-2016,0.3855,-0.4627,1.2409,Stable,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,11.1999,9.4184,13.2195,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,13.9508,12.0055,16.1209,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,12.2993,10.5281,14.2832,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,11.7683,10.0782,13.6607,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,11.8434,10.1865,13.6934,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,11.1098,9.5463,12.8572,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,11.5845,10.0188,13.3263,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,11.492,9.9678,13.1846,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,11.3669,9.8781,13.0177,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,12.9485,11.3938,14.6577,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,13.324,11.7679,15.0298,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,10.4956,9.1314,12.0066,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,12.7238,11.23,14.361,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,12.0673,10.6307,13.6438,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,12.2289,10.7988,13.7955,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,12.6255,11.1731,14.2129,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2000,40.3317,32.5079,49.467,2000-2016,-0.825,-1.7131,0.0711,Stable,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2001,49.8242,41.2004,59.7146,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2002,41.5567,33.8773,50.4558,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2003,43.0888,35.3727,51.9859,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2004,40.0852,32.7767,48.5372,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2005,41.9334,34.5166,50.4644,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2006,37.5708,30.7156,45.4952,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2007,36.0665,29.5126,43.641,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2008,44.8773,37.6328,53.1053,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2009,37.4882,31.0585,44.8553,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2010,35.0274,28.9452,42.0066,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2011,39.4105,33.1255,46.5405,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2012,37.8314,31.8111,44.6526,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2013,32.7757,27.3231,38.9869,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2014,39.2494,33.5305,45.6622,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2015,40.6354,34.9406,46.9869,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2016,39.538,34.0788,45.6164,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,40.3317,32.5079,49.467,2000-2016,-0.4487,-1.3844,0.4958,Stable,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,49.8242,41.2004,59.7146,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,41.5567,33.8773,50.4558,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,43.0888,35.3727,51.9859,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,40.0852,32.7767,48.5372,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,41.9334,34.5166,50.4644,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,37.5708,30.7156,45.4952,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,36.0665,29.5126,43.641,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,45.1047,37.8235,53.3724,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,37.8695,31.3741,45.308,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,35.5598,29.3851,42.6399,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,40.2128,33.7993,47.4819,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,38.8151,32.6385,45.8053,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,33.7965,28.1737,40.1925,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,40.9792,35.0063,47.6652,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,42.5828,36.614,49.228,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,41.9934,36.1956,48.4343,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2000,71.7851,59.0401,86.482,2000-2016,-0.4189,-1.4966,0.6705,Stable,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2001,72.0383,59.6156,86.287,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2002,58.5139,47.8264,70.8888,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2003,75.2911,63.5066,88.6396,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2004,65.4338,54.8061,77.5312,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2005,48.02,39.2276,58.2005,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2006,57.5697,48.1275,68.3236,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2007,62.0825,52.4793,72.9328,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2008,67.2558,57.4924,78.2004,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2009,73.5777,63.5774,84.7031,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2010,61.737,52.7864,71.7653,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2011,68.6484,59.5009,78.8043,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2012,63.7423,55.1317,73.313,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2013,59.0525,50.907,68.1201,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2014,67.4201,59.01,76.6907,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2015,60.3594,52.5613,68.9817,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2016,61.7809,54.0066,70.3481,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,71.7851,59.0401,86.482,2000-2016,-0.0427,-1.1326,1.0592,Stable,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,72.0383,59.6156,86.287,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,58.5139,47.8264,70.8888,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,75.2911,63.5066,88.6396,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,65.4338,54.8061,77.5312,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,48.02,39.2276,58.2005,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,57.5697,48.1275,68.3236,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,62.0825,52.4793,72.9328,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,67.6125,57.7972,78.6128,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,74.2894,64.1924,85.518,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,62.739,53.6429,72.9235,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,69.9876,60.6612,80.3345,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,65.3569,56.5272,75.162,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,60.9687,52.5577,70.3206,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,70.0692,61.3252,79.6951,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,63.2997,55.1206,72.3282,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,65.6437,57.381,74.7306,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2010,1.1576,0.6614,1.8808,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2012,1.1408,0.652,1.8533,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2014,1.5323,0.9603,2.32,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,1.1749,0.6713,1.9073,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,1.1689,0.668,1.8962,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,1.5852,0.9933,2.3967,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2000,11.1434,10.301,12.0343,2000-2016,0.2928,-0.0454,0.6322,Stable,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2001,11.9859,11.1184,12.9012,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2002,11.7818,10.9331,12.6771,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2003,12.302,11.4434,13.2064,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2004,12.4858,11.6242,13.3928,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2005,12.7356,11.8504,13.6679,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2006,12.0319,11.2007,12.9072,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2007,12.2705,11.441,13.1431,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2008,12.045,11.2268,12.9058,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2009,12.8893,12.0482,13.7724,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2010,12.4089,11.5923,13.2667,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2011,12.1253,11.3298,12.961,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2012,13.018,12.2068,13.8685,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2013,12.4684,11.6799,13.2955,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2014,12.1602,11.3985,12.9592,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2015,12.2409,11.4794,13.0394,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Observed Rates,2016,12.3548,11.5997,13.1461,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2000,11.1434,10.301,12.0343,2000-2016,0.5409,0.2279,0.8548,Trend is Rising,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2001,11.9859,11.1184,12.9012,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2002,11.7818,10.9331,12.6771,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2003,12.302,11.4434,13.2064,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2004,12.4858,11.6242,13.3928,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2005,12.7356,11.8504,13.6679,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2006,12.0319,11.2007,12.9072,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2007,12.2705,11.441,13.1431,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2008,12.0834,11.2626,12.9469,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2009,12.9716,12.1252,13.8603,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2010,12.524,11.6998,13.3897,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2011,12.283,11.4771,13.1295,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2012,13.2199,12.3961,14.0833,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2013,12.716,11.9118,13.5594,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2014,12.4706,11.6894,13.2897,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2015,12.6271,11.8416,13.4503,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2016,12.9263,12.1365,13.7534,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2000,4.963,4.3737,5.6078,2000-2016,-1.116,-1.7316,-0.4965,Trend is Falling,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2001,4.6676,4.1008,5.2893,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2002,4.7327,4.165,5.3549,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2003,4.9879,4.4055,5.6245,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2004,4.71,4.1465,5.3277,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2005,4.921,4.3332,5.5655,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2006,4.6212,4.0637,5.233,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2007,4.7762,4.2065,5.4002,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2008,4.6054,4.0509,5.2135,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2009,4.5104,3.9586,5.1163,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2010,4.1231,3.5967,4.7036,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2011,3.8643,3.3572,4.425,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2012,4.8486,4.2746,5.4765,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2013,4.3615,3.8213,4.9554,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2014,4.0397,3.5227,4.6101,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2015,3.8905,3.3779,4.4572,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Observed Rates,2016,4.405,3.862,5.0015,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,4.963,4.3737,5.6078,2000-2016,-0.902,-1.5231,-0.2769,Trend is Falling,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,4.6676,4.1008,5.2893,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,4.7327,4.165,5.3549,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,4.9879,4.4055,5.6245,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,4.71,4.1465,5.3277,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,4.921,4.3332,5.5655,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,4.6212,4.0637,5.233,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,4.7762,4.2065,5.4002,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,4.6194,4.0633,5.2294,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,4.5383,3.983,5.1478,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,4.1587,3.6277,4.744,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,3.909,3.396,4.476,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,4.9175,4.3354,5.5542,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,4.4436,3.8932,5.0483,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,4.1376,3.608,4.7213,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,4.0038,3.4762,4.5865,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,4.5967,4.03,5.2183,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2000,18.1774,15.5092,21.1728,2000-2016,0.6067,-0.0178,1.2352,Stable,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2001,20.7773,17.9687,23.9005,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2002,21.7786,18.9573,24.9017,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2003,23.6353,20.7445,26.8163,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2004,22.7138,19.9297,25.7776,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2005,22.0866,19.3217,25.1359,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2006,23.182,20.4659,26.1586,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2007,22.9876,20.339,25.8854,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2008,20.8295,18.3546,23.545,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2009,22.5802,20.0508,25.3403,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2010,21.0453,18.6594,23.6518,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2011,22.0297,19.6278,24.6443,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2012,24.8757,22.3512,27.6073,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2013,22.3541,19.9846,24.9271,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2014,23.5829,21.1768,26.1875,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2015,22.6356,20.3008,25.1651,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Observed Rates,2016,23.2001,20.8565,25.7354,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,18.1774,15.5092,21.1728,2000-2016,0.8758,0.2585,1.4968,Trend is Rising,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,20.7773,17.9687,23.9005,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,21.7786,18.9573,24.9017,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,23.6353,20.7445,26.8163,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,22.7138,19.9297,25.7776,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,22.0866,19.3217,25.1359,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,23.182,20.4659,26.1586,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,22.9876,20.339,25.8854,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,20.898,18.4149,23.6221,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,22.7256,20.1798,25.5028,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,21.2542,18.8445,23.8857,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,22.3201,19.8866,24.9681,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,25.2898,22.7232,28.0658,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,22.7963,20.3798,25.4187,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,24.1944,21.7252,26.8653,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,23.3742,20.9634,25.9839,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,24.3402,21.8808,26.9971,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2000,38.1847,33.5167,43.3196,2000-2016,0.9067,0.3062,1.5108,Trend is Rising,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2001,43.4572,38.531,48.8391,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2002,40.2812,35.5757,45.4363,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2003,40.7328,36.0325,45.8759,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2004,44.8713,39.9707,50.2072,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2005,46.3839,41.3081,51.9112,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2006,41.2326,36.5851,46.3056,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2007,42.4646,37.8261,47.5158,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2008,44.2187,39.5065,49.3376,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2009,49.3653,44.4357,54.6909,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2010,49.6034,44.7335,54.858,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2011,47.6735,42.9652,52.7561,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2012,45.7245,41.196,50.6139,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2013,47.1562,42.6189,52.0431,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2014,45.1021,40.7907,49.7462,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2015,47.7194,43.3365,52.4248,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Observed Rates,2016,45.0045,40.8208,49.4999,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,38.1847,33.5167,43.3196,2000-2016,1.1626,0.5919,1.7365,Trend is Rising,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,43.4572,38.531,48.8391,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,40.2812,35.5757,45.4363,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,40.7328,36.0325,45.8759,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,44.8713,39.9707,50.2072,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,46.3839,41.3081,51.9112,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,41.2326,36.5851,46.3056,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,42.4646,37.8261,47.5158,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,44.3608,39.6334,49.4957,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,49.685,44.7236,55.0443,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,50.0626,45.1475,55.3648,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,48.3207,43.5475,53.4712,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,46.4354,41.8364,51.3989,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,48.1207,43.4906,53.1051,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,46.2721,41.8491,51.0332,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,49.2497,44.7259,54.1025,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,47.0764,42.7006,51.7729,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2004,0.9668,0.5626,1.5503,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2012,1.2954,0.8118,1.9601,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,0.9668,0.5626,1.5503,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,1.3138,0.8232,1.9867,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2000,4.9742,4.1727,5.8841,2000-2016,-1.6911,-2.3715,-1.0059,Trend is Falling,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2001,4.3493,3.6024,5.2047,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2002,4.1455,3.4185,4.9806,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2003,4.276,3.532,5.1291,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2004,3.9603,3.2404,4.7904,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2005,4.5873,3.7943,5.4954,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2006,3.898,3.1818,4.725,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2007,4.0852,3.3451,4.9369,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2008,3.9672,3.2496,4.7937,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2009,4.14,3.3978,4.9922,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2010,3.7368,3.0379,4.5449,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2011,3.3161,2.6632,4.0773,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2012,4.0512,3.3189,4.8929,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2013,3.841,3.14,4.6487,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2014,3.6305,2.9616,4.4035,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2015,3.2641,2.6273,4.0058,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Observed Rates,2016,3.5821,2.9162,4.3518,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,4.9742,4.1727,5.8841,2000-2016,-1.483,-2.1742,-0.787,Trend is Falling,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,4.3493,3.6024,5.2047,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,4.1455,3.4185,4.9806,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,4.276,3.532,5.1291,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,3.9603,3.2404,4.7904,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,4.5873,3.7943,5.4954,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,3.898,3.1818,4.725,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,4.0852,3.3451,4.9369,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,3.9789,3.2592,4.8077,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,4.1645,3.418,5.0216,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,3.7665,3.062,4.5807,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,3.3539,2.6936,4.1235,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,4.1115,3.3683,4.9651,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,3.9152,3.2007,4.7377,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,3.7203,3.0348,4.5115,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,3.3582,2.7029,4.1202,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,3.7365,3.0419,4.5377,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2000,14.7003,13.027,16.5288,2000-2016,0.1137,-0.4806,0.7115,Stable,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2001,15.7408,14.0327,17.5992,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2002,16.7068,14.9769,18.5817,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2003,18.223,16.4427,20.1434,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2004,17.1132,15.4131,18.9495,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2005,16.7487,15.048,18.5889,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2006,17.4802,15.8048,19.2851,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2007,17.4085,15.7574,19.1858,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2008,15.9986,14.4346,17.6861,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2009,16.5059,14.9391,18.193,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2010,15.5045,14.0061,17.1202,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2011,15.8272,14.3335,17.4353,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2012,18.1714,16.5742,19.8819,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2013,16.472,14.9599,18.0966,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2014,16.6447,15.1393,18.2609,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2015,16.3273,14.835,17.9305,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Observed Rates,2016,17.122,15.6011,18.753,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,14.7003,13.027,16.5288,2000-2016,0.3644,-0.2284,0.9607,Stable,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,15.7408,14.0327,17.5992,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,16.7068,14.9769,18.5817,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,18.223,16.4427,20.1434,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,17.1132,15.4131,18.9495,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,16.7487,15.048,18.5889,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,17.4802,15.8048,19.2851,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,17.4085,15.7574,19.1858,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,16.0506,14.4815,17.7434,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,16.6125,15.0355,18.3102,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,15.6536,14.1408,17.2843,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,16.0293,14.5166,17.6573,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,18.4565,16.8345,20.193,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,16.7884,15.2473,18.4433,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,17.0685,15.5247,18.7249,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,16.8423,15.3033,18.4943,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,17.9313,16.3389,19.6367,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2000,32.0519,26.3619,38.6018,2000-2016,0.9366,0.0078,1.874,Trend is Rising,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2001,38.6735,32.4805,45.7039,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2002,38.0196,31.9079,44.9595,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2003,34.9711,29.1829,41.5713,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2004,43.6821,37.2165,50.9462,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2005,42.1093,35.6616,49.3843,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2006,34.2118,28.5884,40.6135,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2007,38.4516,32.5979,45.0547,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2008,39.7193,33.8296,46.3389,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2009,46.9659,40.6185,54.0217,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2010,42.9427,36.9909,49.5794,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2011,41.8875,36.1415,48.2913,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2012,37.388,32.0891,43.3148,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2013,41.6228,36.1186,47.7281,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2014,43.6767,38.1801,49.7433,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2015,44.6457,39.1756,50.6638,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Observed Rates,2016,39.2159,34.1986,44.7597,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,32.0519,26.3619,38.6018,2000-2016,1.1968,0.2871,2.1149,Trend is Rising,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,38.6735,32.4805,45.7039,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,38.0196,31.9079,44.9595,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,34.9711,29.1829,41.5713,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,43.6821,37.2165,50.9462,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,42.1093,35.6616,49.3843,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,34.2118,28.5884,40.6135,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,38.4516,32.5979,45.0547,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,39.8461,33.9376,46.486,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,47.272,40.8833,54.372,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,43.3448,37.3372,50.0413,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,42.4128,36.5944,48.8942,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,37.9681,32.5867,43.9833,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,42.5047,36.8837,48.7346,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,44.8375,39.1944,51.0599,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,46.0277,40.3891,52.2248,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,41.0516,35.8005,46.8445,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2000,44.8952,37.5296,53.2798,2000-2016,0.8833,0.2067,1.5644,Trend is Rising,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2001,48.6915,41.0847,57.2967,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2002,42.756,35.6938,50.8037,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2003,47.0374,39.6655,55.3788,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2004,46.1726,38.9109,54.3925,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2005,51.0612,43.2824,59.8309,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2006,48.9149,41.5286,57.2325,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2007,46.8557,39.7089,54.9147,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2008,49.1421,41.8217,57.3678,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2009,51.9907,44.5076,60.3614,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2010,56.8916,49.1843,65.4575,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2011,54.0048,46.5467,62.3062,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2012,54.8463,47.4683,63.0386,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2013,53.2109,45.9903,61.2313,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2014,46.6618,40.0574,54.0366,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2015,51.0827,44.2473,58.6655,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Observed Rates,2016,51.3386,44.6235,58.7727,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,44.8952,37.5296,53.2798,2000-2016,1.1358,0.4839,1.7919,Trend is Rising,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,48.6915,41.0847,57.2967,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,42.756,35.6938,50.8037,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,47.0374,39.6655,55.3788,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,46.1726,38.9109,54.3925,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,51.0612,43.2824,59.8309,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,48.9149,41.5286,57.2325,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,46.8557,39.7089,54.9147,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,49.3009,41.9567,57.5522,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,52.3254,44.7941,60.7479,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,57.4134,49.6351,66.0552,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,54.7851,47.2185,63.2029,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,55.7005,48.2075,64.0156,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,54.2659,46.9012,62.4404,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,47.8419,41.0705,55.3958,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,52.7752,45.713,60.6002,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,53.6689,46.6486,61.4286,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2000,0.7447,0.4336,1.1911,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2001,0.8917,0.5516,1.3635,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2002,0.7148,0.4161,1.1459,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2003,0.6854,0.3916,1.1134,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2004,1.0592,0.685,1.5651,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2005,1.224,0.8129,1.7722,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2006,1.1068,0.7289,1.6142,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2007,0.8367,0.5105,1.2943,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2008,1.104,0.7269,1.6094,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2009,0.7993,0.4805,1.2497,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2011,0.6697,0.3825,1.089,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2012,1.1322,0.7394,1.6582,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2013,0.7326,0.4266,1.173,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2014,0.7722,0.4576,1.221,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Observed Rates,2016,1.0496,0.6724,1.5612,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,0.7447,0.4336,1.1911,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,0.8917,0.5516,1.3635,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,0.7148,0.4161,1.1459,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,0.6854,0.3916,1.1134,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,1.0592,0.685,1.5651,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,1.224,0.8129,1.7722,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,1.1068,0.7289,1.6142,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,0.8367,0.5105,1.2943,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,1.1073,0.729,1.614,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,0.8038,0.4832,1.2564,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,0.6766,0.3864,1.0996,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,1.1482,0.7498,1.6808,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,0.7479,0.4356,1.1963,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,0.7873,0.4666,1.2436,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,1.0962,0.7022,1.6279,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2000,14.9428,13.8405,16.1031,2000-2016,0.263,-0.1871,0.7151,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2001,14.1624,13.0975,15.2839,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2002,14.2987,13.2686,15.3817,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2003,15.9672,14.8875,17.0985,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2004,15.9941,14.9358,17.1019,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2005,16.2783,15.2351,17.3688,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2006,15.6787,14.6796,16.7228,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2007,15.3679,14.4016,16.3772,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2008,15.7815,14.8287,16.7753,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2009,16.6381,15.6805,17.6349,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2010,15.7064,14.7936,16.657,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2011,15.7791,14.8805,16.7141,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2012,15.5402,14.6817,16.4329,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2013,15.2725,14.4376,16.1403,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2014,16.6111,15.7593,17.4944,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2015,16.0301,15.2081,16.8827,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Observed Rates,2016,15.0304,14.2512,15.839,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2000,14.9428,13.8405,16.1031,2000-2016,0.4492,0.0268,0.8734,Trend is Rising,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2001,14.1624,13.0975,15.2839,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2002,14.2987,13.2686,15.3817,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2003,15.9672,14.8875,17.0985,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2004,15.9941,14.9358,17.1019,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2005,16.2783,15.2351,17.3688,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2006,15.6787,14.6796,16.7228,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2007,15.3679,14.4016,16.3772,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2008,15.813,14.8583,16.8087,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2009,16.7057,15.7443,17.7065,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2010,15.8007,14.8825,16.7569,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2011,15.9049,14.9992,16.8473,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2012,15.6984,14.8311,16.6001,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2013,15.4564,14.6114,16.3345,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2014,16.8815,16.0158,17.7791,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2015,16.398,15.5571,17.2699,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),All Ages,Delay-adjusted Rates,2016,15.5637,14.7569,16.4007,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2000,4.1271,3.6181,4.6833,2000-2016,0.4868,-0.3687,1.3497,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2001,3.0673,2.6427,3.5369,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2002,3.4847,3.0385,3.9744,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2003,3.3585,2.9256,3.8338,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2004,3.7717,3.3198,4.2647,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2005,3.8077,3.3637,4.2911,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2006,3.2997,2.8932,3.7446,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2007,3.4384,3.0285,3.8857,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2008,4.1843,3.736,4.669,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2009,4.1404,3.7024,4.6137,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2010,3.6738,3.2651,4.1172,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2011,3.6738,3.2671,4.1148,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2012,3.8208,3.415,4.2599,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2013,3.8127,3.4047,4.2541,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2014,3.9826,3.5722,4.4254,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2015,3.8801,3.4759,4.3166,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Observed Rates,2016,3.6058,3.2202,4.0232,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2000,4.1271,3.6181,4.6833,2000-2016,0.6608,-0.1858,1.5146,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2001,3.0673,2.6427,3.5369,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2002,3.4847,3.0385,3.9744,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2003,3.3585,2.9256,3.8338,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2004,3.7717,3.3198,4.2647,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2005,3.8077,3.3637,4.2911,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2006,3.2997,2.8932,3.7446,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2007,3.4384,3.0285,3.8857,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2008,4.1933,3.7441,4.679,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2009,4.1575,3.7177,4.6328,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2010,3.6973,3.286,4.1435,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2011,3.7032,3.2933,4.1477,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2012,3.8578,3.4481,4.301,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2013,3.8609,3.4477,4.3077,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2014,4.0452,3.6284,4.4948,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2015,3.9706,3.557,4.4171,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2016,3.7286,3.3299,4.1599,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2000,24.5224,21.2391,28.1689,2000-2016,0.3867,-0.2956,1.0736,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2001,23.8192,20.6663,27.3165,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2002,26.2717,23.0357,29.834,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2003,27.787,24.5496,31.3321,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2004,24.2806,21.3483,27.5035,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2005,24.4501,21.5681,27.6094,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2006,27.1901,24.2327,30.4084,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2007,24.3169,21.5997,27.2808,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2008,23.2552,20.6703,26.0736,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2009,25.2524,22.63,28.095,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2010,23.3993,20.9489,26.0574,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2011,24.0621,21.6398,26.6814,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2012,27.4057,24.8667,30.1335,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2013,26.6357,24.1848,29.2676,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2014,28.4395,25.9587,31.0934,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2015,26.1936,23.8632,28.6901,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Observed Rates,2016,25.2871,23.0392,27.6951,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2000,24.5224,21.2391,28.1689,2000-2016,0.5759,-0.1098,1.2664,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2001,23.8192,20.6663,27.3165,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2002,26.2717,23.0357,29.834,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2003,27.787,24.5496,31.3321,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2004,24.2806,21.3483,27.5035,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2005,24.4501,21.5681,27.6094,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2006,27.1901,24.2327,30.4084,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2007,24.3169,21.5997,27.2808,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2008,23.3005,20.7105,26.1242,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2009,25.3552,22.7221,28.2091,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2010,23.5444,21.0787,26.2185,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2011,24.2584,21.8163,26.8984,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2012,27.6795,25.1151,30.4339,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2013,26.9415,24.4624,29.6029,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2014,28.9064,26.3848,31.6029,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2015,26.795,24.4111,29.3474,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2016,26.204,23.8746,28.6972,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2000,65.5038,58.3834,73.2613,2000-2004,4.9684,-1.0281,11.3282,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2001,66.2314,59.189,73.8843,2004-2016,-0.6143,-1.473,0.2519,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2002,62.0101,55.3978,69.1993,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2003,74.1362,67.0152,81.8094,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2004,76.1444,69.07,83.7471,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2005,77.9857,71.0009,85.4731,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2006,72.8984,66.2915,79.9859,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2007,73.0545,66.6097,79.9562,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2008,73.3161,67.0018,80.0663,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2009,77.9757,71.6109,84.7554,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2010,75.4744,69.358,81.9859,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2011,75.2627,69.2561,81.6488,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2012,68.5631,63.0032,74.4813,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2013,67.4053,62.019,73.1327,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2014,74.8833,69.3557,80.7337,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2015,73.5384,68.1838,79.2008,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Observed Rates,2016,68.275,63.231,73.6128,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2000,65.5038,58.3834,73.2613,2000-2016,0.3163,-0.3384,0.9753,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2001,66.2314,59.189,73.8843,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2002,62.0101,55.3978,69.1993,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2003,74.1362,67.0152,81.8094,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2004,76.1444,69.07,83.7471,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2005,77.9857,71.0009,85.4731,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2006,72.8984,66.2915,79.9859,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2007,73.0545,66.6097,79.9562,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2008,73.4602,67.1335,80.2234,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2009,78.2902,71.8998,85.0966,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2010,75.9137,69.7618,82.4621,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2011,75.8568,69.8027,82.2922,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2012,69.278,63.6599,75.2568,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2013,68.2214,62.7697,74.0169,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2014,76.1106,70.4921,82.0552,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2015,75.2174,69.7403,81.0067,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2016,70.7031,65.4796,76.2272,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2005,0.7912,0.5011,1.1863,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2007,0.686,0.4188,1.0563,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2008,0.5421,0.3152,0.868,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2009,0.5531,0.3219,0.8837,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2010,0.7571,0.4848,1.1258,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2011,0.7129,0.4467,1.0763,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2012,0.9132,0.6111,1.3102,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2014,0.6333,0.3917,0.9681,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2015,0.7341,0.4702,1.0915,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Observed Rates,2016,0.6608,0.414,1.0002,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2005,0.7912,0.5011,1.1863,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2007,0.686,0.4188,1.0563,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2008,0.5434,0.316,0.87,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2009,0.5554,0.3233,0.8871,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2010,0.7609,0.4872,1.1312,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2011,0.7181,0.45,1.0838,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2012,0.9231,0.6178,1.324,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2014,0.6439,0.3983,0.9838,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2015,0.7503,0.4806,1.1147,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages <15,Delay-adjusted Rates,2016,0.6813,0.4268,1.0298,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2000,3.4164,2.8364,4.0782,2000-2016,0.5382,-0.617,1.7067,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2001,2.6438,2.1448,3.2223,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2002,2.8994,2.3791,3.4977,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2003,2.4051,1.9447,2.9406,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2004,2.8869,2.3769,3.4718,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2005,2.8565,2.3608,3.4243,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2006,2.7624,2.2769,3.3189,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2007,2.6655,2.1955,3.2049,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2008,3.3808,2.8522,3.9772,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2009,3.6073,3.0676,4.2131,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2010,2.8779,2.3987,3.4227,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2011,2.5996,2.1477,3.1164,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2012,3.1956,2.7019,3.7521,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2013,3.1008,2.6094,3.6559,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2014,3.3484,2.848,3.9103,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2015,2.9482,2.4793,3.4786,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Observed Rates,2016,3.0089,2.5367,3.542,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2000,3.4164,2.8364,4.0782,2000-2016,0.7141,-0.4394,1.881,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2001,2.6438,2.1448,3.2223,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2002,2.8994,2.3791,3.4977,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2003,2.4051,1.9447,2.9406,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2004,2.8869,2.3769,3.4718,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2005,2.8565,2.3608,3.4243,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2006,2.7624,2.2769,3.3189,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2007,2.6655,2.1955,3.2049,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2008,3.3877,2.858,3.9854,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2009,3.6218,3.0799,4.23,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2010,2.8966,2.4143,3.4449,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2011,2.6197,2.1644,3.1404,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2012,3.2269,2.7285,3.7886,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2013,3.1414,2.6435,3.7035,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2014,3.4018,2.8934,3.9722,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2015,3.0178,2.5378,3.5602,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2016,3.1175,2.6283,3.6691,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2000,17.5505,15.6457,19.6217,2000-2016,0.366,-0.1437,0.8783,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2001,15.5942,13.8357,17.5121,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2002,17.5359,15.7183,19.5041,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2003,18.574,16.7511,20.5396,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2004,17.2296,15.5302,19.0633,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2005,17.2347,15.5687,19.0293,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2006,17.7272,16.0736,19.5034,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2007,16.5871,15.0308,18.2599,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2008,17.1055,15.5667,18.7548,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2009,17.714,16.1828,19.3507,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2010,16.3965,14.9601,17.9334,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2011,17.0798,15.6455,18.6102,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2012,18.2422,16.7835,19.7937,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2013,18.3122,16.8757,19.8385,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2014,19.1567,17.7125,20.6874,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2015,18.2005,16.8164,19.6686,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Observed Rates,2016,17.0811,15.762,18.4815,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2000,17.5505,15.6457,19.6217,2000-2016,0.5504,0.0448,1.0585,Trend is Rising,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2001,15.5942,13.8357,17.5121,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2002,17.5359,15.7183,19.5041,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2003,18.574,16.7511,20.5396,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2004,17.2296,15.5302,19.0633,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2005,17.2347,15.5687,19.0293,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2006,17.7272,16.0736,19.5034,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2007,16.5871,15.0308,18.2599,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2008,17.1401,15.5982,18.7927,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2009,17.787,16.2495,19.4303,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2010,16.4995,15.054,18.0458,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2011,17.2196,15.7735,18.7622,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2012,18.4218,16.9488,19.9882,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2013,18.5272,17.0737,20.071,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2014,19.4662,17.9987,21.0212,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2015,18.6202,17.2041,20.1214,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2016,17.6848,16.3191,19.1336,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2000,60.4442,51.8959,69.9975,2000-2016,0.0521,-0.7274,0.8377,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2001,51.9621,44.2074,60.6848,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2002,52.7353,45.0465,61.3583,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2003,57.2521,49.34,66.0692,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2004,59.4932,51.4895,68.3809,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2005,63.2078,55.1039,72.1639,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2006,57.3447,49.7728,65.7398,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2007,57.7072,50.3221,65.8742,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2008,63.1995,55.5754,71.5757,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2009,64.7973,57.2895,73.0166,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2010,63.2927,56.0065,71.2628,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2011,53.9796,47.4043,61.2101,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2012,60.2436,53.435,67.6752,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2013,52.9379,46.7841,59.6757,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2014,62.8021,56.2734,69.8811,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2015,58.9863,52.7968,65.7005,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Observed Rates,2016,54.8838,49.0738,61.1909,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2000,60.4442,51.8959,69.9975,2000-2016,0.2362,-0.522,1.0001,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2001,51.9621,44.2074,60.6848,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2002,52.7353,45.0465,61.3583,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2003,57.2521,49.34,66.0692,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2004,59.4932,51.4895,68.3809,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2005,63.2078,55.1039,72.1639,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2006,57.3447,49.7728,65.7398,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2007,57.7072,50.3221,65.8742,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2008,63.3245,55.6853,71.7167,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2009,65.0613,57.5229,73.313,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2010,63.6746,56.3443,71.6911,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2011,54.4117,47.7835,61.6983,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2012,60.8633,53.9846,68.3691,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2013,53.5857,47.3563,60.4034,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2014,63.8129,57.1791,71.0024,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2015,60.3318,54.0012,67.1945,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2016,56.8293,50.8134,63.3534,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2000,71.04,59.6624,83.9625,2000-2016,0.158,-0.7633,1.0879,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2001,81.8452,69.9834,95.15,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2002,72.1588,61.362,84.3171,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2003,92.6111,80.651,105.8513,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2004,94.3644,82.5926,107.3483,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2005,94.1559,82.6962,106.7639,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2006,89.9175,79.0001,101.9243,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2007,89.8477,79.1926,101.5392,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2008,84.3858,74.2835,95.4789,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2009,92.3957,82.0451,103.6896,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2010,88.8037,78.9191,99.5822,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2011,98.5511,88.3558,109.5957,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2012,77.6666,68.8501,87.2937,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2013,83.2357,74.3022,92.9418,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2014,88.1027,79.1084,97.8336,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2015,89.4616,80.6302,98.9919,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Observed Rates,2016,82.9279,74.5934,91.9331,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2000,71.04,59.6624,83.9625,2000-2016,0.3492,-0.5507,1.2573,Stable,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2001,81.8452,69.9834,95.15,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2002,72.1588,61.362,84.3171,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2003,92.6111,80.651,105.8513,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2004,94.3644,82.5926,107.3483,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2005,94.1559,82.6962,106.7639,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2006,89.9175,79.0001,101.9243,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2007,89.8477,79.1926,101.5392,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2008,84.5508,74.4288,95.665,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2009,92.7654,82.3735,104.103,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2010,89.3059,79.3654,100.1435,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2011,99.3224,89.0472,110.4512,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2012,78.4856,69.5759,88.2112,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2013,84.2361,75.195,94.0557,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2014,89.5669,80.4227,99.4555,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2015,91.5055,82.4717,101.2483,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2016,85.884,77.2521,95.202,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2000,0.6748,0.422,1.0205,2000-2016,2.2627,0.2911,4.273,Trend is Rising,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2001,0.6892,0.4362,1.0323,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2002,0.739,0.4776,1.0888,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2003,0.528,0.3173,0.8239,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2004,0.5591,0.3453,0.855,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2005,0.8771,0.6032,1.2313,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2006,0.6094,0.3861,0.9125,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2007,0.7738,0.522,1.1029,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2008,0.7567,0.5137,1.0738,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2009,0.8267,0.5724,1.1542,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2010,0.7337,0.4983,1.0411,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2011,0.7006,0.4692,1.0045,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2012,1.0909,0.7984,1.4543,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2013,0.5196,0.3256,0.7857,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2014,0.9313,0.6651,1.2679,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2015,0.8849,0.626,1.2139,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Observed Rates,2016,0.9469,0.6793,1.284,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2000,0.6748,0.422,1.0205,2000-2016,2.4487,0.4654,4.4711,Trend is Rising,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2001,0.6892,0.4362,1.0323,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2002,0.739,0.4776,1.0888,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2003,0.528,0.3173,0.8239,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2004,0.5591,0.3453,0.855,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2005,0.8771,0.6032,1.2313,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2006,0.6094,0.3861,0.9125,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2007,0.7738,0.522,1.1029,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2008,0.7583,0.5149,1.076,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2009,0.83,0.5746,1.1587,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2010,0.7376,0.5009,1.0464,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2011,0.706,0.4728,1.0119,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2012,1.1026,0.807,1.4696,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2013,0.526,0.3295,0.7949,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2014,0.9479,0.6769,1.29,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2015,0.9051,0.6403,1.241,,,,,,Non-Hodgkin Lymphoma
Female,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2016,0.9786,0.702,1.3261,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2000,17.4986,17.097,17.9077,2000-2007,0.6672,0.2378,1.0985,Trend is Rising,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2001,17.5501,17.1487,17.9589,2007-2016,-0.9531,-1.2407,-0.6647,Trend is Falling,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2002,17.6087,17.2075,18.0175,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2003,18.034,17.6289,18.4465,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2004,18.2806,17.8734,18.6952,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2005,17.7799,17.3748,18.1927,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2006,18.3508,17.9427,18.7664,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2007,18.1949,17.7889,18.6084,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2008,18.1263,17.7221,18.5381,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2009,17.9079,17.5059,18.3173,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2010,18.0952,17.6928,18.5052,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2011,17.5435,17.1463,17.9483,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2012,17.4771,17.083,17.8786,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2013,17.2795,16.8888,17.6778,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2014,17.2744,16.8844,17.6718,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2015,17.0789,16.6929,17.4724,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Observed Rates,2016,16.6531,16.2717,17.0422,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2000,17.4986,17.097,17.9077,2000-2006,0.79,0.2705,1.3123,Trend is Rising,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2001,17.5501,17.1487,17.9589,2006-2016,-0.5045,-0.7385,-0.27,Trend is Falling,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2002,17.6087,17.2075,18.0175,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2003,18.034,17.6289,18.4465,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2004,18.2806,17.8734,18.6952,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2005,17.7799,17.3748,18.1927,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2006,18.3508,17.9427,18.7664,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2007,18.1949,17.7889,18.6084,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2008,18.1746,17.7693,18.5875,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2009,18.0036,17.5995,18.4153,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2010,18.2397,17.834,18.6529,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2011,17.7321,17.3305,18.1412,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2012,17.7109,17.3116,18.1178,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2013,17.5552,17.1582,17.9598,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2014,17.6296,17.2317,18.0352,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2015,17.5497,17.1531,17.9539,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,All Ages,Delay-adjusted Rates,2016,17.3749,16.9769,17.7806,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2000,4.0402,3.7907,4.3022,2000-2016,-0.074,-0.3338,0.1865,Stable,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2001,4.2235,3.9673,4.4923,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2002,4.0014,3.752,4.2635,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2003,4.19,3.9334,4.4594,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2004,4.0788,3.8237,4.347,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2005,3.9805,3.7239,4.2505,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2006,4.1563,3.8954,4.4307,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2007,4.2164,3.9502,4.4963,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2008,4.1089,3.8438,4.3879,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2009,4.2865,4.0133,4.5737,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2010,4.0877,3.8182,4.3715,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2011,4.2276,3.9502,4.5196,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2012,4.0488,3.7763,4.3361,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2013,4.1494,3.872,4.4418,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2014,4.0564,3.7779,4.3502,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2015,3.9509,3.6755,4.2417,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Observed Rates,2016,4.0083,3.7278,4.3044,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2000,4.0402,3.7907,4.3022,2000-2016,0.1186,-0.1217,0.3594,Stable,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2001,4.2235,3.9673,4.4923,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2002,4.0014,3.752,4.2635,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2003,4.19,3.9334,4.4594,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2004,4.0788,3.8237,4.347,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2005,3.9805,3.7239,4.2505,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2006,4.1563,3.8954,4.4307,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2007,4.2164,3.9502,4.4963,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2008,4.1203,3.8545,4.4001,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2009,4.3099,4.0353,4.5987,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2010,4.1215,3.8498,4.4077,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2011,4.2753,3.9948,4.5705,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2012,4.1056,3.8293,4.3968,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2013,4.2175,3.9355,4.5147,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2014,4.137,3.8529,4.4365,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2015,4.0542,3.7716,4.3525,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2016,4.176,3.8837,4.4844,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2000,28.8081,27.4301,30.2373,2000-2016,-0.6736,-0.8965,-0.4501,Trend is Falling,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2001,29.3561,27.9838,30.7784,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2002,29.8925,28.5306,31.3027,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2003,28.9126,27.5953,30.2766,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2004,29.9018,28.5794,31.2696,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2005,28.637,27.3483,29.9709,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2006,29.5071,28.2266,30.8308,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2007,29.264,28.007,30.563,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2008,29.1316,27.8904,30.4139,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2009,27.4447,26.2548,28.6747,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2010,28.3202,27.1223,29.5576,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2011,27.2094,26.0473,28.4101,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2012,27.8142,26.6371,29.0301,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2013,26.8007,25.6457,27.9946,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2014,27.0638,25.9046,28.2617,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2015,27.1711,26.0069,28.3741,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Observed Rates,2016,26.7755,25.6141,27.9763,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2000,28.8081,27.4301,30.2373,2000-2016,-0.4582,-0.6724,-0.2436,Trend is Falling,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2001,29.3561,27.9838,30.7784,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2002,29.8925,28.5306,31.3027,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2003,28.9126,27.5953,30.2766,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2004,29.9018,28.5794,31.2696,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2005,28.637,27.3483,29.9709,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2006,29.5071,28.2266,30.8308,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2007,29.264,28.007,30.563,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2008,29.2119,27.9673,30.4978,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2009,27.5987,26.4022,28.8356,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2010,28.5534,27.3456,29.8008,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2011,27.5097,26.3348,28.7235,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2012,28.1953,27.0021,29.4277,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2013,27.249,26.0746,28.4627,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2014,27.6409,26.4569,28.8641,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2015,27.9466,26.7491,29.1837,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2016,27.9613,26.7481,29.215,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2000,81.1383,78.8377,83.4885,2000-2007,1.0892,0.4412,1.7415,Trend is Rising,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2001,79.8458,77.5674,82.1739,2007-2016,-1.0832,-1.5091,-0.6554,Trend is Falling,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2002,80.9451,78.6338,83.3067,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2003,84.3928,82.0301,86.8059,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2004,85.8067,83.4208,88.2431,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2005,83.9096,81.5244,86.3465,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2006,86.3871,83.9795,88.8456,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2007,85.098,82.7144,87.5324,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2008,85.3278,82.9474,87.7586,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2009,84.5845,82.2211,86.9981,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2010,86.1665,83.7899,88.5928,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2011,82.3179,80.0015,84.6837,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2012,82.0982,79.8083,84.4366,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2013,81.1617,78.9108,83.4599,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2014,81.3415,79.1073,83.6222,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2015,80.2716,78.0715,82.5176,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Observed Rates,2016,77.0437,74.9133,79.2189,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2000,81.1383,78.8377,83.4885,2000-2006,1.2907,0.4886,2.0992,Trend is Rising,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2001,79.8458,77.5674,82.1739,2006-2016,-0.6041,-0.9599,-0.247,Trend is Falling,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2002,80.9451,78.6338,83.3067,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2003,84.3928,82.0301,86.8059,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2004,85.8067,83.4208,88.2431,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2005,83.9096,81.5244,86.3465,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2006,86.3871,83.9795,88.8456,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2007,85.098,82.7144,87.5324,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2008,85.5495,83.1629,87.9865,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2009,85.0249,82.6491,87.4509,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2010,86.8385,84.4434,89.2836,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2011,83.1805,80.8398,85.5709,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2012,83.1712,80.8513,85.5399,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2013,82.4211,80.1353,84.7547,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2014,83.006,80.726,85.3331,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2015,82.4847,80.2238,84.7922,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2016,80.387,78.1639,82.6562,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2000,0.5909,0.4138,0.8185,2000-2016,1.2462,-0.7847,3.3187,Stable,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2001,0.7752,0.5695,1.0315,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2002,0.5821,0.4053,0.8104,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2003,0.5699,0.3945,0.7973,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2004,0.7615,0.5552,1.0199,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2005,0.5338,0.36,0.7628,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2006,0.5147,0.3446,0.74,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2007,0.6804,0.479,0.9379,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2008,0.511,0.3395,0.739,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2009,0.4457,0.2856,0.6637,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2010,0.6722,0.4708,0.9312,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2011,0.7528,0.5378,1.0256,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2012,0.4974,0.3249,0.7292,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2013,0.8559,0.6219,1.1492,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2014,0.8397,0.6076,1.1312,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2015,0.5952,0.4015,0.8496,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Observed Rates,2016,0.8388,0.6045,1.134,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2000,0.5909,0.4138,0.8185,2000-2016,1.4471,-0.6117,3.5486,Stable,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2001,0.7752,0.5695,1.0315,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2002,0.5821,0.4053,0.8104,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2003,0.5699,0.3945,0.7973,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2004,0.7615,0.5552,1.0199,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2005,0.5338,0.36,0.7628,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2006,0.5147,0.3446,0.74,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2007,0.6804,0.479,0.9379,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2008,0.5123,0.3404,0.7408,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2009,0.4483,0.2872,0.6673,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2010,0.6783,0.4751,0.9394,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2011,0.7614,0.5439,1.037,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2012,0.5037,0.329,0.7381,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2013,0.8701,0.6322,1.1678,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2014,0.8577,0.6206,1.1549,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2015,0.6104,0.4118,0.8708,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2016,0.8717,0.6281,1.1774,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2000,3.279,2.9542,3.6302,2000-2016,0.1013,-0.2343,0.4379,Stable,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2001,3.5816,3.2384,3.9515,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2002,3.2696,2.9386,3.6279,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2003,3.4453,3.1017,3.8166,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2004,3.3313,2.9899,3.701,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2005,3.4436,3.0896,3.8269,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2006,3.3523,3.0039,3.7299,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2007,3.4732,3.1156,3.8602,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2008,3.3635,3.0099,3.7469,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2009,3.4918,3.1277,3.8863,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2010,3.3736,3.0148,3.7629,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2011,3.6552,3.2774,4.0641,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2012,3.4801,3.1111,3.8803,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2013,3.3349,2.9775,3.7231,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2014,3.2864,2.9282,3.6756,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2015,3.4324,3.0693,3.8263,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Observed Rates,2016,3.4775,3.1127,3.873,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2000,3.279,2.9542,3.6302,2000-2016,0.2982,-0.0417,0.6392,Stable,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2001,3.5816,3.2384,3.9515,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2002,3.2696,2.9386,3.6279,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2003,3.4453,3.1017,3.8166,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2004,3.3313,2.9899,3.701,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2005,3.4436,3.0896,3.8269,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2006,3.3523,3.0039,3.7299,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2007,3.4732,3.1156,3.8602,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2008,3.3728,3.0182,3.7573,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2009,3.5112,3.145,3.9078,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2010,3.4012,3.0395,3.7936,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2011,3.6939,3.312,4.1069,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2012,3.5293,3.1551,3.9349,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2013,3.388,3.0249,3.7823,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2014,3.3529,2.9875,3.7499,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2015,3.5237,3.1508,3.9278,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2016,3.6217,3.2416,4.0333,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2000,19.5867,18.7781,20.4212,2000-2007,0.091,-0.4794,0.6647,Stable,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2001,19.8099,19.0059,20.6393,2007-2016,-1.0428,-1.4276,-0.6564,Trend is Falling,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2002,20.0466,19.2485,20.8695,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2003,19.8156,19.0301,20.6254,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2004,20.0367,19.2546,20.8427,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2005,19.2081,18.4409,19.9995,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2006,20.1762,19.3999,20.9759,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2007,19.9411,19.174,20.7316,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2008,19.8677,19.1025,20.6561,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2009,19.3542,18.5987,20.1331,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2010,19.291,18.5414,20.0637,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2011,18.6902,17.9531,19.4505,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2012,18.9478,18.203,19.716,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2013,18.6038,17.8581,19.3733,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2014,18.5802,17.8308,19.3538,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2015,18.3841,17.6368,19.1559,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Observed Rates,2016,18.1008,17.3509,18.8756,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2000,19.5867,18.7781,20.4212,2000-2016,-0.3718,-0.5423,-0.201,Trend is Falling,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2001,19.8099,19.0059,20.6393,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2002,20.0466,19.2485,20.8695,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2003,19.8156,19.0301,20.6254,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2004,20.0367,19.2546,20.8427,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2005,19.2081,18.4409,19.9995,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2006,20.1762,19.3999,20.9759,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2007,19.9411,19.174,20.7316,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2008,19.9227,19.1554,20.7133,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2009,19.4617,18.7019,20.2448,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2010,19.4502,18.6944,20.2292,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2011,18.9008,18.1553,19.6695,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2012,19.2093,18.4542,19.988,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2013,18.915,18.1569,19.6973,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2014,18.9664,18.2016,19.7558,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2015,18.8954,18.1276,19.6881,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2016,18.8937,18.1111,19.702,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2000,69.0836,65.9805,72.2951,2000-2016,-0.3316,-0.6629,0.0008,Stable,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2001,64.1856,61.1768,67.3042,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2002,69.7421,66.5791,73.0168,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2003,70.7312,67.5323,74.0426,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2004,69.5726,66.3891,72.8692,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2005,68.5074,65.3053,71.8259,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2006,71.7025,68.458,75.0609,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2007,67.9603,64.8254,71.2075,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2008,70.1128,66.9744,73.36,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2009,68.0574,65.0025,71.2184,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2010,70.7734,67.6933,73.9573,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2011,68.2179,65.2372,71.2996,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2012,67.7704,64.8694,70.7673,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2013,66.3495,63.5475,69.2429,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2014,66.4319,63.6868,69.2645,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2015,66.8753,64.1672,69.668,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Observed Rates,2016,62.7882,60.2059,65.4525,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2000,69.0836,65.9805,72.2951,2000-2016,-0.1213,-0.4114,0.1697,Stable,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2001,64.1856,61.1768,67.3042,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2002,69.7421,66.5791,73.0168,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2003,70.7312,67.5323,74.0426,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2004,69.5726,66.3891,72.8692,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2005,68.5074,65.3053,71.8259,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2006,71.7025,68.458,75.0609,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2007,67.9603,64.8254,71.2075,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2008,70.2959,67.1493,73.5515,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2009,68.4064,65.3358,71.5834,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2010,71.3242,68.22,74.5326,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2011,68.93,65.9181,72.0435,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2012,68.6516,65.7128,71.687,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2013,67.391,64.5449,70.3293,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2014,67.7963,64.9948,70.6865,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2015,68.7036,65.9212,71.572,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2016,65.5063,62.8118,68.285,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2000,94.3287,90.9317,97.8194,2000-2007,1.4679,0.65,2.2924,Trend is Rising,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2001,96.9815,93.5485,100.5075,2007-2016,-1.1995,-1.7569,-0.6388,Trend is Falling,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2002,93.2036,89.8415,96.6585,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2003,99.3416,95.8661,102.9099,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2004,103.5703,100.0099,107.2242,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2005,100.763,97.2251,104.3958,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2006,102.4552,98.8971,106.1076,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2007,103.8503,100.2451,107.5507,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2008,101.9764,98.3836,105.6652,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2009,102.6689,99.0388,106.3963,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2010,103.0098,99.3675,106.7499,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2011,97.7464,94.1749,101.4168,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2012,97.7759,94.1998,101.4512,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2013,97.3693,93.8067,101.0309,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2014,97.6558,94.0856,101.3251,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2015,94.9302,91.4186,98.5402,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Observed Rates,2016,92.6423,89.2058,96.1759,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2000,94.3287,90.9317,97.8194,2000-2007,1.4235,0.6217,2.2317,Trend is Rising,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2001,96.9815,93.5485,100.5075,2007-2016,-0.8267,-1.3756,-0.2749,Trend is Falling,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2002,93.2036,89.8415,96.6585,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2003,99.3416,95.8661,102.9099,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2004,103.5703,100.0099,107.2242,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2005,100.763,97.2251,104.3958,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2006,102.4552,98.8971,106.1076,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2007,103.8503,100.2451,107.5507,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2008,102.2402,98.6381,105.9385,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2009,103.2091,99.5599,106.956,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2010,103.8146,100.1439,107.5837,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2011,98.7736,95.1646,102.4821,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2012,99.0588,95.4357,102.7819,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2013,98.8672,95.2499,102.5844,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2014,99.6487,96.0055,103.3921,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2015,97.5643,93.9554,101.2736,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2016,96.6698,93.0836,100.3558,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2000,0.76,0.5826,0.9745,2000-2016,0.9917,-0.3283,2.3292,Stable,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2001,0.8983,0.704,1.1298,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2002,0.7405,0.565,0.9537,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2003,0.7062,0.5347,0.9156,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2004,0.8841,0.6903,1.1159,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2005,0.7312,0.5536,0.9483,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2006,0.8537,0.6627,1.0836,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2007,0.9671,0.7602,1.2135,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2008,0.6989,0.5247,0.913,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2009,0.6433,0.4756,0.8517,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2010,0.7943,0.6044,1.0255,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2011,0.9257,0.7187,1.1744,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2012,0.7406,0.5562,0.9672,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2013,0.9474,0.7341,1.2037,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2014,1.007,0.7863,1.2707,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2015,0.841,0.64,1.0855,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Observed Rates,2016,0.9443,0.7286,1.2041,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2000,0.76,0.5826,0.9745,2000-2016,1.2014,-0.1317,2.5524,Stable,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2001,0.8983,0.704,1.1298,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2002,0.7405,0.565,0.9537,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2003,0.7062,0.5347,0.9156,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2004,0.8841,0.6903,1.1159,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2005,0.7312,0.5536,0.9483,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2006,0.8537,0.6627,1.0836,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2007,0.9671,0.7602,1.2135,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2008,0.7008,0.5262,0.9155,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2009,0.6469,0.4783,0.8564,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2010,0.8015,0.6099,1.0346,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2011,0.9358,0.7265,1.187,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2012,0.7526,0.5652,0.9825,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2013,0.9642,0.7471,1.2247,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2014,1.028,0.8027,1.2969,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2015,0.8633,0.657,1.1138,,,,,,Non-Hodgkin Lymphoma
Female,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2016,0.9841,0.7593,1.254,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2000,17.3397,16.9623,17.7236,2000-2007,0.7159,0.2581,1.1758,Trend is Rising,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2001,17.2241,16.85,17.6045,2007-2016,-0.9197,-1.2184,-0.6201,Trend is Falling,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2002,17.366,16.9915,17.7469,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2003,17.8037,17.4265,18.1872,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2004,18.0546,17.6761,18.4393,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2005,17.6874,17.3106,18.0706,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2006,18.1065,17.7291,18.4901,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2007,17.9225,17.5486,18.3025,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2008,17.9619,17.5889,18.341,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2009,17.8651,17.4944,18.242,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2010,17.8801,17.5116,18.2547,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2011,17.3382,16.9761,17.7063,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2012,17.3661,17.0065,17.7317,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2013,17.0533,16.699,17.4135,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2014,17.2297,16.8755,17.5897,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2015,17.0086,16.6588,17.3642,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Observed Rates,2016,16.4456,16.1034,16.7937,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2000,17.3397,16.9623,17.7236,2000-2006,0.8423,0.2845,1.4033,Trend is Rising,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2001,17.2241,16.85,17.6045,2006-2016,-0.4769,-0.7221,-0.2311,Trend is Falling,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2002,17.366,16.9915,17.7469,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2003,17.8037,17.4265,18.1872,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2004,18.0546,17.6761,18.4393,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2005,17.6874,17.3106,18.0706,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2006,18.1065,17.7291,18.4901,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2007,17.9225,17.5486,18.3025,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2008,18.0084,17.6345,18.3885,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2009,17.9577,17.5851,18.3365,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2010,18.0185,17.6472,18.396,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2011,17.5188,17.1529,17.8907,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2012,17.5916,17.2273,17.9619,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2013,17.3175,16.9578,17.6833,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2014,17.5762,17.215,17.9434,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2015,17.463,17.104,17.828,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),All Ages,Delay-adjusted Rates,2016,17.1507,16.7939,17.5135,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2000,4.0731,3.8472,4.3089,2000-2005,-0.3781,-1.2799,0.5319,Stable,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2001,4.0324,3.808,4.2667,2005-2009,1.445,-0.6106,3.5432,Stable,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2002,3.9392,3.7178,4.1705,2009-2016,-0.9977,-1.5606,-0.4316,Trend is Falling,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2003,4.0101,3.7866,4.2435,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2004,4.0088,3.785,4.2426,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2005,3.972,3.7466,4.2076,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2006,4.0095,3.784,4.2451,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2007,4.0841,3.8551,4.3233,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2008,4.165,3.9325,4.4077,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2009,4.2909,4.0538,4.5383,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2010,4.0148,3.7843,4.2556,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2011,4.1293,3.8943,4.3748,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2012,4.0422,3.8094,4.2855,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2013,4.0848,3.8498,4.3305,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2014,4.0144,3.7794,4.2601,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2015,3.9781,3.7439,4.2231,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Observed Rates,2016,3.8898,3.6571,4.1334,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,4.0731,3.8472,4.3089,2000-2016,0.1715,-0.0493,0.3927,Stable,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,4.0324,3.808,4.2667,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,3.9392,3.7178,4.1705,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,4.0101,3.7866,4.2435,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,4.0088,3.785,4.2426,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,3.972,3.7466,4.2076,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,4.0095,3.784,4.2451,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,4.0841,3.8551,4.3233,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,4.1749,3.9418,4.4181,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,4.3108,4.0725,4.5593,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,4.0426,3.8106,4.2851,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,4.1687,3.9315,4.4165,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,4.0895,3.854,4.3355,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,4.1422,3.9038,4.3912,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,4.0829,3.8439,4.3328,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,4.0701,3.8304,4.3207,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,4.0382,3.7966,4.291,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2000,28.3567,27.0705,29.6883,2000-2016,-0.5556,-0.7657,-0.3451,Trend is Falling,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2001,28.792,27.5149,30.113,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2002,29.6065,28.3343,30.9212,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2003,28.8154,27.5827,30.0891,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2004,29.3122,28.0868,30.5774,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2005,28.2524,27.0572,29.4867,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2006,29.3631,28.1715,30.5922,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2007,28.7664,27.6066,29.9625,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2008,28.4658,27.3262,29.6408,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2009,27.3135,26.2128,28.4487,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2010,27.8242,26.7271,28.9549,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2011,26.9281,25.8614,28.0276,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2012,28.0137,26.9276,29.1325,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2013,26.8369,25.7785,27.9278,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2014,27.4647,26.3976,28.5641,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2015,27.1177,26.0603,28.207,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Observed Rates,2016,26.636,25.5867,27.7175,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,28.3567,27.0705,29.6883,2000-2016,-0.3369,-0.5402,-0.1332,Trend is Falling,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,28.792,27.5149,30.113,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,29.6065,28.3343,30.9212,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,28.8154,27.5827,30.0891,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,29.3122,28.0868,30.5774,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,28.2524,27.0572,29.4867,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,29.3631,28.1715,30.5922,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,28.7664,27.6066,29.9625,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,28.5449,27.4021,29.7231,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,27.4685,26.3615,28.61,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,28.0553,26.9491,29.1952,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,27.2266,26.1481,28.3382,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,28.4043,27.3031,29.5386,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,27.2865,26.2103,28.3955,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,28.0558,26.9656,29.1786,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,27.8869,26.7995,29.0069,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,27.8151,26.7191,28.9442,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2000,80.2286,78.0274,82.4759,2000-2006,1.4554,0.5173,2.4022,Trend is Rising,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2001,79.0298,76.8519,81.2536,2006-2016,-0.9857,-1.3938,-0.5759,Trend is Falling,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2002,79.7203,77.5231,81.9637,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2003,83.7163,81.4664,86.0122,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2004,85.119,82.8509,87.4331,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2005,83.6824,81.414,85.9976,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2006,85.4655,83.1889,87.7882,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2007,84.2902,82.0379,86.5882,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2008,84.4956,82.2499,86.7867,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2009,84.3764,82.1423,86.6553,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2010,85.4704,83.2337,87.7516,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2011,81.5895,79.414,83.8089,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2012,81.0215,78.8774,83.2086,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2013,79.6982,77.599,81.8393,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2014,80.7523,78.6603,82.8853,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2015,79.623,77.5676,81.7186,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Observed Rates,2016,76.2454,74.259,78.2711,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,80.2286,78.0274,82.4759,2000-2006,1.3659,0.49,2.2494,Trend is Rising,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,79.0298,76.8519,81.2536,2006-2016,-0.6435,-1.0262,-0.2593,Trend is Falling,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,79.7203,77.5231,81.9637,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,83.7163,81.4664,86.0122,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,85.119,82.8509,87.4331,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,83.6824,81.414,85.9976,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,85.4655,83.1889,87.7882,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,84.2902,82.0379,86.5882,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,84.7135,82.4619,87.0104,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,84.8117,82.566,87.1023,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,86.1319,83.8779,88.4306,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,82.4388,80.2406,84.6813,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,82.0712,79.8992,84.2865,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,80.9275,78.7959,83.1014,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,82.4007,80.266,84.5771,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,81.779,79.6679,83.9311,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,79.5753,77.502,81.689,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2000,0.5797,0.4289,0.7665,2000-2016,1.491,0.118,2.8829,Trend is Rising,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2001,0.7099,0.5417,0.9137,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2002,0.5554,0.4081,0.7387,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2003,0.5567,0.4089,0.7403,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2004,0.6752,0.5113,0.875,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2005,0.6219,0.4629,0.8178,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2006,0.5028,0.3607,0.6821,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2007,0.6948,0.5248,0.902,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2008,0.5399,0.3923,0.7248,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2009,0.4715,0.3336,0.647,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2010,0.7449,0.5684,0.9588,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2011,0.7495,0.5719,0.9645,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2012,0.6618,0.4958,0.8656,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2013,0.7018,0.5301,0.9113,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2014,0.7423,0.5651,0.9575,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2015,0.685,0.5146,0.8936,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Observed Rates,2016,0.8018,0.6161,1.0257,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,0.5797,0.4289,0.7665,2000-2016,1.6613,0.2697,3.0722,Trend is Rising,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,0.7099,0.5417,0.9137,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,0.5554,0.4081,0.7387,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,0.5567,0.4089,0.7403,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,0.6752,0.5113,0.875,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,0.6219,0.4629,0.8178,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,0.5028,0.3607,0.6821,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,0.6948,0.5248,0.902,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,0.5412,0.3932,0.7265,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,0.4737,0.3352,0.65,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,0.7498,0.5722,0.965,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,0.7566,0.5774,0.9736,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,0.6693,0.5013,0.8752,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,0.7117,0.5376,0.9239,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,0.7561,0.5755,0.9749,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,0.7002,0.526,0.9131,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,0.8266,0.6351,1.0571,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2000,3.3193,3.0311,3.6276,2000-2016,0.15,-0.1476,0.4484,Stable,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2001,3.3974,3.1043,3.7109,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2002,3.219,2.932,3.5265,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2003,3.1741,2.8874,3.4815,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2004,3.2282,2.9374,3.5398,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2005,3.3153,3.0169,3.635,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2006,3.2278,2.9346,3.5422,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2007,3.2709,2.9742,3.5889,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2008,3.4077,3.1046,3.7322,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2009,3.5631,3.2511,3.8966,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2010,3.2628,2.9643,3.5829,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2011,3.3936,3.0869,3.722,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2012,3.422,3.1152,3.7504,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2013,3.2945,2.9953,3.6153,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2014,3.3089,3.008,3.6313,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2015,3.3147,3.0155,3.6353,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Observed Rates,2016,3.3363,3.0366,3.6571,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,3.3193,3.0311,3.6276,2000-2016,0.3248,0.0282,0.6223,Trend is Rising,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,3.3974,3.1043,3.7109,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,3.219,2.932,3.5265,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,3.1741,2.8874,3.4815,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,3.2282,2.9374,3.5398,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,3.3153,3.0169,3.635,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,3.2278,2.9346,3.5422,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,3.2709,2.9742,3.5889,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,3.4156,3.1118,3.7408,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,3.5799,3.2665,3.9149,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,3.2854,2.9848,3.6077,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,3.425,3.1155,3.7563,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,3.4628,3.1523,3.795,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,3.3396,3.0362,3.6647,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,3.3659,3.0598,3.6937,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,3.3931,3.0867,3.721,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,3.4599,3.149,3.7925,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2000,19.4031,18.6502,20.1786,2000-2006,0.2146,-0.4887,0.9229,Stable,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2001,19.3379,18.5961,20.1017,2006-2016,-0.7962,-1.1021,-0.4894,Trend is Falling,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2002,19.8353,19.095,20.5972,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2003,19.6654,18.9378,20.4139,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2004,19.7605,19.0395,20.502,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2005,19.0859,18.3783,19.814,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2006,19.9094,19.1983,20.6403,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2007,19.6068,18.9075,20.3256,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2008,19.6006,18.9041,20.3166,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2009,19.1987,18.513,19.9037,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2010,18.9508,18.2759,19.6446,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2011,18.6254,17.9588,19.311,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2012,18.9823,18.311,19.6725,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2013,18.6239,17.9548,19.312,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2014,18.7206,18.0499,19.4103,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2015,18.4965,17.8292,19.183,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Observed Rates,2016,17.9411,17.2824,18.6192,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,19.4031,18.6502,20.1786,2000-2016,-0.2724,-0.4206,-0.1239,Trend is Falling,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,19.3379,18.5961,20.1017,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,19.8353,19.095,20.5972,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,19.6654,18.9378,20.4139,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,19.7605,19.0395,20.502,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,19.0859,18.3783,19.814,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,19.9094,19.1983,20.6403,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,19.6068,18.9075,20.3256,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,19.653,18.9546,20.3708,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,19.3012,18.6119,20.0099,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,19.1012,18.4211,19.8004,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,18.8248,18.1511,19.5175,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,19.2347,18.5546,19.9339,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,18.9226,18.2429,19.6215,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,19.099,18.4151,19.8023,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,18.9928,18.308,19.6971,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,18.7143,18.0273,19.4211,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2000,68.3739,65.4321,71.414,2000-2016,-0.3277,-0.6725,0.0182,Stable,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2001,63.2377,60.3972,66.1774,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2002,68.2923,65.3231,71.3618,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2003,69.5744,66.5702,72.6793,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2004,68.6614,65.6719,71.7517,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2005,68.1551,65.1439,71.2695,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2006,70.3755,67.3469,73.5051,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2007,67.0508,64.1226,70.0782,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2008,69.7091,66.7664,72.7478,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2009,68.258,65.3866,71.2227,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2010,70.086,67.2111,73.052,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2011,66.3958,63.6405,69.2396,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2012,67.403,64.6911,70.1989,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2013,64.7792,62.1866,67.4517,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2014,66.0082,63.4485,68.6445,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2015,66.0558,63.5393,68.6461,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Observed Rates,2016,61.9097,59.5154,64.3754,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,68.3739,65.4321,71.414,2000-2016,-0.1163,-0.4184,0.1868,Stable,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,63.2377,60.3972,66.1774,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,68.2923,65.3231,71.3618,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,69.5744,66.5702,72.6793,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,68.6614,65.6719,71.7517,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,68.1551,65.1439,71.2695,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,70.3755,67.3469,73.5051,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,67.0508,64.1226,70.0782,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,69.8905,66.9402,72.937,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,68.6071,65.7211,71.5868,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,70.6318,67.7345,73.6207,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,67.0867,64.3026,69.9598,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,68.2768,65.5297,71.1087,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,65.7903,63.1572,68.5041,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,67.3659,64.7535,70.0559,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,67.84,65.2553,70.4998,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,64.6071,62.1082,67.1794,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2000,93.2002,89.9196,96.5694,2000-2007,1.5021,0.6265,2.3853,Trend is Rising,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2001,96.3099,92.9906,99.7168,2007-2016,-1.2436,-1.8287,-0.6551,Trend is Falling,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2002,92.2251,88.9861,95.5512,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2003,99.1906,95.8344,102.6336,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2004,103.1273,99.7024,106.6388,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2005,100.6726,97.2701,104.163,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2006,101.9772,98.569,105.4722,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2007,103.1538,99.7109,106.684,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2008,100.6753,97.2658,104.1727,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2009,102.0134,98.5644,105.5509,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2010,102.3043,98.8511,105.8461,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2011,98.2146,94.8158,101.7024,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2012,95.9232,92.5695,99.3657,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2013,96.0228,92.68,99.4539,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2014,96.8855,93.5319,100.3271,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2015,94.4685,91.1749,97.8492,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Observed Rates,2016,91.9317,88.7146,95.2345,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,93.2002,89.9196,96.5694,2000-2006,1.7801,0.7083,2.8633,Trend is Rising,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,96.3099,92.9906,99.7168,2006-2016,-0.7282,-1.2099,-0.2441,Trend is Falling,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,92.2251,88.9861,95.5512,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,99.1906,95.8344,102.6336,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,103.1273,99.7024,106.6388,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,100.6726,97.2701,104.163,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,101.9772,98.569,105.4722,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,103.1538,99.7109,106.684,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,100.933,97.5147,104.4392,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,102.543,99.076,106.0987,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,103.0924,99.6125,106.6613,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,99.2374,95.8032,102.7613,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,97.1652,93.768,100.652,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,97.4909,94.0969,100.974,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,98.852,95.4302,102.363,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,97.0313,93.6482,100.503,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,95.9537,92.5957,99.3997,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2000,0.7369,0.586,0.9146,2000-2016,1.3393,0.4512,2.2352,Trend is Rising,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2001,0.8513,0.6887,1.0406,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2002,0.7515,0.5994,0.9304,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2003,0.6685,0.5258,0.838,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2004,0.7895,0.634,0.9717,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2005,0.7856,0.6292,0.9693,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2006,0.7914,0.6354,0.9741,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2007,0.9314,0.7609,1.1288,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2008,0.7374,0.5872,0.9144,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2009,0.7133,0.5655,0.8881,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2010,0.8177,0.6574,1.0052,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2011,0.8599,0.6948,1.0524,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2012,0.8781,0.7112,1.0725,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2013,0.804,0.644,0.9918,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2014,0.9551,0.7796,1.1584,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2015,0.9049,0.7338,1.104,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Observed Rates,2016,0.9664,0.7887,1.1721,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,0.7369,0.586,0.9146,2000-2016,1.5213,0.6154,2.4354,Trend is Rising,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,0.8513,0.6887,1.0406,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,0.7515,0.5994,0.9304,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,0.6685,0.5258,0.838,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,0.7895,0.634,0.9717,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,0.7856,0.6292,0.9693,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,0.7914,0.6354,0.9741,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,0.9314,0.7609,1.1288,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,0.7392,0.5886,0.9166,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,0.7166,0.5681,0.8922,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,0.8234,0.662,1.0122,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,0.8681,0.7014,1.0623,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,0.8897,0.7206,1.0865,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,0.816,0.6536,1.0065,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,0.9722,0.7935,1.179,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,0.9251,0.7502,1.1284,,,,,,Non-Hodgkin Lymphoma
Female,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,1.0003,0.8164,1.2129,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2000,23.2042,22.7519,23.6629,2000-2008,0.9295,0.6415,1.2182,Trend is Rising,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2001,23.589,23.1361,24.0483,2008-2011,-1.3032,-3.698,1.1511,Stable,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2002,23.7426,23.2917,24.1997,2011-2014,0.4962,-1.894,2.9447,Stable,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2003,23.7656,23.3181,24.2194,2014-2016,-3.3749,-5.6436,-1.0516,Trend is Falling,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2004,24.3272,23.8774,24.7831,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2005,24.6793,24.2256,25.1391,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2006,24.4049,23.9617,24.8542,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2007,24.8896,24.4458,25.3392,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2008,24.9379,24.4978,25.3839,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2009,24.8209,24.3852,25.2623,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2010,24.5903,24.1609,25.0252,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2011,24.0891,23.6678,24.5159,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2012,24.2701,23.8524,24.6932,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2013,24.0288,23.6177,24.4452,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2014,24.5056,24.0943,24.9221,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2015,23.9964,23.5936,24.4043,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Observed Rates,2016,22.6842,22.2966,23.0769,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2000,23.2042,22.7519,23.6629,2000-2008,0.8955,0.4107,1.3826,Trend is Rising,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2001,23.589,23.1361,24.0483,2008-2016,-0.5337,-0.9752,-0.0902,Trend is Falling,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2002,23.7426,23.2917,24.1997,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2003,23.7656,23.3181,24.2194,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2004,24.3272,23.8774,24.7831,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2005,24.6793,24.2256,25.1391,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2006,24.4049,23.9617,24.8542,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2007,24.8896,24.4458,25.3392,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2008,24.9852,24.5442,25.4319,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2009,24.9143,24.4769,25.3574,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2010,24.7291,24.2973,25.1664,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2011,24.2736,23.8491,24.7037,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2012,24.5027,24.081,24.9298,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2013,24.3016,23.8858,24.7227,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2014,24.8761,24.4586,25.2989,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2015,24.4777,24.0669,24.8938,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),All Ages,Delay-adjusted Rates,2016,23.3866,22.9869,23.7914,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2000,6.7308,6.4733,6.996,2000-2016,-0.8408,-1.0605,-0.6205,Trend is Falling,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2001,6.6298,6.3755,6.8915,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2002,6.4165,6.167,6.6733,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2003,6.285,6.0386,6.5388,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2004,6.4174,6.1684,6.6738,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2005,6.4242,6.1724,6.6835,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2006,6.232,5.9862,6.4852,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2007,6.2664,6.0197,6.5206,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2008,6.4366,6.1855,6.6951,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2009,6.4152,6.1641,6.6739,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2010,6.2401,5.9921,6.4956,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2011,5.9267,5.6841,6.1769,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2012,5.9242,5.6815,6.1746,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2013,5.9218,5.6789,6.1723,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2014,6.0174,5.7715,6.271,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2015,5.799,5.5571,6.0484,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Observed Rates,2016,5.7101,5.4708,5.957,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,6.7308,6.4733,6.996,2000-2016,-0.7095,-0.9197,-0.499,Trend is Falling,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,6.6298,6.3755,6.8915,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,6.4165,6.167,6.6733,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,6.285,6.0386,6.5388,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,6.4174,6.1684,6.6738,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,6.4242,6.1724,6.6835,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,6.232,5.9862,6.4852,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,6.2664,6.0197,6.5206,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,6.448,6.1965,6.707,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,6.4379,6.1859,6.6975,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,6.2728,6.0235,6.5296,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,5.9703,5.7259,6.2223,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,5.9778,5.7329,6.2304,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,5.985,5.7394,6.2381,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,6.1039,5.8544,6.3612,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,5.9086,5.6622,6.1628,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,5.8641,5.6184,6.1177,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2000,36.7623,35.3907,38.1735,2000-2005,0.9675,-0.367,2.3198,Stable,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2001,37.0799,35.7253,38.4726,2005-2016,-0.815,-1.1664,-0.4623,Trend is Falling,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2002,38.0904,36.7442,39.4733,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2003,37.6892,36.3758,39.0378,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2004,38.129,36.8305,39.4616,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2005,38.5243,37.2283,39.8538,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2006,37.9634,36.7103,39.2484,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2007,38.3513,37.1166,39.6166,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2008,38.3239,37.1084,39.5691,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2009,37.4033,36.2216,38.6138,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2010,36.9968,35.8407,38.1807,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2011,35.9004,34.7779,37.05,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2012,36.919,35.7862,38.0786,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2013,36.1229,35.0088,37.2634,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2014,36.871,35.754,38.0141,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2015,36.2096,35.1077,37.3373,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Observed Rates,2016,34.2039,33.137,35.2966,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,36.7623,35.3907,38.1735,2000-2005,0.8606,-0.3608,2.0968,Stable,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,37.0799,35.7253,38.4726,2005-2016,-0.5843,-0.9069,-0.2606,Trend is Falling,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,38.0904,36.7442,39.4733,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,37.6892,36.3758,39.0378,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,38.129,36.8305,39.4616,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,38.5243,37.2283,39.8538,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,37.9634,36.7103,39.2484,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,38.3513,37.1166,39.6166,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,38.3972,37.1794,39.6447,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,37.5454,36.3592,38.7604,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,37.2091,36.0464,38.3998,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,36.1755,35.0444,37.3338,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,37.2758,36.132,38.4466,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,36.5351,35.4083,37.6885,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,37.4296,36.2957,38.59,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,36.9293,35.8055,38.0793,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,35.2806,34.18,36.4074,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2000,101.4386,98.6273,104.3102,2000-2007,1.6957,1.3866,2.0057,Trend is Rising,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2001,104.6856,101.8461,107.5845,2007-2014,-0.0445,-0.3899,0.3021,Stable,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2002,105.9227,103.0839,108.8201,2014-2016,-3.2557,-5.1206,-1.3542,Trend is Falling,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2003,107.3343,104.4969,110.2294,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2004,110.4972,107.6357,113.4156,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2005,112.7751,109.8821,115.7251,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2006,112.3707,109.5348,115.2615,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2007,115.5476,112.6982,118.4508,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2008,114.9887,112.1748,117.8553,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2009,115.2775,112.4865,118.1201,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2010,114.9375,112.1841,117.7412,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2011,114.0672,111.3561,116.8275,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2012,114.3049,111.6355,117.0218,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2013,113.3545,110.7391,116.016,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2014,115.6919,113.0854,118.3432,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2015,113.6987,111.1541,116.2866,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Observed Rates,2016,106.2047,103.781,108.6705,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,101.4386,98.6273,104.3102,2000-2007,1.8502,1.1088,2.5969,Trend is Rising,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,104.6856,101.8461,107.5845,2007-2016,-0.2066,-0.6477,0.2364,Stable,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,105.9227,103.0839,108.8201,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,107.3343,104.4969,110.2294,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,110.4972,107.6357,113.4156,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,112.7751,109.8821,115.7251,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,112.3707,109.5348,115.2615,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,115.5476,112.6982,118.4508,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,115.2102,112.3909,118.0823,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,115.7176,112.9159,118.571,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,115.5967,112.8276,118.4165,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,114.9518,112.2196,117.7334,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,115.4153,112.72,118.1585,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,114.6621,112.0165,117.3541,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,117.465,114.8185,120.1567,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,116.0251,113.4284,118.6658,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,109.6026,107.1012,112.1471,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2000,1.1438,0.959,1.3539,2000-2016,2.1804,1.3381,3.0296,Trend is Rising,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2001,1.2591,1.065,1.4783,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2002,1.2026,1.0129,1.4175,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2003,0.9943,0.8222,1.1918,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2004,1.2214,1.0299,1.4382,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2005,1.2933,1.0932,1.5195,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2006,1.2029,1.0111,1.4204,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2007,1.3219,1.12,1.5495,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2008,1.4031,1.1947,1.6373,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2009,1.3379,1.1343,1.5674,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2010,1.4544,1.2422,1.6925,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2011,1.1365,0.9495,1.3493,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2012,1.493,1.2776,1.7342,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2013,1.4871,1.2719,1.7281,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2014,1.6161,1.391,1.8671,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2015,1.5684,1.3464,1.8164,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Observed Rates,2016,1.5895,1.3658,1.8394,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,1.1438,0.959,1.3539,2000-2016,2.3221,1.4715,3.1798,Trend is Rising,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,1.2591,1.065,1.4783,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,1.2026,1.0129,1.4175,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,0.9943,0.8222,1.1918,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,1.2214,1.0299,1.4382,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,1.2933,1.0932,1.5195,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,1.2029,1.0111,1.4204,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,1.3219,1.12,1.5495,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,1.4056,1.1968,1.6402,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,1.3427,1.1383,1.573,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,1.4623,1.2489,1.7016,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,1.1445,0.9562,1.3588,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,1.506,1.2887,1.7493,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,1.5025,1.2851,1.746,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,1.64,1.4115,1.8946,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,1.5965,1.3706,1.8488,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,1.6315,1.4018,1.8877,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2000,5.4194,5.0981,5.7555,2000-2016,-0.5526,-0.8781,-0.2261,Trend is Falling,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2001,5.479,5.1554,5.8176,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2002,5.202,4.8854,5.5335,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2003,5.2857,4.9653,5.6212,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2004,5.039,4.7244,5.3689,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2005,5.1631,4.8406,5.5012,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2006,4.8945,4.5834,5.2209,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2007,4.859,4.5499,5.1834,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2008,5.2641,4.9408,5.6028,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2009,5.3645,5.0382,5.7061,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2010,4.9664,4.6528,5.2954,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2011,5.0701,4.7516,5.4039,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2012,4.9157,4.6034,5.2432,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2013,4.9283,4.6172,5.2545,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2014,4.9681,4.6569,5.2943,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2015,4.7699,4.4668,5.0878,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Observed Rates,2016,5.0213,4.7123,5.345,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,5.4194,5.0981,5.7555,2000-2016,-0.4183,-0.7581,-0.0772,Trend is Falling,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,5.479,5.1554,5.8176,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,5.202,4.8854,5.5335,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,5.2857,4.9653,5.6212,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,5.039,4.7244,5.3689,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,5.1631,4.8406,5.5012,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,4.8945,4.5834,5.2209,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,4.859,4.5499,5.1834,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,5.2733,4.9494,5.6125,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,5.3831,5.0557,5.7259,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,4.9925,4.6772,5.3231,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,5.1073,4.7864,5.4435,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,4.9606,4.6455,5.291,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,4.9813,4.6669,5.3109,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,5.0404,4.7247,5.3714,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,4.8605,4.5517,5.1843,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,5.1571,4.8397,5.4895,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2000,27.0272,26.205,27.8687,2000-2008,0.1421,-0.1896,0.4748,Stable,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2001,26.7922,25.9853,27.6178,2008-2011,-2.4439,-5.2049,0.3976,Stable,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2002,27.1464,26.3472,27.9637,2011-2014,0.3732,-2.4779,3.3076,Stable,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2003,26.6847,25.9045,27.4825,2014-2016,-3.7807,-6.5646,-0.9138,Trend is Falling,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2004,27.3446,26.5649,28.1414,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2005,27.3601,26.582,28.1553,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2006,27.0034,26.2461,27.7771,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2007,27.2342,26.4829,28.0017,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2008,27.0953,26.3526,27.8538,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2009,26.519,25.7907,27.2627,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2010,26.2841,25.5656,27.0178,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2011,25.1006,24.4052,25.8109,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2012,25.5257,24.8263,26.2401,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2013,25.1165,24.4234,25.8246,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2014,25.5757,24.8771,26.2893,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2015,24.9944,24.3044,25.6993,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Observed Rates,2016,23.4846,22.8172,24.1668,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,27.0272,26.205,27.8687,2000-2007,0.1442,-0.548,0.8413,Stable,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,26.7922,25.9853,27.6178,2007-2016,-1.0452,-1.4887,-0.5998,Trend is Falling,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,27.1464,26.3472,27.9637,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,26.6847,25.9045,27.4825,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,27.3446,26.5649,28.1414,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,27.3601,26.582,28.1553,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,27.0034,26.2461,27.7771,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,27.2342,26.4829,28.0017,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,27.146,26.4019,27.9059,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,26.618,25.887,27.3645,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,26.4306,25.7081,27.1684,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,25.2909,24.5903,26.0066,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,25.7677,25.0617,26.4888,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,25.3975,24.6966,26.1134,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,25.956,25.247,26.6801,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,25.485,24.7815,26.2036,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,24.1943,23.5071,24.8968,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2000,82.1384,78.8656,85.512,2000-2007,1.3802,0.4705,2.2982,Trend is Rising,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2001,84.7149,81.3936,88.1369,2007-2016,-0.5592,-1.0979,-0.0176,Trend is Falling,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2002,84.0483,80.7438,87.4533,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2003,81.7783,78.5254,85.1311,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2004,83.7916,80.5053,87.1774,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2005,88.1443,84.7533,91.636,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2006,88.8125,85.4586,92.2641,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2007,90.7234,87.3783,94.1636,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2008,88.1999,84.954,91.5376,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2009,87.9092,84.7232,91.1841,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2010,89.2977,86.1348,92.5468,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2011,87.5964,84.5151,90.761,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2012,88.5074,85.4938,91.5997,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2013,87.4784,84.5668,90.4644,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2014,87.302,84.4561,90.2191,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2015,87.1878,84.4016,90.0422,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Observed Rates,2016,82.423,79.7621,85.1496,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,82.1384,78.8656,85.512,2000-2007,1.3394,0.51,2.1758,Trend is Rising,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,84.7149,81.3936,88.1369,2007-2016,-0.2725,-0.7651,0.2227,Stable,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,84.0483,80.7438,87.4533,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,81.7783,78.5254,85.1311,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,83.7916,80.5053,87.1774,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,88.1443,84.7533,91.636,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,88.8125,85.4586,92.2641,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,90.7234,87.3783,94.1636,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,88.3712,85.119,91.7154,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,88.2517,85.0533,91.5392,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,89.8093,86.6282,93.0768,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,88.2814,85.176,91.4706,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,89.3682,86.3252,92.4903,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,88.4949,85.5495,91.5153,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,88.6453,85.7555,91.6069,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,88.9696,86.1263,91.8819,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,85.0473,82.3016,87.8601,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2000,122.5572,117.9046,127.3475,2000-2004,3.3795,1.84,4.9423,Trend is Rising,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2001,126.5379,121.8516,131.3591,2004-2014,0.412,0.0244,0.8011,Trend is Rising,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2002,129.858,125.1589,134.689,2014-2016,-4.114,-7.8892,-0.184,Trend is Falling,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2003,135.2982,130.5594,140.1657,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2004,139.719,134.9444,144.6199,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2005,139.7265,134.9567,144.6222,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2006,138.1484,133.4981,142.9196,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2007,142.7107,138.0166,147.5238,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2008,144.3014,139.617,149.103,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2009,145.2243,140.5502,150.014,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2010,142.9929,138.3981,147.7011,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2011,143.032,138.4804,147.695,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2012,142.5329,138.0348,147.14,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2013,141.6686,137.2284,146.2156,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2014,146.7567,142.2879,151.3297,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2015,142.7073,138.3509,147.1657,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Observed Rates,2016,132.227,128.0832,136.4705,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,122.5572,117.9046,127.3475,2000-2004,3.2988,1.8304,4.7884,Trend is Rising,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,126.5379,121.8516,131.3591,2004-2014,0.5605,0.19,0.9323,Trend is Rising,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,129.858,125.1589,134.689,2014-2016,-3.2284,-6.8676,0.553,Stable,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,135.2982,130.5594,140.1657,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,139.719,134.9444,144.6199,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,139.7265,134.9567,144.6222,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,138.1484,133.4981,142.9196,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,142.7107,138.0166,147.5238,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,144.5779,139.8845,149.3886,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,145.7712,141.0795,150.5788,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,143.8138,139.1926,148.5489,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,144.1349,139.5482,148.8336,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,143.9166,139.3747,148.5681,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,143.2947,138.8036,147.8935,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,148.9999,144.4628,153.6425,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,145.6297,141.1839,150.1788,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,136.4715,132.1943,140.8504,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2000,1.468,1.284,1.6709,2000-2016,1.7188,1.0211,2.4214,Trend is Rising,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2001,1.4904,1.3055,1.694,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2002,1.5457,1.3575,1.7528,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2003,1.3647,1.1883,1.5598,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2004,1.4629,1.2806,1.6639,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2005,1.5927,1.4005,1.804,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2006,1.4612,1.2791,1.6622,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2007,1.591,1.4007,1.7999,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2008,1.5646,1.3757,1.7722,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2009,1.6762,1.4809,1.8902,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2010,1.6569,1.4622,1.8704,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2011,1.4041,1.2249,1.6021,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2012,1.76,1.558,1.9809,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2013,1.7709,1.5677,1.9931,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2014,1.9761,1.7605,2.2109,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2015,1.8542,1.6451,2.0824,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Observed Rates,2016,1.8333,1.6252,2.0607,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,1.468,1.284,1.6709,2000-2016,1.8601,1.1497,2.5755,Trend is Rising,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,1.4904,1.3055,1.694,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,1.5457,1.3575,1.7528,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,1.3647,1.1883,1.5598,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,1.4629,1.2806,1.6639,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,1.5927,1.4005,1.804,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,1.4612,1.2791,1.6622,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,1.591,1.4007,1.7999,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,1.5674,1.3781,1.7753,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,1.6821,1.4861,1.8968,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,1.6659,1.4701,1.8805,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,1.4142,1.2338,1.6136,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,1.7755,1.5718,1.9983,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,1.7896,1.5843,2.0141,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,2.0048,1.7861,2.2429,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,1.8877,1.6748,2.12,,,,,,Non-Hodgkin Lymphoma
Male,All Races (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,1.8829,1.6691,2.1163,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2000,10.3397,5.973,16.4827,2000-2016,-1.1844,-3.2846,0.9614,Stable,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2001,17.4925,11.5424,25.2059,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2002,11.7149,7.3424,17.6525,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2003,14.1538,8.5971,21.5781,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2004,9.2956,5.127,15.1912,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2005,17.2684,11.8427,24.1697,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2006,14.879,9.7613,21.5059,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2007,13.7984,8.9345,20.1297,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2008,14.906,10.4183,20.5963,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2009,15.794,10.7457,22.1758,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2010,15.4462,10.7987,21.2771,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2011,12.7853,8.7432,17.9412,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2012,15.9063,11.0394,21.9833,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2013,11.6382,7.8379,16.5102,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2014,8.6452,5.7375,12.4767,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2015,12.7033,8.6715,17.7997,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Observed Rates,2016,11.6622,8.0583,16.2249,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2000,10.3397,5.973,16.4827,2000-2016,-0.5975,-2.6613,1.5102,Stable,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2001,17.4925,11.5424,25.2059,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2002,11.7149,7.3424,17.6525,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2003,14.1538,8.5971,21.5781,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2004,9.2956,5.127,15.1912,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2005,17.2684,11.8427,24.1697,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2006,14.879,9.7613,21.5059,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2007,13.7984,8.9345,20.1297,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2008,15.0046,10.4872,20.7292,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2009,16.0035,10.8883,22.4641,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2010,15.7546,11.0142,21.6934,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2011,13.1268,8.9767,18.4092,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2012,16.439,11.4092,22.7068,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2013,12.1075,8.154,17.1604,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2014,9.0882,6.0316,13.0954,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2015,13.642,9.3124,19.0892,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),All Ages,Delay-adjusted Rates,2016,13.1625,9.095,18.2677,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2005,82.7157,46.6635,137.208,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2009,81.7803,46.7838,132.686,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2010,74.294,43.2154,119.7493,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2012,80.4719,47.0366,128.0462,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2015,70.3219,41.9996,110.3674,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Observed Rates,2016,59.365,35.0521,94.4058,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,82.7157,46.6635,137.208,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,82.8651,47.4044,134.3427,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,75.7771,44.0782,121.9884,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,83.1672,48.612,132.1187,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,75.5185,45.1033,118.1175,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,67.0023,39.5615,105.8594,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2001,22.6063,13.1146,36.1802,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2002,23.7286,14.4604,36.7162,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2006,17.9563,10.6126,28.4063,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2008,19.21,11.8805,29.3622,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2009,13.8306,7.8984,22.4707,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2010,14.6136,8.6552,23.1343,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2011,14.8611,8.7866,23.5002,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2012,13.1931,7.6687,21.1899,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2013,14.2994,8.4486,22.6355,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2015,11.2665,6.4182,18.4415,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,22.6063,13.1146,36.1802,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,23.7286,14.4604,36.7162,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,17.9563,10.6126,28.4063,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,19.337,11.9591,29.5476,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,14.0141,8.0032,22.7513,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,14.9053,8.828,23.5711,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,15.258,9.0213,24.0956,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,13.635,7.9256,21.8587,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,14.8761,8.7893,23.5009,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,12.0991,6.8925,19.7146,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,American Indian / Alaska Native (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2000,15.9881,14.4579,17.6268,2000-2016,0.017,-0.3935,0.4292,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2001,17.0702,15.543,18.699,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2002,16.3668,14.8811,17.9519,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2003,15.4583,14.0437,16.9685,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2004,16.3739,14.9655,17.8723,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2005,16.6903,15.3019,18.1646,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2006,15.1737,13.8728,16.5577,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2007,16.5986,15.2653,18.0116,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2008,16.8766,15.5735,18.255,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2009,16.9136,15.6201,18.2806,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2010,16.3701,15.1415,17.6681,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2011,16.3814,15.1869,17.6419,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2012,16.8484,15.6657,18.0942,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2013,16.9188,15.7641,18.1337,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2014,16.4207,15.3131,17.5856,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2015,16.9048,15.7993,18.0657,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Observed Rates,2016,15.2383,14.23,16.2987,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2000,15.9881,14.4579,17.6268,2000-2016,0.3829,-0.0031,0.7704,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2001,17.0702,15.543,18.699,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2002,16.3668,14.8811,17.9519,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2003,15.4583,14.0437,16.9685,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2004,16.3739,14.9655,17.8723,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2005,16.6903,15.3019,18.1646,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2006,15.1737,13.8728,16.5577,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2007,16.5986,15.2653,18.0116,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2008,16.9622,15.6524,18.3474,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2009,17.0828,15.7764,18.4634,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2010,16.6158,15.3687,17.9329,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2011,16.7123,15.4934,17.9982,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2012,17.2689,16.0564,18.5455,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2013,17.4394,16.2489,18.6913,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2014,17.0572,15.9065,18.2668,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2015,17.6748,16.5189,18.8878,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),All Ages,Delay-adjusted Rates,2016,16.1601,15.0901,17.2843,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2000,4.6087,3.8705,5.4457,2000-2002,-13.8954,-35.7846,15.4552,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2001,4.829,4.0806,5.6734,2002-2016,1.4758,0.1425,2.8268,Trend is Rising,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2002,3.4997,2.8783,4.2144,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2003,3.7341,3.1044,4.4537,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2004,4.2215,3.5523,4.9793,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2005,3.7964,3.1666,4.5138,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2006,3.6128,3.0071,4.304,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2007,3.6736,3.0671,4.3639,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2008,4.0791,3.4474,4.7923,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2009,3.8511,3.2433,4.5391,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2010,3.6371,3.0532,4.2998,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2011,3.6429,3.0642,4.299,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2012,4.4316,3.7992,5.1392,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2013,4.8455,4.1845,5.5808,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2014,4.9447,4.2843,5.678,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2015,4.1247,3.5266,4.7946,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Observed Rates,2016,4.3433,3.7454,5.0101,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,4.6087,3.8705,5.4457,2000-2006,-3.7103,-8.9255,1.8036,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,4.829,4.0806,5.6734,2006-2016,3.0058,0.5942,5.4752,Trend is Rising,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,3.4997,2.8783,4.2144,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,3.7341,3.1044,4.4537,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,4.2215,3.5523,4.9793,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,3.7964,3.1666,4.5138,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,3.6128,3.0071,4.304,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,3.6736,3.0671,4.3639,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,4.0982,3.4635,4.8146,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,3.886,3.2727,4.5799,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,3.6878,3.0957,4.3593,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,3.7091,3.1198,4.3765,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,4.5247,3.879,5.2466,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,4.974,4.2954,5.7281,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,5.125,4.4404,5.884,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,4.2998,3.6763,4.997,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,4.5845,3.9533,5.2871,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2000,21.1386,17.2858,25.5905,2000-2016,0.0194,-0.6334,0.6764,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2001,25.4689,21.3623,30.1344,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2002,23.6798,19.8221,28.0666,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2003,22.4147,18.7894,26.5355,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2004,23.653,20.0262,27.7469,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2005,24.0663,20.4743,28.1048,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2006,21.4294,18.1504,25.1288,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2007,22.7169,19.426,26.4052,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2008,25.7668,22.3498,29.5586,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2009,22.2179,19.1301,25.6626,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2010,24.3533,21.1968,27.8481,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2011,25.41,22.2392,28.9063,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2012,24.2333,21.1955,27.5853,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2013,22.9644,20.0407,26.1945,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2014,22.1285,19.3239,25.2273,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2015,24.3771,21.467,27.5734,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Observed Rates,2016,22.4313,19.6705,25.4722,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,21.1386,17.2858,25.5905,2000-2016,0.3933,-0.2474,1.0381,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,25.4689,21.3623,30.1344,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,23.6798,19.8221,28.0666,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,22.4147,18.7894,26.5355,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,23.653,20.0262,27.7469,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,24.0663,20.4743,28.1048,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,21.4294,18.1504,25.1288,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,22.7169,19.426,26.4052,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,25.9027,22.4676,29.7137,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,22.4443,19.325,25.9227,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,24.7263,21.5214,28.2726,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,25.9079,22.675,29.4702,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,24.8635,21.7465,28.2998,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,23.7002,20.6824,27.0303,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,23.0097,20.0932,26.2278,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,25.5451,22.4949,28.8901,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,23.785,20.8567,27.0039,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2000,75.0323,64.8441,86.3694,2000-2016,-0.2054,-0.797,0.3897,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2001,77.1949,67.1935,88.2743,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2002,81.3629,71.3014,92.4504,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2003,74.3343,64.814,84.8502,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2004,77.3186,67.9396,87.6298,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2005,81.7655,72.451,91.9511,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2006,73.9457,65.211,83.5225,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2007,83.3447,74.3107,93.1746,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2008,79.6028,70.9745,88.9901,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2009,85.4119,76.6322,94.9186,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2010,79.8034,71.5991,88.6906,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2011,78.6057,70.7109,87.1424,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2012,79.1817,71.4573,87.5122,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2013,78.8745,71.4305,86.8843,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2014,75.3565,68.2968,82.9481,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2015,81.2142,74.0478,88.8842,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Observed Rates,2016,69.0854,62.7715,75.8656,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,75.0323,64.8441,86.3694,2000-2016,0.171,-0.3665,0.7113,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,77.1949,67.1935,88.2743,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,81.3629,71.3014,92.4504,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,74.3343,64.814,84.8502,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,77.3186,67.9396,87.6298,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,81.7655,72.451,91.9511,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,73.9457,65.211,83.5225,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,83.3447,74.3107,93.1746,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,80.0094,71.3373,89.443,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,86.2833,77.4141,95.884,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,81.0146,72.6858,90.0328,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,80.2546,72.1932,88.9663,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,81.2274,73.3031,89.7676,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,81.3846,73.7036,89.6427,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,78.3154,70.977,86.199,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,84.9182,77.4238,92.9309,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,73.3917,66.6806,80.5877,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2009,1.9578,1.1956,3.0198,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2014,1.5258,0.8887,2.4417,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2015,1.5014,0.8745,2.4015,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Observed Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,1.9728,1.2047,3.0417,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,1.5803,0.9204,2.5242,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,1.5591,0.908,2.4891,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2000,4.0506,3.1292,5.1575,2000-2007,-4.5996,-9.4624,0.5244,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2001,3.7376,2.8673,4.7879,2007-2016,5.1339,1.9097,8.46,Trend is Rising,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2002,3.0913,2.3113,4.0484,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2003,3.5035,2.6876,4.4896,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2004,3.6971,2.8539,4.7098,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2005,2.7935,2.0756,3.6781,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2006,2.8564,2.1362,3.7396,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2007,2.4699,1.8127,3.2862,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2008,3.4082,2.639,4.3311,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2009,3.2004,2.4567,4.0968,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2010,2.8583,2.168,3.6981,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2011,3.3006,2.5547,4.1945,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2012,3.8986,3.0996,4.8404,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2013,3.8108,3.0207,4.7429,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2014,4.6992,3.8206,5.7174,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2015,3.4032,2.6658,4.2789,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Observed Rates,2016,4.4156,3.5993,5.3619,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,4.0506,3.1292,5.1575,2000-2007,-4.6429,-9.4986,0.4733,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,3.7376,2.8673,4.7879,2007-2016,5.7165,2.4775,9.0579,Trend is Rising,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,3.0913,2.3113,4.0484,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,3.5035,2.6876,4.4896,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,3.6971,2.8539,4.7098,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,2.7935,2.0756,3.6781,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,2.8564,2.1362,3.7396,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,2.4699,1.8127,3.2862,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,3.4231,2.6505,4.3497,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,3.2296,2.4791,4.1337,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,2.8959,2.1965,3.7459,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,3.364,2.6038,4.2742,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,3.982,3.166,4.9428,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,3.9083,3.098,4.8629,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,4.8715,3.9607,5.925,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,3.5538,2.7837,4.4659,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,4.6509,3.791,5.6451,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2000,15.6941,13.3911,18.2775,2000-2016,-0.0436,-0.7101,0.6273,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2001,18.9776,16.5089,21.7104,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2002,16.0939,13.8717,18.5691,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2003,15.177,13.0827,17.5107,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2004,16.4269,14.2974,18.784,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2005,17.0586,14.9218,19.415,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2006,15.1142,13.1576,17.2799,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2007,16.206,14.2214,18.3909,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2008,17.5269,15.5053,19.7401,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2009,15.0111,13.1859,17.0199,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2010,16.4806,14.6029,18.5346,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2011,16.7545,14.8945,18.7844,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2012,16.982,15.1307,18.999,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2013,17.6318,15.7519,19.6747,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2014,16.1253,14.3671,18.041,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2015,16.8133,15.047,18.732,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Observed Rates,2016,15.3843,13.7154,17.2025,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,15.6941,13.3911,18.2775,2000-2016,0.3124,-0.3567,0.986,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,18.9776,16.5089,21.7104,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,16.0939,13.8717,18.5691,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,15.177,13.0827,17.5107,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,16.4269,14.2974,18.784,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,17.0586,14.9218,19.415,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,15.1142,13.1576,17.2799,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,16.206,14.2214,18.3909,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,17.6178,15.5857,19.842,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,15.1611,13.3177,17.1892,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,16.7301,14.824,18.8141,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,17.0739,15.1786,19.1412,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,17.3984,15.5019,19.463,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,18.167,16.2303,20.2699,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,16.7497,14.9234,18.7371,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,17.5899,15.7422,19.5944,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,16.3041,14.5351,18.2279,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2000,58.5767,47.6896,71.1932,2000-2016,0.4321,-0.2817,1.151,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2001,56.2586,45.9388,68.2102,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2002,60.3907,49.8186,72.5387,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2003,44.774,35.8709,55.2044,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2004,55.3528,45.6488,66.504,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2005,62.8349,52.7279,74.3146,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2006,55.6184,46.2092,66.3636,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2007,63.2025,53.4696,74.1882,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2008,59.4119,50.2361,69.7766,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2009,60.3862,51.3174,70.5907,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2010,60.396,51.5899,70.2735,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2011,63.3907,54.5612,73.2393,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2012,57.6167,49.4726,66.7171,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2013,63.053,54.7576,72.2474,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2014,60.4048,52.5171,69.1387,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2015,58.7668,51.1958,67.1358,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Observed Rates,2016,58.9694,51.6807,67.0003,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,58.5767,47.6896,71.1932,2000-2016,0.8084,0.1135,1.5081,Trend is Rising,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,56.2586,45.9388,68.2102,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,60.3907,49.8186,72.5387,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,44.774,35.8709,55.2044,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,55.3528,45.6488,66.504,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,62.8349,52.7279,74.3146,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,55.6184,46.2092,66.3636,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,63.2025,53.4696,74.1882,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,59.7259,50.5015,70.143,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,61.0181,51.8543,71.3247,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,61.3336,52.3903,71.3585,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,64.6805,55.671,74.7221,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,59.1305,50.7709,68.462,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,65.0752,56.514,74.5531,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,62.7245,54.5332,71.7821,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,61.4436,53.5261,70.1821,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,62.5481,54.8124,71.0543,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2000,93.0384,75.7109,113.1545,2000-2016,-0.6137,-1.4727,0.2527,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2001,100.1037,82.794,120.0007,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2002,104.3109,87.0216,124.0508,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2003,106.6796,89.5577,126.1315,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2004,101.3539,85.117,119.7967,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2005,102.4797,86.6929,120.3288,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2006,93.9998,79.1517,110.8302,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2007,105.3846,90.0043,122.6462,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2008,101.6959,86.9141,118.2725,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2009,112.7955,97.5399,129.7609,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2010,101.0393,87.0334,116.6607,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2011,95.2543,82.0536,109.975,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2012,102.7785,89.468,117.5118,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2013,96.1866,83.7019,110.0088,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2014,91.7168,79.892,104.7986,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2015,105.7765,93.4206,119.3109,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Observed Rates,2016,80.1545,69.771,91.6487,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,93.0384,75.7109,113.1545,2000-2016,-0.239,-1.049,0.5778,Stable,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,100.1037,82.794,120.0007,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,104.3109,87.0216,124.0508,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,106.6796,89.5577,126.1315,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,101.3539,85.117,119.7967,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,102.4797,86.6929,120.3288,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,93.9998,79.1517,110.8302,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,105.3846,90.0043,122.6462,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,102.2039,87.3485,118.8595,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,113.9288,98.5197,131.0584,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,102.5498,88.3341,118.396,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,97.296,83.8118,112.3203,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,105.4062,91.7547,120.5029,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,99.2307,86.3499,113.4752,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,95.3753,83.0772,108.9615,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,110.6045,97.683,124.7381,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,85.2571,74.2106,97.4581,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2000,1.7836,1.104,2.7275,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2004,1.344,0.7826,2.1501,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2008,1.3857,0.8336,2.1624,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2009,2.073,1.3877,2.9765,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2010,1.2427,0.7361,1.9654,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2011,1.1117,0.6352,1.8056,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2012,1.5727,0.9968,2.3605,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2013,1.9097,1.2688,2.7588,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2014,2.2142,1.5241,3.109,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2015,1.9165,1.2835,2.7512,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Observed Rates,2016,1.3093,0.7997,2.0214,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,1.7836,1.104,2.7275,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,1.344,0.7826,2.1501,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,1.3916,0.8372,2.1712,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,2.0896,1.3988,2.9994,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,1.2594,0.746,1.9905,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,1.1324,0.6471,1.8372,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,1.6008,1.0146,2.401,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,1.9586,1.3013,2.8272,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,2.2945,1.5793,3.2185,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,1.9973,1.3374,2.8634,,,,,,Non-Hodgkin Lymphoma
Male,Asian / Pacific Islander (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,1.3817,0.8438,2.128,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2000,16.8748,15.6308,18.1875,2000-2016,-0.0496,-0.4563,0.3589,Stable,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2001,18.2346,16.9652,19.5706,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2002,17.7722,16.5275,19.0826,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2003,17.9062,16.6531,19.2248,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2004,19.2327,17.9348,20.5956,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2005,18.7196,17.4485,20.0558,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2006,17.7554,16.5509,19.0214,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2007,17.3608,16.1848,18.5969,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2008,18.7875,17.5755,20.0581,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2009,18.5724,17.3781,19.8242,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2010,18.8314,17.64,20.0792,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2011,18.7766,17.5912,20.0177,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2012,17.5862,16.4689,18.7568,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2013,17.4157,16.3168,18.5666,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2014,18.4518,17.3457,19.608,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2015,17.1725,16.1149,18.2792,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Observed Rates,2016,17.8715,16.8,18.9913,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2000,16.8748,15.6308,18.1875,2000-2016,0.2007,-0.1887,0.5916,Stable,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2001,18.2346,16.9652,19.5706,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2002,17.7722,16.5275,19.0826,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2003,17.9062,16.6531,19.2248,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2004,19.2327,17.9348,20.5956,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2005,18.7196,17.4485,20.0558,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2006,17.7554,16.5509,19.0214,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2007,17.3608,16.1848,18.5969,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2008,18.8491,17.6331,20.1239,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2009,18.693,17.4909,19.9529,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2010,19.01,17.8073,20.2694,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2011,19.0217,17.8206,20.2789,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2012,17.8694,16.7339,19.0588,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2013,17.7537,16.6334,18.9268,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2014,18.9281,17.7932,20.1139,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2015,17.7214,16.6296,18.8635,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),All Ages,Delay-adjusted Rates,2016,18.7178,17.5952,19.8904,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2000,7.9124,7.1114,8.7753,2000-2016,-1.5731,-2.0574,-1.0864,Trend is Falling,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2001,8.6353,7.8047,9.5269,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2002,8.0865,7.29,8.9432,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2003,7.2492,6.5038,8.0539,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2004,7.8139,7.0406,8.6464,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2005,7.4577,6.6873,8.29,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2006,7.3026,6.5565,8.1078,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2007,7.0982,6.3689,7.8859,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2008,7.3023,6.5596,8.1035,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2009,7.9511,7.1762,8.7842,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2010,7.0144,6.2929,7.7936,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2011,6.8749,6.1514,7.6571,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2012,6.5229,5.8274,7.2759,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2013,6.6409,5.936,7.4038,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2014,6.7804,6.0678,7.551,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2015,6.2147,5.5342,6.9528,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Observed Rates,2016,6.3825,5.6954,7.127,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,7.9124,7.1114,8.7753,2000-2016,-1.3645,-1.8506,-0.8761,Trend is Falling,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,8.6353,7.8047,9.5269,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,8.0865,7.29,8.9432,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,7.2492,6.5038,8.0539,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,7.8139,7.0406,8.6464,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,7.4577,6.6873,8.29,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,7.3026,6.5565,8.1078,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,7.0982,6.3689,7.8859,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,7.3245,6.5795,8.1281,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,7.9965,7.2173,8.8342,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,7.0728,6.3453,7.8583,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,6.9562,6.2241,7.7474,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,6.6199,5.9142,7.3838,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,6.7614,6.0436,7.5378,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,6.9379,6.2086,7.7259,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,6.395,5.6949,7.154,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,6.6631,5.9457,7.4395,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2000,28.6756,24.9248,32.8319,2000-2016,-0.1979,-0.9733,0.5836,Stable,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2001,32.9554,29.0118,37.2867,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2002,32.703,28.8349,36.9455,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2003,34.0494,30.1852,38.2716,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2004,35.1069,31.2649,39.2911,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2005,39.3081,35.2267,43.7342,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2006,31.5167,28.0112,35.3397,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2007,32.1123,28.6566,35.8702,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2008,35.8062,32.2313,39.6693,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2009,35.0497,31.589,38.7861,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2010,35.5874,32.1843,39.2525,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2011,33.7791,30.5251,37.2854,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2012,31.7308,28.6266,35.0803,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2013,31.9076,28.8239,35.2313,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2014,34.9126,31.7217,38.3374,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2015,31.1448,28.1675,34.3512,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Observed Rates,2016,31.5047,28.5258,34.7099,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,28.6756,24.9248,32.8319,2000-2016,0.0683,-0.68,0.8223,Stable,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,32.9554,29.0118,37.2867,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,32.703,28.8349,36.9455,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,34.0494,30.1852,38.2716,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,35.1069,31.2649,39.2911,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,39.3081,35.2267,43.7342,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,31.5167,28.0112,35.3397,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,32.1123,28.6566,35.8702,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,35.9243,32.3377,39.7999,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,35.2921,31.8073,39.0536,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,35.9586,32.5199,39.661,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,34.2388,30.9404,37.7917,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,32.2617,29.1054,35.6659,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,32.5691,29.4209,35.9604,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,35.8673,32.589,39.3836,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,32.1629,29.088,35.4718,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,33.034,29.9099,36.3913,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2000,54.1886,46.8882,62.3278,2000-2016,1.0218,0.4982,1.5482,Trend is Rising,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2001,55.7307,48.4088,63.8739,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2002,55.5133,48.2678,63.5661,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2003,59.7701,52.2526,68.0858,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2004,65.7777,57.8747,74.4719,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2005,58.7724,51.316,67.0295,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2006,61.2769,53.9931,69.2943,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2007,58.618,51.5338,66.4233,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2008,64.3548,57.0246,72.3843,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2009,59.8358,52.7242,67.6448,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2010,66.6106,59.2963,74.588,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2011,69.1215,61.7739,77.1098,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2012,64.1489,57.2927,71.6104,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2013,61.9136,55.2625,69.1512,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2014,65.7472,59.1142,72.9325,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2015,63.335,56.9416,70.2589,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Observed Rates,2016,67.4772,60.9627,74.5047,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,54.1886,46.8882,62.3278,2000-2016,1.2923,0.7778,1.8095,Trend is Rising,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,55.7307,48.4088,63.8739,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,55.5133,48.2678,63.5661,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,59.7701,52.2526,68.0858,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,65.7777,57.8747,74.4719,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,58.7724,51.316,67.0295,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,61.2769,53.9931,69.2943,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,58.618,51.5338,66.4233,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,64.5748,57.2196,72.6308,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,60.2424,53.0825,68.1025,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,67.2483,59.8645,75.2988,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,70.0494,62.6026,78.1422,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,65.204,58.2336,72.786,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,63.1137,56.3324,70.4888,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,67.4812,60.6724,74.8512,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,65.4377,58.8297,72.5874,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,70.7529,63.9205,78.1137,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2002,1.1702,0.7331,1.7745,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2004,0.9209,0.5358,1.478,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2005,1.1365,0.6934,1.7601,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2006,0.9327,0.5429,1.4974,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2007,1.2805,0.8114,1.9227,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2008,1.6911,1.1408,2.4141,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2009,1.3094,0.8299,1.9639,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2010,1.3703,0.8778,2.0376,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2011,1.1364,0.694,1.7538,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2012,1.5319,1.0094,2.2279,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2013,0.9054,0.5175,1.4696,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2014,1.4876,0.9717,2.1781,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2015,1.0312,0.6111,1.6283,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Observed Rates,2016,1.6029,1.065,2.3155,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,-,-,-,2000-2016,-,-,-,-,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,1.1702,0.7331,1.7745,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,-,-,-,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,0.9209,0.5358,1.478,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,1.1365,0.6934,1.7601,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,0.9327,0.5429,1.4974,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,1.2805,0.8114,1.9227,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,1.6961,1.1441,2.4211,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,1.3168,0.8345,1.9744,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,1.3818,0.8852,2.054,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,1.1469,0.7004,1.7693,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,1.5547,1.0244,2.2599,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,0.9175,0.5244,1.4881,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,1.5213,0.9937,2.2258,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,1.0587,0.6273,1.6695,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,1.6747,1.1126,2.4159,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2000,6.1081,5.1652,7.1707,2000-2016,-1.4347,-2.2649,-0.5976,Trend is Falling,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2001,7.5152,6.4661,8.6833,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2002,6.2355,5.281,7.3098,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2003,6.9647,5.9548,8.0942,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2004,6.6512,5.6605,7.7621,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2005,6.7454,5.7174,7.9008,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2006,6.0912,5.1345,7.1699,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2007,6.2092,5.2539,7.2843,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2008,6.4598,5.4774,7.5625,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2009,6.8778,5.8678,8.007,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2010,5.1419,4.2923,6.1074,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2011,6.1181,5.1609,7.1949,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2012,6.261,5.3105,7.3276,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2013,6.1021,5.1732,7.1451,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2014,5.2631,4.4145,6.2235,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2015,5.2111,4.3808,6.15,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Observed Rates,2016,5.4955,4.64,6.459,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,6.1081,5.1652,7.1707,2000-2016,-1.2213,-2.0426,-0.3931,Trend is Falling,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,7.5152,6.4661,8.6833,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,6.2355,5.281,7.3098,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,6.9647,5.9548,8.0942,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,6.6512,5.6605,7.7621,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,6.7454,5.7174,7.9008,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,6.0912,5.1345,7.1699,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,6.2092,5.2539,7.2843,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,6.4789,5.4936,7.5848,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,6.9155,5.9,8.0505,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,5.1848,4.328,6.158,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,6.19,5.2216,7.279,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,6.3548,5.3902,7.4367,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,6.2166,5.2703,7.2783,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,5.3832,4.5151,6.3645,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,5.3641,4.5097,6.329,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,5.7415,4.8474,6.7469,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2000,25.2838,22.8736,27.8795,2000-2016,-0.8361,-1.4428,-0.2256,Trend is Falling,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2001,27.6674,25.1818,30.3325,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2002,27.2802,24.8484,29.8857,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2003,25.4017,23.09,27.8818,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2004,27.5078,25.1465,30.0311,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2005,28.4704,26.0457,31.0601,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2006,25.1647,22.9693,27.5134,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2007,24.5886,22.4535,26.8722,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2008,26.3143,24.1335,28.6395,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2009,27.2671,25.0765,29.5982,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2010,27.2866,25.1287,29.5808,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2011,25.0874,23.0423,27.2661,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2012,22.7923,20.869,24.8466,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2013,23.7888,21.8219,25.8863,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2014,26.1723,24.1153,28.3589,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2015,23.3493,21.4139,25.4138,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Observed Rates,2016,23.1906,21.2725,25.2368,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,25.2838,22.8736,27.8795,2000-2016,-0.594,-1.1868,0.0022,Stable,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,27.6674,25.1818,30.3325,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,27.2802,24.8484,29.8857,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,25.4017,23.09,27.8818,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,27.5078,25.1465,30.0311,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,28.4704,26.0457,31.0601,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,25.1647,22.9693,27.5134,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,24.5886,22.4535,26.8722,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,26.3995,24.2117,28.7321,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,27.4457,25.2407,29.7917,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,27.5508,25.3722,29.8666,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,25.4163,23.3444,27.6229,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,23.1596,21.2054,25.246,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,24.2597,22.254,26.3977,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,26.8542,24.744,29.0961,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,24.0829,22.0871,26.2103,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,24.2751,22.2678,26.4141,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2000,52.9828,44.1945,63.0052,2000-2016,0.506,-0.073,1.0883,Stable,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2001,55.0984,46.2377,65.1631,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2002,53.277,44.6465,63.0875,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2003,55.8614,47.1657,65.7,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2004,56.8835,48.0038,66.9136,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2005,52.903,44.4137,62.5462,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2006,59.8159,51.0536,69.6517,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2007,52.4827,44.3892,61.625,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2008,59.8606,51.3465,69.3853,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2009,49.9511,42.3034,58.5821,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2010,58.7727,50.5321,67.97,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2011,57.3,49.3661,66.1492,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2012,57.9333,50.0913,66.6523,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2013,52.7273,45.4074,60.8858,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2014,61.6776,53.9855,70.1576,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2015,58.7508,51.3781,66.8801,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Observed Rates,2016,57.9775,50.8423,65.8325,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,52.9828,44.1945,63.0052,2000-2016,0.7697,0.1802,1.3627,Trend is Rising,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,55.0984,46.2377,65.1631,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,53.277,44.6465,63.0875,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,55.8614,47.1657,65.7,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,56.8835,48.0038,66.9136,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,52.903,44.4137,62.5462,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,59.8159,51.0536,69.6517,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,52.4827,44.3892,61.625,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,60.0732,51.5287,69.6306,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,50.3008,42.5994,58.9896,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,59.3505,51.0291,68.6342,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,58.0762,50.0329,67.0425,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,58.85,50.8841,67.7016,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,53.7092,46.2521,62.0147,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,63.3209,55.4202,72.0229,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,60.6345,53.0248,69.0158,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,60.7837,53.3015,69.0074,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2000,55.5079,43.9447,69.2137,2000-2016,1.4871,0.6395,2.3418,Trend is Rising,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2001,56.4225,44.8614,70.0906,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2002,57.9602,46.3869,71.5928,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2003,64.0471,51.8,78.3418,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2004,75.51,62.3864,90.6132,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2005,65.1948,52.9281,79.492,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2006,62.8755,51.2914,76.3348,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2007,65.3313,53.6844,78.7953,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2008,69.2724,57.3288,82.9974,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2009,70.6518,58.5681,84.4955,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2010,75.187,63.0391,89.0062,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2011,82.0567,69.5673,96.1503,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2012,70.9501,59.6563,83.7737,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2013,71.9654,60.7718,84.6339,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2014,70.2002,59.3555,82.462,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2015,68.351,57.8618,80.1986,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Observed Rates,2016,77.8719,66.8615,90.1846,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,55.5079,43.9447,69.2137,2000-2016,1.7658,0.9362,2.6023,Trend is Rising,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,56.4225,44.8614,70.0906,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,57.9602,46.3869,71.5928,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,64.0471,51.8,78.3418,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,75.51,62.3864,90.6132,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,65.1948,52.9281,79.492,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,62.8755,51.2914,76.3348,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,65.3313,53.6844,78.7953,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,69.5005,57.5173,83.2685,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,71.1206,58.9563,85.0519,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,75.8901,63.629,89.8318,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,83.1507,70.4944,97.4241,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,72.1566,60.6691,85.1898,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,73.4043,61.9865,86.3148,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,72.0335,60.9056,84.601,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,70.6936,59.8433,82.9308,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,81.6613,70.113,94.5508,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2000,0.824,0.5031,1.2733,2000-2016,2.8741,1.3001,4.4724,Trend is Rising,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2001,1.0491,0.6786,1.548,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2002,1.2611,0.8565,1.7914,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2003,1.2695,0.8622,1.8032,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2004,1.2608,0.8563,1.7914,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2005,1.5588,1.0971,2.1517,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2006,1.3538,0.9371,1.8952,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2007,1.4468,1.0126,2.0053,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2008,1.746,1.2627,2.3536,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2009,1.4953,1.0518,2.0633,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2010,1.5103,1.0624,2.0832,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2011,1.1954,0.8001,1.7173,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2012,1.8937,1.386,2.5267,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2013,1.4022,0.9709,1.9602,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2014,1.7686,1.2745,2.3904,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2015,1.5126,1.0593,2.0941,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Observed Rates,2016,1.8167,1.3146,2.4468,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,0.824,0.5031,1.2733,2000-2016,3.1177,1.5564,4.7029,Trend is Rising,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,1.0491,0.6786,1.548,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,1.2611,0.8565,1.7914,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,1.2695,0.8622,1.8032,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,1.2608,0.8563,1.7914,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,1.5588,1.0971,2.1517,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,1.3538,0.9371,1.8952,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,1.4468,1.0126,2.0053,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,1.751,1.2663,2.3602,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,1.5035,1.0575,2.0744,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,1.5237,1.0719,2.1012,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,1.2091,0.8093,1.7362,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,1.9226,1.4072,2.5645,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,1.4266,0.9878,1.9933,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,1.8108,1.3049,2.4462,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,1.5535,1.0879,2.1493,,,,,,Non-Hodgkin Lymphoma
Male,Black (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,1.8974,1.3729,2.5532,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2000,20.9249,19.4045,22.5232,2000-2016,-0.153,-0.5748,0.2707,Stable,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2001,19.9187,18.4442,21.4695,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2002,22.0629,20.4994,23.7024,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2003,20.0944,18.6818,21.5762,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2004,21.5144,20.0745,23.0209,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2005,21.4464,20.038,22.9186,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2006,21.2728,19.9251,22.6798,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2007,21.2194,19.8997,22.5959,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2008,21.431,20.1349,22.7812,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2009,20.7718,19.519,22.0768,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2010,22.9949,21.6953,24.3448,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2011,21.0122,19.8257,22.2452,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2012,20.8972,19.7445,22.0941,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2013,21.5357,20.3772,22.7374,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2014,20.8395,19.7352,21.9845,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2015,19.5673,18.5257,20.6477,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Observed Rates,2016,20.5499,19.5003,21.6368,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2000,20.9249,19.4045,22.5232,2000-2016,0.0333,-0.3659,0.4341,Stable,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2001,19.9187,18.4442,21.4695,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2002,22.0629,20.4994,23.7024,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2003,20.0944,18.6818,21.5762,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2004,21.5144,20.0745,23.0209,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2005,21.4464,20.038,22.9186,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2006,21.2728,19.9251,22.6798,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2007,21.2194,19.8997,22.5959,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2008,21.4739,20.1754,22.8268,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2009,20.8574,19.5994,22.1676,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2010,23.1349,21.8275,24.4929,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2011,21.1833,19.9872,22.4261,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2012,21.1081,19.9439,22.3169,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2013,21.7964,20.6238,23.0125,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2014,21.1839,20.0615,22.3476,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2015,20.0139,18.9485,21.1188,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),All Ages,Delay-adjusted Rates,2016,21.2852,20.1979,22.4108,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2000,6.4144,5.7772,7.0979,2000-2016,-1.8241,-2.2286,-1.4179,Trend is Falling,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2001,6.3191,5.7065,6.9754,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2002,6.487,5.8801,7.1358,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2003,5.7932,5.2305,6.3963,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2004,6.2192,5.6452,6.8325,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2005,5.7091,5.1633,6.2936,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2006,6.198,5.6426,6.7904,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2007,5.5771,5.0585,6.1317,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2008,5.4094,4.9093,5.9441,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2009,5.3108,4.8209,5.8346,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2010,5.1908,4.7137,5.701,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2011,5.3685,4.8877,5.8818,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2012,5.4871,5.003,6.0033,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2013,4.8797,4.4294,5.3617,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2014,5.0238,4.5682,5.5108,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2015,4.77,4.3309,5.2399,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Observed Rates,2016,4.9612,4.5158,5.437,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2000,6.4144,5.7772,7.0979,2000-2016,-1.6556,-2.0746,-1.2348,Trend is Falling,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2001,6.3191,5.7065,6.9754,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2002,6.487,5.8801,7.1358,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2003,5.7932,5.2305,6.3963,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2004,6.2192,5.6452,6.8325,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2005,5.7091,5.1633,6.2936,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2006,6.198,5.6426,6.7904,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2007,5.5771,5.0585,6.1317,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2008,5.4207,4.9196,5.9566,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2009,5.3326,4.8408,5.8586,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2010,5.2226,4.7426,5.7357,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2011,5.4149,4.93,5.9325,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2012,5.546,5.0567,6.0677,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2013,4.9392,4.4834,5.4269,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2014,5.1081,4.6449,5.6031,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2015,4.8786,4.4295,5.359,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 50,Delay-adjusted Rates,2016,5.1375,4.6762,5.6299,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2000,37.3982,33.0512,42.1561,2000-2012,0.1077,-0.6583,0.8797,Stable,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2001,31.556,27.6912,35.8082,2012-2016,-2.4641,-5.6322,0.8104,Stable,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2002,32.8311,29.0031,37.0233,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2003,31.1489,27.5366,35.104,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2004,33.5127,29.8639,37.485,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2005,32.5512,29.021,36.391,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2006,34.2061,30.7082,37.993,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2007,33.0114,29.6714,36.6239,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2008,34.485,31.1642,38.0626,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2009,32.8719,29.7282,36.2572,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2010,33.8353,30.7372,37.1604,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2011,33.6037,30.5943,36.8282,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2012,33.9535,31.0116,37.0993,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2013,33.2779,30.4257,36.3253,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2014,32.5228,29.7627,35.4693,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2015,30.49,27.8912,33.2658,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Observed Rates,2016,30.7936,28.2353,33.5213,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2000,37.3982,33.0512,42.1561,2000-2016,-0.2305,-0.6747,0.2157,Stable,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2001,31.556,27.6912,35.8082,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2002,32.8311,29.0031,37.0233,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2003,31.1489,27.5366,35.104,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2004,33.5127,29.8639,37.485,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2005,32.5512,29.021,36.391,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2006,34.2061,30.7082,37.993,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2007,33.0114,29.6714,36.6239,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2008,34.5561,31.2285,38.1409,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2009,33.0121,29.855,36.4114,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2010,34.0454,30.9281,37.3907,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2011,33.8762,30.8424,37.1263,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2012,34.2969,31.3252,37.4738,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2013,33.6861,30.7988,36.7699,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2014,33.0738,30.2668,36.0692,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2015,31.1959,28.5369,34.0345,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 50-64,Delay-adjusted Rates,2016,31.8845,29.2355,34.7067,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2000,84.461,74.3925,95.5442,2000-2016,0.4905,-0.1981,1.1839,Stable,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2001,83.9781,73.9968,94.9436,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2002,98.4696,87.6446,110.2554,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2003,88.8631,79.1877,99.409,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2004,94.8536,84.9688,105.5769,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2005,98.3771,88.6503,108.8884,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2006,92.2411,83.0639,102.1619,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2007,96.7911,87.7011,106.577,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2008,97.6771,88.751,107.2638,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2009,94.9402,86.2886,104.2244,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2010,112.0738,102.9489,121.7915,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2011,95.6432,87.4925,104.3509,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2012,93.6393,85.7643,102.0428,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2013,102.9707,94.9233,111.5175,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2014,97.5329,89.9349,105.6016,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2015,91.3322,84.1821,98.9272,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Observed Rates,2016,97.652,90.4189,105.3084,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2000,84.461,74.3925,95.5442,2000-2016,0.6841,0.0172,1.3555,Trend is Rising,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2001,83.9781,73.9968,94.9436,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2002,98.4696,87.6446,110.2554,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2003,88.8631,79.1877,99.409,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2004,94.8536,84.9688,105.5769,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2005,98.3771,88.6503,108.8884,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2006,92.2411,83.0639,102.1619,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2007,96.7911,87.7011,106.577,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2008,97.8679,88.9244,107.4729,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2009,95.3256,86.6388,104.6464,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2010,112.7506,103.5708,122.5254,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2011,96.4083,88.1928,105.1835,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2012,94.5636,86.6105,103.0484,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2013,104.2087,96.0638,112.8567,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2014,99.1218,91.4,107.3191,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2015,93.4066,86.0934,101.1711,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65+,Delay-adjusted Rates,2016,101.166,93.672,109.0931,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2000,1.0761,0.7197,1.5445,2000-2016,-0.2999,-2.2567,1.6961,Stable,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2001,1.1782,0.8106,1.6532,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2002,1.5933,1.166,2.1244,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2003,0.8951,0.5845,1.3095,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2004,1.3405,0.9571,1.8244,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2005,0.875,0.5712,1.2801,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2006,0.8752,0.5765,1.2722,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2007,1.0436,0.7136,1.471,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2008,1.1157,0.7767,1.5499,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2009,0.9347,0.6302,1.3331,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2010,1.2557,0.9007,1.7025,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2011,0.9272,0.6296,1.3154,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2012,1.3776,1.0081,1.837,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2013,1.3656,0.9994,1.8212,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2014,1.0308,0.7177,1.433,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2015,1.1286,0.7985,1.5481,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Observed Rates,2016,0.9994,0.6919,1.3957,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2000,1.0761,0.7197,1.5445,2000-2016,-0.1285,-2.0891,1.8714,Stable,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2001,1.1782,0.8106,1.6532,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2002,1.5933,1.166,2.1244,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2003,0.8951,0.5845,1.3095,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2004,1.3405,0.9571,1.8244,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2005,0.875,0.5712,1.2801,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2006,0.8752,0.5765,1.2722,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2007,1.0436,0.7136,1.471,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2008,1.1181,0.7784,1.5531,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2009,0.9397,0.6336,1.3399,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2010,1.2648,0.9072,1.7146,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2011,0.9362,0.6357,1.3279,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2012,1.3913,1.0181,1.855,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2013,1.3844,1.0131,1.8457,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2014,1.0476,0.7294,1.4558,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2015,1.1549,0.8171,1.5832,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages <15,Delay-adjusted Rates,2016,1.0365,0.7176,1.4462,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2000,4.5787,3.9299,5.3016,2000-2016,-0.9643,-1.5158,-0.4097,Trend is Falling,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2001,5.0005,4.3295,5.7437,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2002,4.8604,4.2088,5.5821,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2003,4.4799,3.8628,5.1655,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2004,4.605,3.9841,5.2932,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2005,4.0954,3.5097,4.7485,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2006,4.6944,4.081,5.3725,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2007,4.0823,3.5174,4.7107,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2008,4.4859,3.8943,5.1401,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2009,4.5054,3.914,5.1589,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2010,4.1495,3.5912,4.7683,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2011,4.5246,3.9451,5.1639,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2012,3.9039,3.3703,4.4966,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2013,4.0634,3.5151,4.6711,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2014,4.2764,3.7159,4.8957,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2015,4.0233,3.4884,4.6155,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Observed Rates,2016,4.2215,3.6769,4.8228,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2000,4.5787,3.9299,5.3016,2000-2016,-0.7957,-1.3646,-0.2236,Trend is Falling,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2001,5.0005,4.3295,5.7437,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2002,4.8604,4.2088,5.5821,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2003,4.4799,3.8628,5.1655,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2004,4.605,3.9841,5.2932,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2005,4.0954,3.5097,4.7485,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2006,4.6944,4.081,5.3725,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2007,4.0823,3.5174,4.7107,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2008,4.4949,3.9022,5.1504,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2009,4.5247,3.9307,5.1809,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2010,4.1759,3.6141,4.7984,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2011,4.5649,3.9802,5.2096,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2012,3.9452,3.406,4.5439,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2013,4.1134,3.5583,4.7284,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2014,4.3479,3.778,4.9773,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2015,4.1165,3.5693,4.722,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 15-39,Delay-adjusted Rates,2016,4.3679,3.8043,4.9894,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2000,27.6173,25.1047,30.3111,2000-2016,-1.0898,-1.5105,-0.6673,Trend is Falling,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2001,23.943,21.6806,26.3758,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2002,24.8423,22.6024,27.2429,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2003,23.2979,21.1924,25.5553,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2004,25.018,22.8883,27.2917,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2005,24.253,22.1952,26.4488,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2006,25.5337,23.4863,27.711,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2007,24.0619,22.1206,26.1268,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2008,23.8673,21.9752,25.8774,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2009,22.9418,21.138,24.8574,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2010,23.3204,21.5463,25.2007,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2011,23.4232,21.6851,25.2627,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2012,24.2848,22.5569,26.1097,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2013,22.3276,20.6978,24.0513,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2014,22.2859,20.6867,23.9755,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2015,20.9051,19.3903,22.5068,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Observed Rates,2016,21.3697,19.8637,22.9597,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2000,27.6173,25.1047,30.3111,2000-2016,-0.9098,-1.3163,-0.5017,Trend is Falling,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2001,23.943,21.6806,26.3758,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2002,24.8423,22.6024,27.2429,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2003,23.2979,21.1924,25.5553,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2004,25.018,22.8883,27.2917,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2005,24.253,22.1952,26.4488,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2006,25.5337,23.4863,27.711,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2007,24.0619,22.1206,26.1268,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2008,23.9172,22.0211,25.9314,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2009,23.0369,21.2256,24.9604,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2010,23.4624,21.6775,25.354,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2011,23.6146,21.8623,25.4689,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2012,24.5366,22.7907,26.38,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2013,22.5989,20.9492,24.3432,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2014,22.663,21.0367,24.3808,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2015,21.3845,19.8349,23.0223,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 40-64,Delay-adjusted Rates,2016,22.1306,20.5709,23.7762,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2000,75.061,64.0818,87.3775,2000-2016,0.2497,-0.4736,0.9782,Stable,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2001,69.3073,58.9068,81.0029,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2002,66.4972,56.545,77.6897,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2003,69.9671,59.9519,81.1728,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2004,68.6336,58.8263,79.5984,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2005,74.1011,64.0894,85.227,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2006,75.6601,65.8089,86.5719,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2007,82.7453,72.6069,93.9034,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2008,82.0679,72.1872,92.9216,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2009,70.0274,61.0512,79.9417,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2010,84.1114,74.5608,94.543,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2011,77.0103,68.0539,86.8115,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2012,73.2594,64.7496,82.5683,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2013,78.199,69.6672,87.4807,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2014,73.0064,65.0876,81.623,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2015,71.0312,63.3809,79.3456,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Observed Rates,2016,74.3291,66.6938,82.5921,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2000,75.061,64.0818,87.3775,2000-2016,0.4354,-0.2633,1.1391,Stable,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2001,69.3073,58.9068,81.0029,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2002,66.4972,56.545,77.6897,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2003,69.9671,59.9519,81.1728,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2004,68.6336,58.8263,79.5984,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2005,74.1011,64.0894,85.227,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2006,75.6601,65.8089,86.5719,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2007,82.7453,72.6069,93.9034,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2008,82.2275,72.3277,93.1015,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2009,70.3145,61.3016,80.2679,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2010,84.6228,75.014,95.116,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2011,77.6562,68.6244,87.5372,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2012,73.9692,65.377,83.3654,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2013,79.0998,70.4699,88.4849,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2014,74.2103,66.1602,82.9654,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2015,72.6065,64.7863,81.0999,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 65-74,Delay-adjusted Rates,2016,76.9611,69.0558,85.5081,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2000,94.7466,77.7753,114.3876,2000-2016,0.6122,-0.3582,1.5921,Stable,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2001,100.0311,82.8257,119.7867,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2002,133.4544,113.8426,155.4821,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2003,109.5393,92.7733,128.5056,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2004,123.544,106.0934,143.0766,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2005,124.9403,108.01,143.808,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2006,110.3842,94.7207,127.9066,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2007,112.1602,96.9303,129.1195,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2008,114.7569,99.7331,131.4133,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2009,122.2003,107.1718,138.7567,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2010,142.6707,126.8584,159.916,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2011,116.0315,102.2415,131.1689,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2012,115.9394,102.5004,130.653,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2013,130.0764,116.2047,145.1508,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2014,124.3703,111.1721,138.7064,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2015,113.5459,101.2748,126.895,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Observed Rates,2016,123.1723,110.6722,136.6978,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2000,94.7466,77.7753,114.3876,2000-2016,0.8108,-0.1482,1.779,Stable,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2001,100.0311,82.8257,119.7867,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2002,133.4544,113.8426,155.4821,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2003,109.5393,92.7733,128.5056,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2004,123.544,106.0934,143.0766,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2005,124.9403,108.01,143.808,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2006,110.3842,94.7207,127.9066,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2007,112.1602,96.9303,129.1195,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2008,114.9819,99.9285,131.6697,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2009,122.6932,107.6039,139.314,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2010,143.5284,127.6215,160.8735,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2011,116.9271,103.0306,132.1773,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2012,117.0983,103.5245,131.9545,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2013,131.6833,117.6397,146.9388,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2014,126.3804,112.9688,140.9413,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2015,116.1665,103.6119,129.8146,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages 75+,Delay-adjusted Rates,2016,127.6514,114.6963,141.6552,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2000,1.2818,0.9342,1.7145,2000-2016,0.0471,-1.7581,1.8855,Stable,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2001,1.2021,0.873,1.6131,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2002,1.964,1.5387,2.4689,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2003,1.1166,0.8044,1.508,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2004,1.4094,1.0612,1.834,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2005,1.0984,0.7946,1.4782,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2006,1.2301,0.9128,1.6209,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2007,1.1903,0.8804,1.5725,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2008,1.0446,0.7587,1.4013,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2009,1.1301,0.8358,1.4936,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2010,1.4548,1.1201,1.8574,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2011,1.3027,0.989,1.6836,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2012,1.4871,1.1498,1.8916,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2013,1.5511,1.2065,1.9627,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2014,1.0951,0.81,1.4475,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2015,1.42,1.091,1.816,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Observed Rates,2016,1.3883,1.0642,1.7791,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2000,1.2818,0.9342,1.7145,2000-2016,0.2247,-1.5977,2.0809,Stable,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2001,1.2021,0.873,1.6131,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2002,1.964,1.5387,2.4689,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2003,1.1166,0.8044,1.508,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2004,1.4094,1.0612,1.834,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2005,1.0984,0.7946,1.4782,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2006,1.2301,0.9128,1.6209,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2007,1.1903,0.8804,1.5725,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2008,1.0469,0.7603,1.4043,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2009,1.1358,0.84,1.5009,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2010,1.4647,1.1277,1.8698,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2011,1.3143,0.9977,1.6983,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2012,1.5012,1.1607,1.9093,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2013,1.5734,1.2239,1.9906,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2014,1.1141,0.824,1.4721,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2015,1.4538,1.117,1.8587,,,,,,Non-Hodgkin Lymphoma
Male,Hispanic (any race),Ages < 20,Delay-adjusted Rates,2016,1.4379,1.1023,1.8417,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2000,24.4687,23.9353,25.0111,2000-2007,1.3058,0.4965,2.1217,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2001,24.798,24.2629,25.342,2007-2016,-0.6486,-1.1652,-0.1293,Trend is Falling,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2002,24.9766,24.4426,25.5194,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2003,25.3034,24.7685,25.8471,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2004,25.7039,25.1665,26.25,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2005,26.2181,25.6714,26.7738,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2006,26.1334,25.5955,26.6801,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2007,26.8032,26.2611,27.3539,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2008,26.5585,26.0207,27.1049,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2009,26.5825,26.0466,27.1271,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2010,26.0661,25.5377,26.603,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2011,25.5944,25.0734,26.1239,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2012,25.9959,25.4753,26.525,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2013,25.6688,25.1546,26.1914,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2014,26.3996,25.8798,26.9277,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2015,26.0038,25.4903,26.5255,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Observed Rates,2016,24.1453,23.6523,24.6466,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2000,24.4687,23.9353,25.0111,2000-2007,1.2604,0.5483,1.9776,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2001,24.798,24.2629,25.342,2007-2016,-0.2742,-0.7306,0.1842,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2002,24.9766,24.4426,25.5194,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2003,25.3034,24.7685,25.8471,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2004,25.7039,25.1665,26.25,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2005,26.2181,25.6714,26.7738,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2006,26.1334,25.5955,26.6801,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2007,26.8032,26.2611,27.3539,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2008,26.6287,26.0895,27.1765,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2009,26.7228,26.184,27.2702,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2010,26.2711,25.7386,26.8123,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2011,25.8683,25.3417,26.4034,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2012,26.3421,25.8146,26.8782,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2013,26.0776,25.5552,26.6084,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2014,26.9421,26.4117,27.481,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2015,26.7176,26.1901,27.2535,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,All Ages,Delay-adjusted Rates,2016,25.1792,24.665,25.7018,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2000,6.795,6.4711,7.1313,2000-2016,-0.5268,-0.8701,-0.1823,Trend is Falling,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2001,6.5413,6.2226,6.8724,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2002,6.4137,6.0974,6.7426,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2003,6.4632,6.144,6.7949,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2004,6.4556,6.1353,6.7886,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2005,6.7656,6.4305,7.1141,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2006,6.3151,5.9927,6.6505,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2007,6.5994,6.2672,6.945,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2008,6.7673,6.4275,7.1207,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2009,6.7032,6.3618,7.0584,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2010,6.6323,6.2891,6.9895,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2011,6.1299,5.797,6.4772,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2012,6.0641,5.7307,6.4119,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2013,6.1704,5.8326,6.5227,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2014,6.2559,5.9116,6.615,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2015,6.224,5.8782,6.5848,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Observed Rates,2016,5.9203,5.5817,6.2741,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2000,6.795,6.4711,7.1313,2000-2016,-0.3372,-0.6571,-0.0162,Trend is Falling,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2001,6.5413,6.2226,6.8724,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2002,6.4137,6.0974,6.7426,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2003,6.4632,6.144,6.7949,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2004,6.4556,6.1353,6.7886,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2005,6.7656,6.4305,7.1141,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2006,6.3151,5.9927,6.6505,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2007,6.5994,6.2672,6.945,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2008,6.7856,6.4449,7.1399,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2009,6.7393,6.3961,7.0964,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2010,6.6857,6.3398,7.0458,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2011,6.199,5.8623,6.5501,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2012,6.1476,5.8096,6.5001,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2013,6.2712,5.9279,6.6293,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2014,6.3822,6.031,6.7486,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2015,6.3876,6.0327,6.7577,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 50,Delay-adjusted Rates,2016,6.1673,5.8145,6.5356,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2000,38.9022,37.2586,40.5997,2000-2007,0.6841,0.2603,1.1097,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2001,39.1704,37.5431,40.85,2007-2011,-2.1464,-3.5611,-0.7108,Trend is Falling,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2002,40.3702,38.7471,42.0437,2011-2014,1.5781,-1.3036,4.5439,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2003,40.3441,38.7488,41.9883,2014-2016,-3.8846,-6.6611,-1.0255,Trend is Falling,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2004,40.2199,38.6497,41.8376,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2005,40.2713,38.7068,41.883,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2006,40.6234,39.0865,42.2054,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2007,41.2785,39.7541,42.8465,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2008,40.0372,38.5525,41.5646,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2009,39.4358,37.9788,40.9345,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2010,38.8002,37.3711,40.27,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2011,37.1622,35.7797,38.5847,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2012,39.15,37.7288,40.6112,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2013,38.1393,36.7382,39.5803,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2014,39.3914,37.9677,40.855,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2015,38.6101,37.1987,40.0615,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Observed Rates,2016,36.1716,34.8037,37.5797,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2000,38.9022,37.2586,40.5997,2000-2007,0.6844,0.2606,1.11,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2001,39.1704,37.5431,40.85,2007-2011,-1.8813,-3.3,-0.4418,Trend is Falling,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2002,40.3702,38.7471,42.0437,2011-2014,1.8694,-1.0208,4.8439,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2003,40.3441,38.7488,41.9883,2014-2016,-2.8169,-5.6248,0.0745,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2004,40.2199,38.6497,41.8376,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2005,40.2713,38.7068,41.883,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2006,40.6234,39.0865,42.2054,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2007,41.2785,39.7541,42.8465,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2008,40.147,38.6582,41.6784,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2009,39.652,38.187,41.1588,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2010,39.1156,37.6749,40.5973,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2011,37.5699,36.1721,39.0078,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2012,39.6896,38.2488,41.1708,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2013,38.7675,37.3433,40.2321,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2014,40.2264,38.7725,41.7209,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2015,39.69,38.239,41.1817,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 50-64,Delay-adjusted Rates,2016,37.7631,36.3348,39.2328,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2000,108.5374,105.3059,111.8432,2000-2006,2.0727,1.6105,2.5369,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2001,112.2773,108.9998,115.6287,2006-2014,0.1959,-0.132,0.5249,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2002,112.997,109.7209,116.3463,2014-2016,-3.6922,-5.9449,-1.3856,Trend is Falling,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2003,115.331,112.0342,118.7003,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2004,118.6904,115.3555,122.0974,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2005,120.9229,117.5379,124.3808,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2006,122.4152,119.0587,125.8423,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2007,125.3086,121.9347,128.7521,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2008,123.8844,120.5533,127.2841,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2009,125.1555,121.831,128.5474,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2010,122.2293,118.9699,125.5551,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2011,123.317,120.0688,126.6305,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2012,124.5129,121.2935,127.7958,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2013,122.5151,119.3638,125.7283,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2014,126.3216,123.1509,129.553,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2015,124.2996,121.1917,127.4669,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Observed Rates,2016,114.2275,111.2766,117.2365,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2000,108.5374,105.3059,111.8432,2000-2007,1.995,1.1122,2.8855,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2001,112.2773,108.9998,115.6287,2007-2016,-0.0545,-0.595,0.4889,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2002,112.997,109.7209,116.3463,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2003,115.331,112.0342,118.7003,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2004,118.6904,115.3555,122.0974,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2005,120.9229,117.5379,124.3808,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2006,122.4152,119.0587,125.8423,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2007,125.3086,121.9347,128.7521,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2008,124.2051,120.8653,127.6134,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2009,125.8019,122.4603,129.2113,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2010,123.1715,119.887,126.5228,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2011,124.605,121.3229,127.9529,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2012,126.1337,122.8723,129.4591,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2013,124.4264,121.2259,127.6894,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2014,128.9003,125.6647,132.1973,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2015,127.7296,124.5357,130.9839,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65+,Delay-adjusted Rates,2016,119.1051,116.0278,122.2421,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2000,1.1757,0.9262,1.472,2000-2016,2.8414,1.6091,4.0888,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2001,1.4763,1.1942,1.8054,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2002,1.1178,0.8712,1.4129,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2003,1.0659,0.8241,1.3567,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2004,1.194,0.9372,1.4999,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2005,1.5415,1.2408,1.8934,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2006,1.4669,1.1731,1.8121,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2007,1.4291,1.1381,1.772,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2008,1.4146,1.1233,1.7585,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2009,1.377,1.0884,1.719,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2010,1.6584,1.3384,2.032,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2011,1.2275,0.9532,1.5564,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2012,1.495,1.1889,1.8559,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2013,1.7322,1.3998,2.12,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2014,1.842,1.497,2.2427,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2015,1.9394,1.583,2.3522,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Observed Rates,2016,1.8916,1.5373,2.303,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2000,1.1757,0.9262,1.472,2000-2016,3.0473,1.7975,4.3125,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2001,1.4763,1.1942,1.8054,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2002,1.1178,0.8712,1.4129,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2003,1.0659,0.8241,1.3567,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2004,1.194,0.9372,1.4999,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2005,1.5415,1.2408,1.8934,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2006,1.4669,1.1731,1.8121,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2007,1.4291,1.1381,1.772,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2008,1.4183,1.1262,1.763,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2009,1.3846,1.0944,1.7283,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2010,1.6716,1.3491,2.0481,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2011,1.2406,0.9633,1.5728,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2012,1.5145,1.2045,1.8799,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2013,1.7601,1.4223,2.1538,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2014,1.8776,1.5259,2.2856,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2015,1.9894,1.6238,2.4123,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages <15,Delay-adjusted Rates,2016,1.9656,1.5974,2.3922,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2000,5.6369,5.2113,6.0882,2000-2016,-0.4373,-0.8272,-0.0458,Trend is Falling,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2001,5.4199,4.999,5.8669,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2002,5.346,4.9238,5.7947,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2003,5.4173,4.9875,5.8743,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2004,4.9912,4.5744,5.4357,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2005,5.5018,5.0552,5.9771,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2006,4.9456,4.5246,5.3951,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2007,5.1532,4.7207,5.6143,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2008,5.4906,5.0403,5.9699,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2009,5.5693,5.1141,6.0538,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2010,5.4023,4.9496,5.8848,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2011,5.2176,4.769,5.6964,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2012,5.0617,4.6201,5.5335,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2013,5.0322,4.5953,5.4991,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2014,5.0348,4.5976,5.5018,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2015,5.0732,4.6353,5.5409,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Observed Rates,2016,5.1615,4.7207,5.6319,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2000,5.6369,5.2113,6.0882,2000-2016,-0.242,-0.6425,0.1602,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2001,5.4199,4.999,5.8669,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2002,5.346,4.9238,5.7947,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2003,5.4173,4.9875,5.8743,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2004,4.9912,4.5744,5.4357,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2005,5.5018,5.0552,5.9771,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2006,4.9456,4.5246,5.3951,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2007,5.1532,4.7207,5.6143,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2008,5.5049,5.0534,5.9854,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2009,5.598,5.1404,6.0849,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2010,5.4456,4.9893,5.9318,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2011,5.2753,4.8218,5.7593,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2012,5.1311,4.6834,5.6092,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2013,5.1143,4.6703,5.5886,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2014,5.1402,4.6938,5.6169,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2015,5.2058,4.7565,5.6854,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 15-39,Delay-adjusted Rates,2016,5.3803,4.9208,5.8701,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2000,27.9593,26.9733,28.9722,2000-2008,0.4458,0.0819,0.811,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2001,27.5286,26.5611,28.5225,2008-2011,-3.079,-6.1706,0.1145,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2002,28.1565,27.1908,29.1478,2011-2014,1.2099,-2.0814,4.6119,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2003,28.2147,27.2592,29.1952,2014-2016,-4.3828,-7.6153,-1.0372,Trend is Falling,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2004,28.5425,27.5892,29.5204,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2005,28.4643,27.5097,29.4439,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2006,28.2674,27.332,29.227,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2007,29.0521,28.1087,30.0194,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2008,28.4555,27.5238,29.411,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2009,27.9406,27.0194,28.8857,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2010,27.4545,26.5438,28.3888,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2011,25.9703,25.0887,26.8755,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2012,26.7874,25.8906,27.708,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2013,26.4087,25.5118,27.3298,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2014,27.1496,26.2328,28.0911,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2015,26.5744,25.6617,27.512,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Observed Rates,2016,24.5789,23.6996,25.4834,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2000,27.9593,26.9733,28.9722,2000-2008,0.4691,0.1051,0.8344,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2001,27.5286,26.5611,28.5225,2008-2011,-2.7552,-5.8571,0.449,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2002,28.1565,27.1908,29.1478,2011-2014,1.4723,-1.8276,4.8832,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2003,28.2147,27.2592,29.1952,2014-2016,-3.3327,-6.6002,0.0492,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2004,28.5425,27.5892,29.5204,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2005,28.4643,27.5097,29.4439,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2006,28.2674,27.332,29.227,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2007,29.0521,28.1087,30.0194,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2008,28.5338,27.5996,29.492,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2009,28.0945,27.1682,29.0448,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2010,27.6774,26.7594,28.6193,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2011,26.2592,25.3678,27.1745,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2012,27.1577,26.2484,28.0909,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2013,26.8432,25.9315,27.7792,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2014,27.7142,26.7783,28.6749,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2015,27.3065,26.3688,28.2696,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 40-64,Delay-adjusted Rates,2016,25.6444,24.7271,26.5875,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2000,87.7264,83.8968,91.6857,2000-2007,1.5243,0.4105,2.6504,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2001,91.162,87.2428,95.2118,2007-2016,-0.7085,-1.3833,-0.029,Trend is Falling,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2002,91.5913,87.6477,95.6665,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2003,88.8081,84.9183,92.83,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2004,91.4306,87.4779,95.5157,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2005,95.3668,91.2845,99.5843,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2006,97.1764,93.1022,101.3827,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2007,98.753,94.6897,102.9457,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2008,94.3037,90.3888,98.344,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2009,96.8847,92.9818,100.9089,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2010,95.2887,91.4648,99.2309,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2011,93.9492,90.207,97.8064,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2012,96.7599,93.0663,100.5618,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2013,94.1807,90.6408,97.823,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2014,94.374,90.8941,97.9524,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2015,94.7891,91.3689,98.304,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Observed Rates,2016,87.3404,84.1027,90.6702,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2000,87.7264,83.8968,91.6857,2000-2007,1.4712,0.4711,2.4814,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2001,91.162,87.2428,95.2118,2007-2016,-0.3293,-0.9378,0.2829,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2002,91.5913,87.6477,95.6665,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2003,88.8081,84.9183,92.83,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2004,91.4306,87.4779,95.5157,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2005,95.3668,91.2845,99.5843,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2006,97.1764,93.1022,101.3827,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2007,98.753,94.6897,102.9457,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2008,94.5456,90.6206,98.5961,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2009,97.3825,93.4595,101.4271,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2010,96.014,92.1609,99.9859,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2011,94.921,91.14,98.8177,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2012,98.0072,94.2659,101.8577,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2013,95.6483,92.0532,99.3469,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2014,96.2951,92.7441,99.9459,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2015,97.3934,93.879,101.0043,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 65-74,Delay-adjusted Rates,2016,91.0561,87.6805,94.5263,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2000,131.3091,126.0212,136.7632,2000-2007,2.409,1.1906,3.6421,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2001,135.3821,130.0488,140.879,2007-2016,-0.2471,-0.9892,0.5005,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2002,136.4195,131.1115,141.888,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2003,144.3528,138.9419,149.9211,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2004,148.5185,143.0601,154.1324,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2005,148.8869,143.4083,154.5215,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2006,150.0318,144.6226,155.5918,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2007,154.3661,148.8996,159.9818,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2008,156.2522,150.7702,161.8823,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2009,156.0899,150.6149,161.7124,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2010,151.7081,146.3383,157.2241,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2011,155.4517,150.0421,161.0059,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2012,154.8806,149.5057,160.3988,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2013,153.5191,148.1965,158.9835,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2014,161.2793,155.8591,166.8392,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2015,156.5906,151.2848,162.0345,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Observed Rates,2016,143.6477,138.6033,148.8283,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2000,131.3091,126.0212,136.7632,2000-2007,2.3597,1.2497,3.4819,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2001,135.3821,130.0488,140.879,2007-2016,0.1299,-0.5489,0.8133,Stable,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2002,136.4195,131.1115,141.888,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2003,144.3528,138.9419,149.9211,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2004,148.5185,143.0601,154.1324,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2005,148.8869,143.4083,154.5215,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2006,150.0318,144.6226,155.5918,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2007,154.3661,148.8996,159.9818,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2008,156.659,151.1627,162.3036,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2009,156.8989,151.3956,162.5504,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2010,152.8878,147.4761,158.4463,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2011,157.0858,151.6194,162.6978,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2012,156.9101,151.4648,162.5,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2013,155.9159,150.5102,161.4648,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2014,164.5775,159.0463,170.2504,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2015,160.924,155.471,166.5176,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages 75+,Delay-adjusted Rates,2016,149.7967,144.5356,155.1978,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2000,1.5885,1.3336,1.8781,2000-2016,1.9127,0.9992,2.8345,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2001,1.7299,1.4632,2.0314,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2002,1.5287,1.2771,1.8157,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2003,1.5121,1.2613,1.7985,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2004,1.5127,1.2618,1.7994,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2005,1.794,1.5144,2.1107,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2006,1.6788,1.409,1.9857,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2007,1.8359,1.5533,2.1555,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2008,1.7395,1.4628,2.0539,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2009,1.8289,1.5438,2.152,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2010,1.8777,1.5851,2.209,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2011,1.4814,1.2217,1.7805,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2012,1.8158,1.5251,2.146,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2013,1.9039,1.6033,2.2446,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2014,2.303,1.9704,2.6758,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2015,2.1261,1.8043,2.4889,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Observed Rates,2016,2.0581,1.7396,2.4182,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2000,1.5885,1.3336,1.8781,2000-2016,2.1161,1.1895,3.0512,Trend is Rising,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2001,1.7299,1.4632,2.0314,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2002,1.5287,1.2771,1.8157,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2003,1.5121,1.2613,1.7985,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2004,1.5127,1.2618,1.7994,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2005,1.794,1.5144,2.1107,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2006,1.6788,1.409,1.9857,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2007,1.8359,1.5533,2.1555,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2008,1.7441,1.4666,2.0592,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2009,1.839,1.5523,2.1638,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2010,1.8926,1.5976,2.2264,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2011,1.4976,1.235,1.7997,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2012,1.8409,1.5463,2.1755,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2013,1.9346,1.6292,2.2806,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2014,2.3488,2.0097,2.7288,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2015,2.1802,1.8502,2.5518,,,,,,Non-Hodgkin Lymphoma
Male,Non-Hispanic White,Ages < 20,Delay-adjusted Rates,2016,2.142,1.8105,2.516,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2000,24.2327,23.7296,24.7436,2000-2007,1.2183,1.0185,1.4186,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2001,24.4334,23.9306,24.9439,2007-2011,-0.9864,-1.6751,-0.2928,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2002,24.7663,24.2637,25.2765,2011-2014,0.4986,-0.8709,1.887,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2003,24.8532,24.3532,25.3608,2014-2016,-3.6445,-4.9528,-2.3183,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2004,25.39,24.8871,25.9004,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2005,25.7217,25.2139,26.2371,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2006,25.777,25.2765,26.2848,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2007,26.2798,25.7781,26.7887,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2008,26.0583,25.5621,26.5618,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2009,25.9342,25.4422,26.4334,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2010,25.7028,25.2167,26.1959,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2011,25.1137,24.6365,25.5978,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2012,25.4659,24.9904,25.9482,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2013,25.1153,24.6472,25.59,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2014,25.6805,25.2105,26.1572,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2015,25.0875,24.6267,25.5549,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Observed Rates,2016,23.6161,23.1721,24.0665,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2000,24.2327,23.7296,24.7436,2000-2007,1.1695,0.5792,1.7634,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2001,24.4334,23.9306,24.9439,2007-2016,-0.3981,-0.7697,-0.0251,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2002,24.7663,24.2637,25.2765,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2003,24.8532,24.3532,25.3608,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2004,25.39,24.8871,25.9004,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2005,25.7217,25.2139,26.2371,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2006,25.777,25.2765,26.2848,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2007,26.2798,25.7781,26.7887,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2008,26.125,25.6275,26.6297,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2009,26.0663,25.5718,26.568,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2010,25.8983,25.4085,26.3951,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2011,25.373,24.8909,25.862,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2012,25.7955,25.3139,26.284,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2013,25.5018,25.0266,25.9837,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2014,26.1952,25.7158,26.6814,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2015,25.7496,25.2767,26.2293,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),All Ages,Delay-adjusted Rates,2016,24.6136,24.1509,25.0829,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2000,6.6832,6.395,6.981,2000-2009,-0.3619,-0.808,0.0863,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2001,6.5007,6.2174,6.7936,2009-2016,-1.6905,-2.3857,-0.9904,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2002,6.4543,6.1722,6.7461,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2003,6.3311,6.0516,6.6202,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2004,6.438,6.1558,6.7299,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2005,6.5044,6.2173,6.8014,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2006,6.3345,6.0528,6.6259,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2007,6.3923,6.1083,6.6862,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2008,6.4754,6.1879,6.7729,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2009,6.4033,6.1159,6.7007,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2010,6.3169,6.0301,6.6137,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2011,5.9473,5.6679,6.2368,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2012,5.9356,5.6554,6.2261,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2013,5.8227,5.5443,6.1114,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2014,5.9045,5.6222,6.1971,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2015,5.7987,5.5181,6.0897,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Observed Rates,2016,5.6273,5.3508,5.9142,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2000,6.6832,6.395,6.981,2000-2003,-1.3821,-3.3247,0.5995,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2001,6.5007,6.2174,6.7936,2003-2009,0.2188,-0.6841,1.1299,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2002,6.4543,6.1722,6.7461,2009-2012,-2.6161,-6.6552,1.5978,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2003,6.3311,6.0516,6.6202,2012-2016,-0.3185,-1.7098,1.0924,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2004,6.438,6.1558,6.7299,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2005,6.5044,6.2173,6.8014,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2006,6.3345,6.0528,6.6259,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2007,6.3923,6.1083,6.6862,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2008,6.4902,6.202,6.7883,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2009,6.4326,6.1439,6.7314,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2010,6.3597,6.071,6.6585,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2011,6.0034,5.7214,6.2956,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2012,6.0053,5.7218,6.2991,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2013,5.9021,5.6199,6.1947,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2014,6.0087,5.7215,6.3065,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2015,5.9317,5.6446,6.2293,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 50,Delay-adjusted Rates,2016,5.8378,5.5509,6.1353,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2000,38.9985,37.4441,40.6009,2000-2007,0.5707,0.14,1.0033,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2001,38.3718,36.8529,39.9371,2007-2011,-1.9007,-3.3295,-0.4509,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2002,39.7067,38.1906,41.2676,2011-2014,1.0748,-1.787,4.0199,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2003,39.4015,37.9182,40.9281,2014-2016,-3.9955,-6.7464,-1.1636,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2004,39.6893,38.2239,41.1965,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2005,39.4623,38.0114,40.9544,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2006,40.0656,38.6369,41.5335,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2007,40.5159,39.1053,41.9644,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2008,39.5625,38.1866,40.9753,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2009,38.7587,37.4157,40.1376,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2010,38.2073,36.8929,39.5565,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2011,36.8577,35.5841,38.1653,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2012,38.6236,37.3219,39.9594,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2013,37.5721,36.2939,38.8839,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2014,38.4772,37.19,39.7976,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2015,37.3599,36.0953,38.6577,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Observed Rates,2016,35.3706,34.1437,36.6306,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2000,38.9985,37.4441,40.6009,2000-2007,0.571,0.1403,1.0035,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2001,38.3718,36.8529,39.9371,2007-2011,-1.6325,-3.065,-0.1789,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2002,39.7067,38.1906,41.2676,2011-2014,1.3655,-1.5041,4.3188,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2003,39.4015,37.9182,40.9281,2014-2016,-2.9637,-5.7441,-0.1013,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2004,39.6893,38.2239,41.1965,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2005,39.4623,38.0114,40.9544,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2006,40.0656,38.6369,41.5335,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2007,40.5159,39.1053,41.9644,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2008,39.6719,38.2922,41.0886,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2009,38.9726,37.6222,40.359,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2010,38.5211,37.196,39.8814,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2011,37.2646,35.9769,38.5866,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2012,39.1621,37.8421,40.5163,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2013,38.1952,36.8958,39.5286,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2014,39.2995,37.9847,40.648,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2015,38.392,37.0923,39.7254,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 50-64,Delay-adjusted Rates,2016,36.9064,35.6259,38.2208,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2000,107.1959,104.0946,110.3666,2000-2006,2.0431,1.787,2.2998,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2001,110.5725,107.4348,113.779,2006-2014,0.1279,-0.052,0.3081,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2002,111.8882,108.747,115.0974,2014-2016,-3.6151,-4.8504,-2.3637,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2003,113.6439,110.4975,116.8573,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2004,116.9373,113.759,120.182,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2005,119.451,116.2289,122.7398,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2006,120.1455,116.9656,123.39,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2007,123.2581,120.0619,126.5178,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2008,122.1616,119.0069,125.3787,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2009,122.5464,119.4125,125.7416,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2010,121.8645,118.7698,125.0193,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2011,120.9208,117.8666,124.0338,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2012,121.6788,118.6604,124.7543,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2013,120.7985,117.834,123.8186,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2014,123.7293,120.7616,126.7511,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2015,120.9686,118.0735,123.9164,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Observed Rates,2016,112.6678,109.9048,115.4825,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2000,107.1959,104.0946,110.3666,2000-2006,2.0126,1.7568,2.2691,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2001,110.5725,107.4348,113.779,2006-2014,0.3649,0.1847,0.5454,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2002,111.8882,108.747,115.0974,2014-2016,-2.4898,-3.739,-1.2244,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2003,113.6439,110.4975,116.8573,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2004,116.9373,113.759,120.182,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2005,119.451,116.2289,122.7398,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2006,120.1455,116.9656,123.39,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2007,123.2581,120.0619,126.5178,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2008,122.4745,119.3116,125.6997,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2009,123.17,120.0201,126.3813,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2010,122.7937,119.6753,125.9724,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2011,122.1681,119.0824,125.313,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2012,123.2488,120.1914,126.3638,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2013,122.663,119.6527,125.7294,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2014,126.2288,123.2011,129.3115,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2015,124.221,121.2479,127.2479,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65+,Delay-adjusted Rates,2016,117.5329,114.6503,120.4687,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2000,1.1457,0.9342,1.3908,2000-2016,1.7956,0.7435,2.8588,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2001,1.4268,1.1894,1.6976,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2002,1.2874,1.0619,1.5466,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2003,1.036,0.834,1.2719,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2004,1.2482,1.0257,1.5046,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2005,1.3204,1.088,1.5876,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2006,1.3038,1.0734,1.5688,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2007,1.3362,1.1021,1.6051,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2008,1.3548,1.1185,1.6262,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2009,1.2077,0.9847,1.466,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2010,1.5157,1.2645,1.8021,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2011,1.1194,0.9045,1.3697,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2012,1.4784,1.2296,1.7626,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2013,1.6047,1.3445,1.9005,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2014,1.5789,1.3201,1.8735,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2015,1.6486,1.3832,1.95,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Observed Rates,2016,1.5587,1.3003,1.8532,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2000,1.1457,0.9342,1.3908,2000-2016,1.9742,0.9095,3.0502,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2001,1.4268,1.1894,1.6976,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2002,1.2874,1.0619,1.5466,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2003,1.036,0.834,1.2719,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2004,1.2482,1.0257,1.5046,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2005,1.3204,1.088,1.5876,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2006,1.3038,1.0734,1.5688,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2007,1.3362,1.1021,1.6051,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2008,1.3579,1.121,1.6298,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2009,1.213,0.989,1.4723,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2010,1.5263,1.2734,1.8147,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2011,1.13,0.9131,1.3826,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2012,1.495,1.2435,1.7823,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2013,1.625,1.3615,1.9243,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2014,1.6069,1.3435,1.9065,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2015,1.6847,1.4135,1.9925,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages <15,Delay-adjusted Rates,2016,1.6155,1.3477,1.9203,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2000,5.3544,4.9934,5.7347,2000-2006,-1.5297,-2.4848,-0.5652,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2001,5.3202,4.959,5.7007,2006-2009,2.698,-3.2539,9.016,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2002,5.263,4.9012,5.6443,2009-2012,-3.6948,-9.3228,2.2826,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2003,5.1762,4.8153,5.5569,2012-2016,0.3786,-1.5524,2.3474,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2004,4.9441,4.5888,5.3195,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2005,5.1577,4.7899,5.5461,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2006,4.9215,4.5646,5.2986,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2007,4.886,4.5302,5.2621,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2008,5.2147,4.8446,5.6053,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2009,5.3386,4.9631,5.7345,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2010,5.0875,4.7198,5.4758,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2011,5.0621,4.6937,5.4511,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2012,4.688,4.3341,5.0626,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2013,4.7613,4.4056,5.1377,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2014,4.8209,4.4639,5.1983,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2015,4.7566,4.4037,5.1299,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Observed Rates,2016,4.8525,4.4975,5.2276,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2000,5.3544,4.9934,5.7347,2000-2006,-1.5401,-2.5214,-0.549,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2001,5.3202,4.959,5.7007,2006-2009,2.8698,-3.2516,9.3785,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2002,5.263,4.9012,5.6443,2009-2012,-3.5351,-9.3234,2.6226,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2003,5.1762,4.8153,5.5569,2012-2016,0.9475,-1.0475,2.9827,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2004,4.9441,4.5888,5.3195,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2005,5.1577,4.7899,5.5461,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2006,4.9215,4.5646,5.2986,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2007,4.886,4.5302,5.2621,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2008,5.2262,4.8553,5.6177,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2009,5.3627,4.9856,5.7604,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2010,5.122,4.7518,5.5129,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2011,5.1103,4.7385,5.5031,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2012,4.7429,4.3849,5.1219,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2013,4.8271,4.4665,5.2086,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2014,4.9082,4.5448,5.2923,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2015,4.8669,4.5058,5.2488,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 15-39,Delay-adjusted Rates,2016,5.0326,4.6645,5.4215,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2000,28.0917,27.1652,29.0417,2000-2007,0.2918,-0.5192,1.1095,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2001,27.1894,26.2897,28.112,2007-2016,-1.4563,-1.9844,-0.9253,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2002,27.903,27.0052,28.823,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2003,27.7378,26.855,28.6423,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2004,28.2556,27.3746,29.1578,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2005,28.0012,27.1256,28.898,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2006,28.1819,27.3188,29.0655,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2007,28.5604,27.7,29.4409,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2008,27.8906,27.0462,28.7549,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2009,27.2816,26.4518,28.1311,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2010,26.8795,26.0617,27.7167,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2011,25.6432,24.8511,26.4546,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2012,26.6701,25.8613,27.4982,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2013,25.7076,24.9146,26.5199,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2014,26.2975,25.4939,27.1205,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2015,25.5202,24.7272,26.3326,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Observed Rates,2016,24.0821,23.3121,24.8716,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2000,28.0917,27.1652,29.0417,2000-2007,0.2514,-0.504,1.0124,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2001,27.1894,26.2897,28.112,2007-2016,-1.0968,-1.5905,-0.6006,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2002,27.903,27.0052,28.823,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2003,27.7378,26.855,28.6423,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2004,28.2556,27.3746,29.1578,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2005,28.0012,27.1256,28.898,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2006,28.1819,27.3188,29.0655,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2007,28.5604,27.7,29.4409,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2008,27.9643,27.1177,28.8309,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2009,27.4251,26.5909,28.2789,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2010,27.0884,26.2643,27.932,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2011,25.9138,25.1134,26.7335,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2012,27.0258,26.2063,27.8647,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2013,26.1128,25.3075,26.9376,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2014,26.8297,26.0101,27.669,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2015,26.1918,25.3782,27.025,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 40-64,Delay-adjusted Rates,2016,25.0904,24.2886,25.9124,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2000,86.8209,83.174,90.5865,2000-2007,1.5673,0.5959,2.548,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2001,89.5877,85.8759,93.4185,2007-2016,-0.7666,-1.3489,-0.1808,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2002,89.3319,85.6186,93.1647,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2003,87.3143,83.6423,91.1058,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2004,89.412,85.6962,93.2472,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2005,93.5538,89.7197,97.5094,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2006,95.4125,91.5877,99.3556,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2007,97.5228,93.7005,101.4609,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2008,93.6338,89.9437,97.4358,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2009,94.2687,90.6276,98.0182,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2010,94.6908,91.0911,98.3958,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2011,92.4137,88.9105,96.0191,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2012,94.5621,91.1151,98.1054,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2013,92.607,89.295,96.01,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2014,92.3284,89.0867,95.6574,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2015,92.1921,89.0167,95.4513,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Observed Rates,2016,86.1975,83.1733,89.3031,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2000,86.8209,83.174,90.5865,2000-2007,1.5135,0.6613,2.3729,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2001,89.5877,85.8759,93.4185,2007-2016,-0.3884,-0.9014,0.1272,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2002,89.3319,85.6186,93.1647,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2003,87.3143,83.6423,91.1058,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2004,89.412,85.6962,93.2472,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2005,93.5538,89.7197,97.5094,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2006,95.4125,91.5877,99.3556,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2007,97.5228,93.7005,101.4609,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2008,93.8741,90.1746,97.6859,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2009,94.7517,91.0919,98.5202,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2010,95.4065,91.7796,99.1393,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2011,93.3691,89.8297,97.0115,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2012,95.7765,92.2852,99.3649,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2013,94.0381,90.6749,97.4933,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2014,94.1895,90.8823,97.5852,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2015,94.6588,91.3982,98.0047,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 65-74,Delay-adjusted Rates,2016,89.9001,86.7458,93.138,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2000,129.4906,124.3903,134.7477,2000-2004,3.3675,2.0305,4.722,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2001,133.5345,128.3928,138.8303,2004-2014,0.5635,0.2235,0.9047,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2002,136.5697,131.4197,141.8704,2014-2016,-4.1271,-7.4887,-0.6434,Trend is Falling,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2003,142.4541,137.2547,147.8009,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2004,147.056,141.8091,152.448,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2005,147.7881,142.5266,153.1944,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2006,147.2088,142.0517,152.5055,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2007,151.418,146.2145,156.7593,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2008,153.3773,148.1696,158.7212,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2009,153.4883,148.2939,158.8178,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2010,151.5984,146.4724,156.8577,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2011,152.1137,147.0136,157.3452,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2012,151.3504,146.2972,156.5333,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2013,151.6462,146.6237,156.7964,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2014,158.0886,153.003,163.2998,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2015,152.4563,147.5051,157.5309,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Observed Rates,2016,141.632,136.9022,146.4832,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2000,129.4906,124.3903,134.7477,2000-2004,3.2623,2.0267,4.5129,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2001,133.5345,128.3928,138.8303,2004-2014,0.7599,0.4449,1.076,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2002,136.5697,131.4197,141.8704,2014-2016,-2.9349,-6.0865,0.3224,Stable,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2003,142.4541,137.2547,147.8009,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2004,147.056,141.8091,152.448,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2005,147.7881,142.5266,153.1944,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2006,147.2088,142.0517,152.5055,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2007,151.418,146.2145,156.7593,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2008,153.7694,148.5484,159.1269,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2009,154.2657,149.045,159.6221,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2010,152.7612,147.5958,158.0605,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2011,153.6804,148.5278,158.9653,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2012,153.3095,148.1908,158.5589,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2013,153.9849,148.8848,159.2138,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2014,161.2867,156.098,166.6026,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2015,156.5686,151.4835,161.7793,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages 75+,Delay-adjusted Rates,2016,147.7692,142.8339,152.8294,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2000,1.5007,1.2877,1.7387,2000-2016,1.2388,0.5204,1.9623,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2001,1.6041,1.3841,1.8491,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2002,1.691,1.4647,1.9423,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2003,1.4061,1.2003,1.637,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2004,1.5084,1.2954,1.7464,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2005,1.5885,1.3677,1.8349,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2006,1.5604,1.3429,1.8033,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2007,1.6693,1.4441,1.9198,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2008,1.5529,1.3353,1.796,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2009,1.591,1.3709,1.8366,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2010,1.7567,1.5237,2.0153,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2011,1.4275,1.2179,1.6629,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2012,1.7305,1.4977,1.9892,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2013,1.7827,1.5453,2.0463,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2014,1.9175,1.6702,2.191,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2015,1.8693,1.6244,2.1407,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Observed Rates,2016,1.814,1.5724,2.0823,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2000,1.5007,1.2877,1.7387,2000-2016,1.4175,0.6823,2.1582,Trend is Rising,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2001,1.6041,1.3841,1.8491,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2002,1.691,1.4647,1.9423,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2003,1.4061,1.2003,1.637,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2004,1.5084,1.2954,1.7464,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2005,1.5885,1.3677,1.8349,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2006,1.5604,1.3429,1.8033,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2007,1.6693,1.4441,1.9198,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2008,1.5564,1.3382,1.7999,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2009,1.5983,1.3772,1.8449,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2010,1.769,1.5344,2.0294,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2011,1.4415,1.2298,1.6791,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2012,1.7503,1.5149,2.0119,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2013,1.8055,1.565,2.0724,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2014,1.9519,1.7002,2.2302,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2015,1.9107,1.6603,2.1879,,,,,,Non-Hodgkin Lymphoma
Male,White (includes Hispanic),Ages < 20,Delay-adjusted Rates,2016,1.8813,1.6307,2.1592,,,,,,Non-Hodgkin Lymphoma
